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ABSTRACT 
 Pathogenic Salmonella strains are responsible for millions of human and livestock 
infections each year. The mechanisms of Salmonella pathogenesis are of great interest, 
along with the capacity of strains to survive in the environment and complete the 
transmission cycle. This survival is predicted to be related to a specific physiology called 
a biofilm. Biofilms are communities of cells within a self-produced extracellular matrix 
that are often associated with a physical surface. For Salmonella, the biofilm phenotype is 
activated by the transcriptional regulator CsgD and is associated with the production of 
an extracellular matrix consisting of protein polymers and exopolysaccharides. 
Salmonella biofilm formation is induced during growth at low temperatures and in 
conditions of nutrient limitation and low osmolarity. The biofilm phenotype is highly 
conserved across nontyphoidal Salmonella strains that briefly colonize the host and cause 
gastroenteritis. It is hypothesized that biofilm formation is important for increasing the 
transmission success of nontyphoidal Salmonella by enhancing their persistence in non-
host environments. 
 Salmonella biofilms have traditionally been studied as a population-level 
phenotype associated with colony formation, known as the red, dry, and rough (rdar) 
morphotype. However, Salmonella grown in liquid broth cultures under biofilm-inducing 
conditions form clonal subpopulations of multicellular aggregates and planktonic cells. 
This phenomenon is attributed to bistable expression of CsgD, where aggregated cells 
exist in a CsgD-ON state and planktonic cells are associated with a CsgD-OFF state. We 
performed comparative transcriptomic sequencing (RNA-seq), which revealed 1856 
genes that were differentially expressed between these two S. Typhimurium cell 
subpopulations. Multicellular aggregates were associated with increased gene expression 
typical of Salmonella biofilm formation, including nutrient scavenging, reactive oxygen 
species defenses, and osmoprotection. In contrast, planktonic cells were associated with 
higher expression of multiple virulence pathways associated with the SPI-1 and SPI-2 
type three secretion systems, cell motility, and chemotaxis. Increased synthesis of the 
SPI-1 type three secretion system in planktonic cells correlated with enhanced invasion of 
polarized Caco-2 human intestinal cells.  
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 We modified an existing Tn7-based transposition system to generate 
chromosomally marked strains of Salmonella to facilitate tracking of multicellular 
aggregates and planktonic cells in competitive fitness assays. Planktonic cells were 
associated with increased virulence in mice compared to multicellular aggregates. 
However, when these same cell subpopulations were exposed to desiccation, 
multicellular aggregates were associated with greater cell survival and the virulence 
advantage of planktonic cells was lost. We hypothesize that bistable CsgD expression and 
the generation of specialized cell types may represent a form of bet hedging, where 
planktonic cells are adapted for direct host-to-host transmission, and multicellular 
aggregates can survive long-term in the environment to cause infections later. This 
strategy would prepare nontyphoidal Salmonella for the unpredictable nature of the fecal-
oral transmission process and improve their potential to cause future infections.  
 Salmonella serovars that cause systemic disease within a restricted range of hosts 
have been shown to be biofilm-negative. In sub-Saharan Africa, a phylogenetically 
distinct group of nontyphoidal Salmonella has recently been identified for its role in an 
emerging epidemic of invasive extraintestinal infections. These invasive nontyphoidal 
Salmonella are associated with chronic persistence within the human host and do not 
have an identified environmental reservoir. We compared the biofilm phenotype of two 
invasive nontyphoidal Salmonella strains (S. Typhimurium D23580 and S. Enteritidis 
D7795) to a panel of strains consisting of ‘typical’ gastroenteritis-causing, nontyphoidal 
Salmonella and Salmonella strains that cause systemic typhoid fever. Both strains of 
invasive nontyphoidal Salmonella demonstrated an impaired biofilm phenotype, which 
we attributed to strain-specific genetic polymorphisms. We predict that the impaired 
biofilm phenotype of invasive nontyphoidal Salmonella correlates with their occupation 
of the systemic niche within the host and a reduced capacity to survive in the 
environment.  
 My research has brought insight into how pathogenic Salmonella strains are able 
to navigate through unpredictable areas of their lifecycle and increased our understanding 
of their potential transmission mechanisms. 
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1.0 LITERATURE REVIEW 
1.1 Salmonella 
1.1.1 Classification 
1.1.1.2 Taxonomy and Nomenclature 
Salmonella is named after Dr. David E. Salmon, who first isolated the bacterium from 
porcine intestine in 1884 (1). Salmonellae are gram-negative, motile, facultative 
anaerobic rods that measure 0.7-1.5 µm in width by 2.0-5.0 µm in length (2). Salmonella 
is a genus belonging to the kingdom Eubacteria, class Gammaproteobacteria, order 
Enterobacteriales, and family Enterobacteriaceae (Fig. 1.1). The genus is further 
subdivided into species, subspecies, serovars, and strains based on a mixture of 
taxonomic and serological classifications. A newly identified strain of Salmonella is 
categorized into species and subspecies according to deoxyribonucleic acid (DNA) 
relatedness at the genomic level, originally shown through DNA-DNA hybridization, and 
the presence or absence of 11 biochemical traits (3, 4). Two species have been defined, 
Salmonella bongori and Salmonella enterica, of which Salmonella enterica is further 
split into six subspecies that are designated by a Roman numeral and name (I, enterica; 
II, salamae; IIIa, arizonae, IIIb, diarizonae, IV, houtenae; and VI, indica) (5). 
Serological characterization, originally established by Kauffman and White, was 
historically used to classify newly isolated Salmonella strains and continues to be used in 
addition to traditional taxonomic classification (6). Salmonella isolates are assigned to a 
serovar based on the presented combination of flagellar antigens (H1 and H2) and 
(lipopolysaccharide) oligosaccharide (O) or capsular polysaccharide (K) antigen (7). 
Using this system, more than 2600 serovars have been identified, with their given name 
reflecting their combination of antigens, or in the case of serovars in subspecies enterica, 
a name representing their associated disease, host specificity, geographic origin, or 
relationship to other identified serovars (1, 7, 8). Salmonella enterica subspecies enterica 
is the most well-represented amongst serovars and disease, accounting for approximately 
60% of all serovars identified and greater than 95% of Salmonella isolates obtained from 
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humans and domestic mammals (9, 10). In contrast, Salmonella isolates belonging to the 
remaining species and subspecies are normally obtained from cold-blooded hosts, but are 
sometimes able to cause infections in humans (11). 
 In presenting a Salmonella enterica strain, the genus, species, and subspecies 
names are provided, followed by “serovar” and the serovar name, which is capitalized 
and non-italicized (7). For all subsequent mentions, the name is shortened and only the 
genus and serovar name are given (e.g., Salmonella ser. Typhimurium or S. Typhimurium 
in place of Salmonella enterica subspecies enterica serovar Typhimurium) (1, 7). For the 
purposes of my thesis, I will only be talking about isolates of S. enterica subspecies 
enterica and will refer to them by their common serovar names. 
1.1.1.2 Classification by Disease and Host Range 
 Aside from taxonomic convention, Salmonella isolates are often described based 
on their associated disease or for their associated range of susceptible hosts. Serovars 
associated with disease in humans are divided into nontyphoidal Salmonellae (NTS), 
which classically induce a self-limited gastroenteritis, or typhoidal Salmonellae, the 
causative agents of enteric fever (Fig. 1.1). However, recent increases in the global cases 
of nontyphoidal Salmonella associated with and invasive, systemic disease has resulted in 
an addendum to this reference system. Strains of nontyphoidal Salmonella associated 
with invasive disease are as such referred to as invasive nontyphoidal Salmonellae, or 
iNTS. Serovars may also be described in the literature according to their host range. In 
this system, a Salmonella serovar may be classified as host-generalist, host-adapted, or 
host-restricted (12). Host generalist Salmonella serovars, such as S. Typhimurium and S. 
Enteritidis, are able to colonize multiple host species (12). In contrast, host-adapted and 
host-restricted serovars are associated with an invasive extra-intestinal disease in the host. 
Host-adapted species, including S. Choleraesuis and S. Dublin, have narrowed their host 
range to preferentially infect a particular host (in these examples, swine or cattle), but 
retain the capacity to cause infections in other hosts (12). In contrast, host-restricted 
serovars, such as S. Typhi or S. Paratyphi in humans or S. Gallinarum in fowl, produce a 
systemic disease in only one species (12). As the majority of Salmonella research is 
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Figure 1.1. Salmonella taxonomy and general classifications. 
The genus Salmonella is classified into species, subspecies, and serovars based on the 
White-Kauffman-Le Minor scheme. Serovars are often grouped into nontyphoidal or 
typhoidal categories; however, this referencing approach is not a part of the official 
Salmonella classification scheme. 
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focused on disease, pathogenesis, and epidemiology affecting humans, I will refer to 
typhoidal and nontyphoidal Salmonella classifications. 
1.1.2 Nontyphoidal, typhoidal, and invasive nontyphoidal Salmonella 
1.1.2.1 Epidemiology 
 Nontyphoidal Salmonella serovars are responsible for the majority of global cases 
of human salmonellosis. It is estimated that nontyphoidal Salmonella account for 
approximately 153 million annual cases of gastroenteritis, with 57 000 deaths (13). 
Nontyphoidal Salmonella infections are associated with the ingestion of contaminated 
food or water, but can also be transmitted directly between people or from zoonotic 
sources, such as domestic or food animals, through the fecal-oral route (10). Outbreaks of 
nontyphoidal Salmonella have traditionally been associated with a wide range of food 
products, including animal-based (meat, poultry, eggs), plant-based (tomatoes, sprouts, 
melons, lettuce, mangoes, raw almonds) and processed foods (powdered infant formula, 
dry seasonings, cereals, peanut butter) (10). S. Enteritidis and S. Typhimurium are the 
serovars most frequently associated with nontyphoidal Salmonella infections (14, 15). On 
a global scale, S. Enteritidis was responsible for 65% of all human infections, followed 
by S. Typhimurium with 12% and S. Newport with 4% (14). For North America, 
nontyphoidal Salmonella illnesses are more frequently caused by S. Typhimurium (29% 
of all human infections) than by S. Enteritidis (21%) (14).  
 Typhoidal Salmonella infections are estimated to cause approximately 21 million 
illnesses and 145 000 deaths worldwide (13). Typhoidal Salmonella infections are 
unequally distributed between high-income and low-income nations. In the United States 
and some European countries, the annual rate of typhoidal Salmonella infections is less 
than 10 infections per 100 000 population (20). However, many Asian countries (China, 
Indonesia, and Vietnam) have greater than 100 cases per 100 000 population, with 
Pakistan and India have a disproportionately high incidence of typhoidal infection (451.7 
and 214.2 cases per 100 000, respectively) (21). Typhoidal Salmonella serovars are 
transmitted primarily from person to person through food and water contaminated with 
human feces; as such, infections are more frequent in low-income countries that lack 
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available safe water resources and have poor sanitation standards (17). Cases of typhoidal 
infections in high-income countries are usually the result of patients travelling to endemic 
areas, but can also be spread by individuals that are chronically infected with S. Typhi 
(17). 
 The number of incidences of nontyphoidal Salmonella infections associated with 
an invasive disease has increased dramatically in recent years, resulting in an estimated 
3.4 million illnesses and 681 000 deaths annually (16). The continent of Africa accounted 
for almost 2 million cases of iNTS infections alone in 2010, representing more than half 
of the total number of global cases of this disease (16). Nontyphoidal Salmonella strains 
associated with an invasive disease are speculated to have a greater dependency on direct 
transmission from person to person (16). Immunosuppression is an important host factor 
associated with the spread of iNTS disease. These infections occur predominately in 
children between 6 and 18 months of age and in adults between 25 and 40 years old (17). 
For children, the predominant host risk factors for iNTS disease are human 
immunodeficiency virus (HIV) infection, malnutrition, and malaria, while advanced HIV 
infection is the main risk factor for adults (18). Further, cases of iNTS disease in children 
and adults are strongly correlated with the rainy season in sub-Saharan Africa, which 
could be the result of waterborne transmission, malaria, or malnutrition during this season 
(17, 19). Community-acquired iNTS infections in Africa are most frequently associated 
with S. Typhimurium, accounting for 65.2% of all iNTS infections, or S. Enteritidis, 
accounting for 33.1%, (15). 
1.1.2.2 Disease Symptoms in Humans 
 Nontyphoidal Salmonella infections in immunocompetent individuals normally 
result in a severe, self-limiting gastroenteritis (22-24). The characteristic symptoms last 
for 4 to 7 days and include profuse amounts of non-bloody diarrhea, as well as nausea, 
vomiting, and abdominal cramps (18, 23, 24). Symptoms are preceded by an incubation 
period that averages 6 to 12 hours, but can be up to 72 hours post-infection (22-24). 
Continued shedding of Salmonella in the feces occurs long after symptoms have cleared; 
with a median shedding time of 1 month post-symptoms for adults, or 7 weeks for 
children under the age of 5 years (22). Antibiotic use is normally discouraged during such 
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infections in immunocompetent patients, as some studies have demonstrated increased 
duration of asymptomatic shedding of the pathogen following treatment (22, 23). In most 
nontyphoidal Salmonella infections, the pathogen is spatially limited to the 
gastrointestinal tract (24). However a secondary bacteremia can arise in approximately 
5% of cases, where the pathogen has disseminated past the lamina propria and invaded 
further into the body (22-24). In such cases, treatment with bactericidal antibiotics is 
recommended (third generation cephalosporin or intravenous fluoroquinolone) and 
results in clearance of the pathogen after 7 to 14 days of therapy (23). 
 Typhoidal Salmonella infections in humans are caused by S. Typhi and S. 
Paratyphi and are associated with enteric fever. The incubation period preceding 
symptoms is longer for typhoidal Salmonella infections, averaging 1 to 2 weeks but 
extending for as long as 60 days is some cases (25). As the pathogen enters the 
bloodstream, patients present with the initial symptoms of headache, gradual fever, and 
lethargy (25). This fever can persist for up to 4 weeks if left untreated (23). Additional 
symptoms are infrequent in their presence between cases, but may include the appearance 
of “rose spots” with a 2 to 4 mm diameter on the abdomen and chest, bradycardia, 
enlargement of the spleen and liver, anorexia, vomiting, and a dry, coated tongue (25). In 
contrast to gastroenteritis caused by nontyphoidal Salmonella, these infections can result 
in constipation for immunocompetent adults, but diarrhea may occur in young children or 
in adults with HIV infection (25). Typhoidal Salmonella infections are usually 
successfully treated with 5 to 7 days of antimicrobial treatment with fluoroquinolones 
such as ciprofloxacin (23). However, the rise of typhoidal Salmonella strains resistant to 
quinolones in some parts of the world, such as Asia, necessitate the use of alternative 
drugs such as ceftriaxone, cefixime, or azithromycin (23).  Left untreated, 10 to 15% of 
cases result in complications that may involve gastrointestinal bleeding, intestinal 
perforation, and encephalopathy (25). In an additional 5 to 10% of cases, the patient will 
experience a relapse in infection 2 to 3 weeks following fever (25). The period of 
asymptomatic carriage during this complication of typhoidal Salmonella infection is 
generally longer than that for nontyphoidal Salmonella, with 10% of patients shedding 
the pathogen for 3 months, and 1 to 4% of patients shedding for greater than 1 year (25). 
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 Invasive nontyphoidal Salmonella strains cause a typhoid-like illness and are 
often associated with immunocompromised individuals (17, 18). These infections are 
mainly characterized by a primary bacteremia, and symptoms of diarrhea are observed in 
only 20 to 50% of cases (18). Patients frequently present with respiratory symptoms (i.e., 
an increased respiratory rate and chest crackles) which are often due to co-infection with 
other pathogens, such as Mycobacterium tuberculosis or Streptococcus pneumoniae (17, 
18). Additional symptoms, such as hepatomegaly and splenomegaly, are less frequently 
observed (18); however, splenomegaly was reported as a useful indicator of iNTS disease 
in adults with HIV infection (26). Invasive nontyphoidal Salmonella infections can 
further develop into bacterial meningitis, which is associated with a high case fatality in 
both children (52%) and adults (80%) (18). Further, approximately 20 to 30% of HIV-
infected adults that have received treatment for iNTS disease will experience a relapse in 
infection due to an identical Salmonella strain between 4 and 6 months after the primary 
illness, suggesting that the pathogen may persist within the patient (17). The most 
striking feature of iNTS disease is its high case fatality despite correct microbiological 
diagnosis and treatment – in Africa, up to 22% of children and 47% of adults succumb to 
the infection despite appropriate intervention (27). To further complicate efficacious 
treatment, some iNTS strains are associated with multidrug resistance, namely ampicillin, 
chloramphenicol, and co-trimoxazole, resulting in the need to use expensive 
antimicrobial treatments such as third-generation cephalosporins and fluoroquinolones 
(18). For HIV-infected individuals, initiation of antiretroviral therapy has been reported 
as effective in preventing relapse in iNTS infections (18). 
1.1.2.3 Pathogenesis of Disease 
 Central to Salmonella pathogenesis is its ability to modify host cell biology via 
two type-three secretion systems (T3SS), T3SS-1 and T3SS-2 (28). These specialized 
organelles span the bacterial inner and outer membranes and allow for the delivery of 
effector proteins into the cytoplasm of eukaryotic cells (29, 30). Type three secretion 
systems are found exclusively in gram-negative bacteria (28, 31). For Salmonella, genes 
for the T3SS-1 or T3SS-2 apparatus, regulatory components, and nearly all associated 
effector proteins are found within horizontally acquired DNA regions known as 
 8 
Salmonella Pathogenicity Islands (SPIs) (30). The SPI-1 region contains genes associated 
with T3SS-1, is found in all serovars of S. enterica and S. bongori, and is important for 
the invasion of intestinal epithelial cells (32, 33). In contrast, the full-length SPI-2 region 
harbouring genes for T3SS-2 is present exclusively in S. enterica, and is associated with 
the intracellular survival of Salmonella within eukaryotic cells (33). 
 Following Salmonella entry into the host via contaminated food or water, cells 
travel through the digestive system and localize to the distal ileum and colon of the 
gastrointestinal tract (34). Salmonella cells rely on flagellar motility and chemotaxis 
systems to traverse the intestinal mucus layer and identify sites on the host cell that are 
permissive for invasion (35). Fimbriae and other protein adhesins on the bacterial cell 
surface initiate association of the pathogen to the targeted epithelial cell; however, the 
needle complex of the SPI-1 T3SS is critical for stabilizing this interaction (36, 37). It is 
currently hypothesized that expression and synthesis of the SPI-1 T3SS is induced by 
several important cues provided by the local host environment, including low oxygen 
tension, high osmolarity, near-neutral pH, and acetate production levels from the resident 
microflora (38). The secretion apparatus is established in a step-wise manner, requiring 
formation of the basal body within the bacterial cell membranes to facilitate secretion of 
the needle complex (39). Proteins attached to the end of the SPI-1 T3SS needle, 
collectively referred to as the translocon, are then inserted into the host cell membrane, 
creating a pore that allows for the injection of Salmonella effector proteins into the host 
cell (36).  
 Establishment of a secretion-competent SPI-1 T3SS is a mandatory prerequisite 
for the process of host cell invasion (39). Of the repertoire of 11 effector proteins known 
to be secreted by the SPI-1 T3SS, early translocation of the proteins SopE, SopE2, SopB, 
and SipA is essential to promoting bacterial-mediated endocytosis (reviewed in (40)). 
SopE, SopE2, and SopB act in a functionally redundant manner by inducing the host 
cell’s Rho GTPases, which activate the signaling transduction pathway that leads to actin 
cytoskeleton rearrangement. The unique functional activities of the effector protein SipA 
and the translocon protein SipC coordinate the localization of this cytoskeleton 
rearrangement to the site of interaction between the bacterial and host cell surfaces, 
resulting in dramatic actin filament accumulation and host cell membrane ruffling. 
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Salmonella cells are then internalized into the host within endosomes termed Salmonella-
containing vacuoles (SCVs), a process facilitated by SopB and an additional effector 
protein, SopD. Following bacterial uptake, the host cell cytoskeleton is then returned to a 
state of homeostasis through deactivation of the Rho GTPases by another T3SS effector, 
SptP. 
 Following the invasion process, Salmonella depend on the SPI-2 T3SS and 
associated effectors to further manipulate the host cell environment and promote 
pathogen survival and replication within the SCV. Expression and activation of the SPI-2 
T3SS is induced by changes in the SCV environment, including vacuolar acidification 
(pH 5 to 5.5), decreased concentrations of divalent cations and phosphates, and the 
presence of antimicrobial peptides (41). Many of the effector proteins secreted by the 
SPI-2 T3SS contribute important functions for manipulating the movement of the SCV 
along host cell microtubules. For example, the effector proteins SopB and SsaB prevent 
bacterial killing by inhibiting SCV trafficking and fusion to lysosomes (42). A series of 
additional effector proteins (SifA, SseF, SseG, and PipB2) are responsible for the 
redirection of the SCV towards the Golgi apparatus, which may be an important location 
for the acquisition of nutrients and cell components from other host cell vesicles (30, 40). 
Following this localization near the Golgi apparatus, two effector-mediated processes are 
activated during Salmonella cell replication in the SCV. To maintain the membrane 
integrity of the SCV during this cell replication, interactions between the effectors SspH2 
and SseI and host proteins filamin and profilin result in the polymerization of an actin 
meshwork that surrounds the vacuolar membrane (30, 40). Further, in vitro studies have 
shown that Salmonella replication coincides with the production of Salmonella-induced 
filaments that extend from the SCV. Several SPI-2 T3SS effectors, including SifA, SseJ, 
and SopD2, are implemented in inducing the formation of these SIFs, which are 
hypothesized to provide a potential source of nutrients during pathogen replication (40). 
 Pathogen cells that traverse the epithelial cell layer encounter tissue mononuclear 
cells (i.e., macrophages and dendritic cells) within the lamina propria, resulting in the 
uptake of the pathogen into a phagosome (34). Detection of pathogen-associated 
molecular patterns (PAMPs) and components injected by the pathogen during its uptake 
into host cells elicits the production of a proinflammatory immune response (34). This 
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response inhibits the spread of nontyphoidal Salmonella past the lamina propria in three 
ways: by activating infected macrophages and inducing killing of intracellular 
Salmonella, through recruitment of neutrophils to the infection site for extracellular 
killing, and by stimulating epithelial cells to release antimicrobial peptides into the 
intestinal lumen to control the replication of nontyphoidal Salmonella cells (34). While 
host inflammation effectively controls those nontyphoidal Salmonella that have invaded 
the epithelial cell layer, it acts as a potent stimulator of growth of the nontyphoidal 
Salmonella population in the intestinal lumen (34). Recent studies have shown two 
mechanisms by which nontyphoidal Salmonella are able to exploit the host inflammatory 
response. Epithelial cells release the antimicrobial agent lipocalin-2, a molecule that 
binds to enterochelin, an iron chelation molecule used by gram-negative bacteria in the 
gut to acquire iron from the host (43). In addition to enterochelin, nontyphoidal 
Salmonella are able to produce a second iron chelation molecule, salmochelin, which 
cannot be bound by lipocalin-2 (43). As a result, nontyphoidal Salmonella cells in the 
intestinal lumen continue to replicate while the local microbiota are starved for iron. The 
low-oxygen conditions of the intestinal lumen promote the establishment of an anaerobic 
microbiota that use fermentation to derive energy from available amino acids and 
complex polysaccharide (34). Hydrogen sulfide is produced as a byproduct of this 
fermentation, which is immediately converted to thiosulfate by the epithelial cell layer of 
the colon (44). During inflammation, neutrophils infiltrate the intestinal lumen and 
release reactive oxygen species molecules as part of the mechanism for the extracellular 
killing of bacterial pathogens (45). The association of reactive oxygen species with 
thiosulfate molecules results in tetrathionate, which can be used by nontyphoidal 
Salmonella as an electron acceptor during anaerobic respiration (44). In addition to 
activating a metabolic response that promotes growth of the pathogen, anaerobic 
respiration further allows nontyphoidal Salmonella to utilize carbon sources that would 
otherwise metabolize poorly during aerobic fermentation (46). Altogether, nontyphoidal 
Salmonella can use these mechanisms to promote their own growth at the expense of the 
existing host microbiota. 
 Two features that distinguish enteric fever from gastroenteritis are the absence of 
inflammation and an innate immune response, and the replication of typhoidal 
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Salmonella in the systemic compartment of the host. These changes in pathogenesis are 
linked to genomic differences between typhoidal and nontyphoidal Salmonella. 
Approximately 200 functional genes in nontyphoidal Salmonella have been inactivated or 
functionally disrupted in S. Typhi and S. Paratyphi A (47). Many of these mutations in S. 
Typhi affect processes used by nontyphoidal Salmonella to induce intestinal 
inflammation, including motility and chemotaxis, adherence to and invasion of host cells, 
and loss of virulence factors associated with intracellular replication (47). The loss of 
these functions suggest that S. Typhi may gain access to the systemic compartment 
through a mechanism distinct from active invasion of intestinal epithelial cells. Although 
this mechanism remains elusive, it is hypothesized that microfold (M) cells that sample 
the intestinal lumen actively take in S. Typhi cells and transfer them to macrophages and 
dendritic cells within the gut-associated lymphoid tissue (GALT) of the Peyer’s patches, 
located in the small intestine (48). Typhoidal Salmonella are unique/distinct from 
nontyphoidal serovars in that they are able to persist in this intracellular niche without 
activating the immune response and infiltration of neutrophils that would otherwise 
restrict typhoidal infections (49). Within these immune cells, typhoidal Salmonella are 
shuttled to other sites in the body associated with the mononuclear phagocyte system 
(previously known as the reticuloendothelial system), taking residence in such places as 
the liver, spleen, mesenteric lymph nodes, bone marrow, as well as the gall bladder (50, 
51). Typhoidal Salmonella are thought to transfer back into the duodenum via the biliary 
tract, resulting in shedding of typhoidal cells in the feces and potential transmission to a 
new host (50).  
 The lack of inflammation associated with typhoidal Salmonella infections 
suggests important differences in the pathogen’s surface antigens or its interactions with 
host cells. For example, the potential down-regulation in S. Typhi flagellar expression 
reduces the presence of this PAMP and results in decreased inflammation (52). Other 
gene mutations identified in S. Typhi include regulatory elements affecting the O-antigen 
structure, which may limit exposure of this important PAMP to immune cells (53). 
Further, the typhoidal Salmonella genome has approximately 300 to 400 unique genes 
that are absent in nontyphoidal Salmonella. Of these additional accessory genes, the Vi 
capsule plays an important role in reducing the host inflammatory response to the 
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presence of S. Typhi cells. Production of the Vi capsule limits complement deposition on 
the surface of S. Typhi cells, masks surface antigens that would normally activate the host 
immune response, and provides resistance to phagocytic killing (48, 50, 54). Further, the 
Vi capsule has also been demonstrated to induce increases in production of the cytokine 
interleukin 10 (IL-10), an important anti-inflammatory molecule (55). Vi-negative 
mutants of S. Typhi were unable to cause enteric fever in human infection trials (56). 
However, the Vi capsule cannot solely account for differences between typhoidal and 
nontyphoidal Salmonella infections, as this capsule is not expressed by other typhoidal 
serovars (i.e., S. Paratyphi A and S. Sendai) (49). Therefore, it is likely that serovar-
specific combinations of gene acquisition and gene loss is responsible for the ability of 
typhoidal Salmonella strains to evade the host immune response. 
1.1.2.4 Pathogen Transmission 
 Microorganisms are under evolutionary pressure to define a niche that allows for 
their continued survival and replication. For pathogens, addressing this requirement 
means finding a balance between optimizing their fitness within a given host and 
maximizing their potential for transmission to new hosts (57). The diversity of available 
hosts species presents an opportunity for pathogens to exploit new, additional niches for 
their own replication (58). Pathogens that successfully adopt new niches and broaden 
their host range are known as host generalists (59). However, pathogens that overcome 
the barriers to infecting a new host species face attempts by the host to constrain their 
ability to survive and reproduce (60, 61). Host pressures can drive genetic changes within 
the pathogen, some of which may permit the pathogen to replicate in the new niche at the 
cost of impacting its fitness in other host species (58, 59). These host-restricted pathogens 
face the new challenge of ensuring their transmission success to a narrowed pool of 
susceptible hosts (58). 
 Host generalist pathogens transmit between several potential host species. An 
estimated 60% of human pathogens and 80% of pathogens infecting domestic animals are 
zoonotic in nature (62, 63). Nontyphoidal Salmonella species represent host generalist 
pathogens that have adopted niches in mammals, birds, and reptiles (58). In contrast, 
some typhoidal Salmonella species demonstrate host restriction, establishing long-term 
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relationships in humans (S. Typhi and S. Paratyphi serovars) or chickens (S. Gallinarum, 
S. Pullorum) (12, 64). Other typhoidal Salmonella are host adapted, having specific 
preference for replication in certain species (S. Dublin and cattle, S. Choleraesuis and 
pigs) while still retaining the ability to infect humans (12). Despite this change in host 
range, nontyphoidal and typhoidal Salmonella serovars maintain a genetic relatedness at 
the species level (49). Therefore, Salmonella pathogens present an opportunity to study 
the biological factors that are important to different modes of transmission (58). 
 Typhoidal Salmonella depend upon establishing chronic persistence within their 
current host to increase the opportunities for subsequent transmission events. Between 5 
and 10% of patients recovering from enteric fever experience a relapse in infection with 
the same typhoidal Salmonella strain, resulting in milder symptoms than before and fecal 
shedding of the pathogen for 3 weeks to 3 months following the initial infection (25, 50). 
While the mechanism behind this short-term persistence in the host is unclear, it is 
hypothesized that typhoidal Salmonella remain dormant within immature immune cells in 
the bone marrow (48). In contrast, between 2 and 4% of people living in areas endemic 
for enteric fever are associated with a chronic carrier state that involves asymptomatic 
carriage of typhoidal Salmonella for more than a year (48). Epidemiological studies 
hoping to identify factors associated with the chronic carrier state are difficult due to the 
asymptomatic nature of infections in these hosts (50). However, recent evidence points to 
persistence of typhoidal Salmonella within the gall bladder. It is currently hypothesized 
that typhoidal Salmonella cells first localize to the liver and replicate in the resident 
macrophage (Kupffer) cells before traveling to the gall bladder via the biliary tract (50). 
Bile, a digestive secretion with detergent and antimicrobial properties, contributes to the 
sterility of the gall bladder. In a landmark study assessing the incidence of gall bladder 
disease in patients associated with acute or chronic infections with typhoidal Salmonella, 
the authors detected gallstones in nearly 90% of chronically-infected patients (65). 
Research by the John Gunn and his colleagues revealed the presence of typhoidal 
Salmonella cells associated with gallstones. Microscopic analysis of this interaction 
suggested that typhoidal Salmonella cells use fimbrial protein structures on their surface 
to attach to gallstones, while growth in the presence of bile stimulates the production of 
protective extracellular polysaccharides (66). It is currently hypothesized that short-term 
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human carriers are mainly responsible for the transmission of enteric fever in endemic 
areas, while long-term chronic carriers are responsible for resurgence of infections in 
endemic regions despite attempts to control such infections (50). 
 Nearly all nontyphoidal Salmonella serovars associated with human disease 
demonstrate the ability to colonize multiple host species and induce gastroenteritis. This 
ability to infect a wide host range maximizes the potential for nontyphoidal Salmonella to 
directly transmit from one host to the next, via the fecal-oral route. However, a number of 
nontyphoidal Salmonella outbreaks in developed countries emphasize the importance of 
environmental reservoirs as an intermediary step for transmission of this pathogen. 
Several reported cases exemplify the ability of nontyphoidal Salmonella to persist in non-
host environments. Surface runoff of water contaminated with animal feces was 
suspected as the source of two separate 2008 cases of drinking water contamination 
affecting communities in the United States (67, 68). Similarly, a study analyzing 288 
cases of drinking water-related outbreaks in Canada between the years 1971 and 2001 
noted water treatment practices and nearby wildlife as the most frequently reported 
sources of contamination (69). Several reports of nontyphoidal Salmonella outbreaks 
associated with fresh produce have traced contamination to irrigation water or animal 
manure used to fertilize fields (70-72). Of particular interest are two separate outbreaks of 
nontyphoidal Salmonella infections in the United States in 2002 and 2005, both of which 
were linked to a rare strain of S. Newport in tomatoes (70). In both outbreaks, 
investigators were able to trace back the unique strain to a Virginian farm, where the 
strain had been isolated from a contaminated pond used to irrigate the fields (70). The 
identification of this same rare strain in pond water samples taken years apart indicates 
the added importance of Salmonella persistence in environmental reservoirs (70). A 
similar case of nontyphoidal S. Typhimurium persistence was observed for a Danish pig 
farm associated with recurring infections in its herd (73). Samples collected by Baloda 
and colleagues over a two-year period revealed the presence of the same Salmonella 
clone in the piggery, the feed provided to the animals, and in the pig manure used to 
fertilize agricultural soil (73). Farmland soil treated with manure yielded viable S. 
Typhimurium cells for 14 days following spread, providing further evidence for the 
survival of nontyphoidal Salmonella within the non-host environment. The authors 
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hypothesized that the persistence of Salmonella in this setting could result in a cycle of 
re-infection of the pig herd from environmental reservoirs, potentially explaining the 
long-term presence of nontyphoidal Salmonella at the farm. 
1.2 Salmonella Biofilms 
 Bacterial biofilms are communities of bacterial cells within a self-produced 
extracellular matrix that are often associated with a physical surface. For Salmonella, the 
biofilm phenotype is described as the rdar morphotype, named for the red, dry, and rough 
appearance of colonies grown on agar plates containing Congo Red dye (74, 75) (Fig. 
1.2a). Salmonella biofilms in liquid cultures have also been described as pellicles, which 
refers to a film of cell growth that appears at the air-liquid interface (75-77) (Fig. 1.2b). 
The structure of the extracellular matrix consistently includes the presence of protein 
polymers (curli fimbriae) and extracellular polysaccharides (cellulose and O-antigen 
capsule) (74, 75, 78, 79). For Salmonella, biofilm formation is induced by conditions of 
nutrient starvation, low osmolarity, and growth at temperatures below 30˚C (74, 75, 80). 
The resulting biofilm phenotype has been demonstrated to enhance the persistence of 
Salmonella cells exposed to conditions of nutrient stress, desiccation, and disinfection 
(76, 80-84). Salmonella cells within a biofilm are able to cause infection; however, the 
biofilm phenotype is not a virulence adaptation (85). Biofilm formation is hypothesized 
to enhance Salmonella survival in the non-host environment and improve its odds of 
transmission to a susceptible host (85). 
1.2.1 Structural and Regulatory Elements Responsible for Biofilm Formation  
 Curli fimbriae are protein polymers of repetitive subunits that are important for 
short-distance interactions between Salmonella cells within a biofilm (reviewed in (86)). 
The aggregative nature of cells expressing curli fimbriae was described in their original 
discovery within a strain of E. coli isolated from cattle manure (87). Similar fimbriae 
were later described in an enterotoxinogenic Salmonella Enteritidis strain isolated from a 
patient in India and given the name thin aggregative fimbriae to reflect their small 
structural diameter and aggregative nature (74). Collinson et al. demonstrated the unique 
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Figure 1.2. Examples of Salmonella biofilm formation. 
Salmonella biofilm formation has been characterized in the laboratory using several 
formats of growth. (A) Colonies on 1% tryptone agar form the red, dry, and rough 
morphotype associated with Salmonella biofilm formation. The red appearance of the 
colony is visible when the media is supplemented with Congo Red dye. (B) Pellicle 
formation at the air-liquid interface of a liquid culture (adapted from (126)). (C) 
Salmonella form multicellular aggregates and planktonic cells within the bulk liquid 
phase of a flask culture. 
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recalcitrant nature of this new fimbrial type through observations that the polymer could 
only be depolymerized by treatment with 90% formic acid, unlike other fimbriae that 
were soluble by other means of denaturation (74). Thin aggregative fimbriae in S. 
Enteritidis were originally considered distinct from curli fimbriae in E. coli due in part to 
differences in amino acid residues but mainly to their constitutive expression in S. 
Enteritidis at 37˚C and 28˚C (74). However, this analysis was based on a false 
identification of the curli subunit, where Olsen et al. had in fact identified Crl, a biofilm 
regulatory protein (named Crl for curli) (87). Upon identifying the genes responsible for 
the subunits of curli fimbriae, sequence homology revealed significant identity between 
the genes for thin aggregative fimbriae in Salmonella and were curli fimbriae in E. coli, 
hence the adoption of the gene symbol for curli synthesis genes (csg) in Salmonella (88-
90).  
  At the time of their discovery, curli fimbriae were unique/distinct from other 
identified pili or fimbriae in that their expression required not only low osmolarity, but 
also starvation due to extended growth periods and an ambient temperature of less than 
32˚C (87). These specific activating conditions suggested the potential for multiple 
regulatory inputs into expression of curli fimbriae. Using transposon mutagenesis. 
Hammar et al. identified the presence of two polycistronic csg operons responsible for 
curli biosynthesis in E. coli, including csgD, the main transcriptional regulator 
demonstrated as necessary for curli biosynthesis (91). The requirement for csgD 
expression for curli fimbriae biosynthesis was later confirmed in Salmonella (88, 89). 
Since then, multiple other transcriptional regulators have been identified that influence 
biofilm formation through regulation of csgD expression, as opposed to direct regulation 
of the genes responsible for biosynthesis of the biofilm extracellular matrix. The csgD 
promoter has significant sequence homology with other promoters activated by RpoD, 
the RNA polymerase sigma factor responsible for vegetative cell growth (75). However, 
limitation of csgD expression to stationary phase growth is likely the consequence the 
csgD promoter region being silenced by the histone-like nucleoid structural (H-NS) 
protein (92-94). Activation of csgD expression requires the presence of RpoS, the 
primary sigma factor during stationary phase growth and regulator of the general stress 
response. Crl, a DNA-binding transcriptional regulator, facilitates transcription of RpoS-
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dependent genes like csgD by facilitating efficient open complex formation specifically 
at lower temperatures (95). In addition, Gerstel et al. provided experiment evidence 
proving regulation of csgD expression by OmpR, the response regulator of the 
EnvZ/OmpR two-component signal transduction system, in response to changes in 
osmolarity (93). Using DNA footprinting assays, the authors revealed multiple binding 
sites for OmpR in the csg intergenic region. Under conditions of low osmolarity, low 
cellular concentrations of phosphorylated OmpR bind a high-affinity site directly 
upstream of the -35 region of the csgD promoter and promote expression of biofilm 
formation. In contrast, conditions of high osmolarity result in high intracellular 
concentrations of phosphorylated OmpR, which bind low-affinity sites further upstream 
of the csgD promoter and inhibit its expression. CpxAR, an additional two-component 
signal transduction system, has also been demonstrated to respond to changes in 
osmolarity. This system has been mainly associated with relaying envelope stress sensed 
by CpxA to the response regulator CpxR through transfer of a phosphate group. In E.coli, 
CpxR~P has been shown to bind the promoters for both csg operons, through its binding 
sites that either overlap the activating binding site for OmpR in the csgD promoter, or 
exist immediately downstream of the transcriptional start site for csgBAC (96). The 
environmental signals that were initially identified for the expression of curli fimbriae 
hinges on the involvement of these pivotal transcription factors that regulate csgD 
expression (87). 
 Several additional regulatory components have since been identified for their 
effects on csgD expression (reviewed in (97)). However, only a few of these factors 
directly interact with the intergenic region between the csg operons, in addition to those 
factors already described. Integration host factor (IHF) is a histone-like DNA-binding 
protein that induces DNA topology changes to either activate or repress the expression of 
the corresponding promoter region. A total of three IHF binding sites have been 
identified for the csg region; IHF1, which when bound by IHF activates csgD expression, 
IHF3, which exists within the csgD coding sequence and represses csgD transcription 
when bound by IHF, and IHF2, which does not affect csgD transcription when bound 
(93, 98). An additional transcriptional regulator, MlrA, is also hypothesized to induce 
DNA topology changes through its binding to a site near IHF1 (99). While no 
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information exists on factors that influence MlrA activity, a cosmid screen by Brown et 
al. identified this regulator for its specificity on promoting transcriptional activation of 
csgDEFG (100). In addition to this transcriptional regulation, csgD also contends with 
multiple small RNA molecules that inhibit its post-transcriptional expression. Through 
their interaction with Hfq, an RNA-binding protein, these sRNA target the 5’ untranslated 
region of csgD mRNA molecules and can activate or repress translation (101-105). While 
many of these sRNA molecules are expressed in response to the known environmental 
conditions that also activate transcription factors (i.e., increased cell envelope stress, high 
osmolarity, and carbon limitation), some sRNA molecules point to potentially novel 
biofilm regulation (e.g. GcvB, which is induced by the glycine cleavage system in 
response to high amino acid supply) (Reviewed (106, 107)). Based on their activating 
signals and regulatory impact, post-transcriptional modulation by sRNA molecules likely 
acts as a potent inhibitory cue in the regulation of CsgD synthesis, functioning as a novel 
and potent response that shuts down biofilm expression once cells sense the presence of 
an established extracellular matrix structure and a mature state of biofilm development. 
Altogether, the accumulation of multiple regulatory signals into csgD expression and 
synthesis provides strong evidence that CsgD is the main transcriptional regulator 
controlling the biosynthesis of extracellular matrix components and biofilm development 
in Salmonella. 
 Cellulose is recognized as the second major component of the biofilm 
extracellular matrix. This exopolysaccharide is fundamental in all lab-modeled formats of 
Salmonella biofilm formation (reviewed in (97)). Cellulose facilitates long-distance 
interactions between Salmonella cells and physical adherence of the biofilm to different 
surfaces (108). In E. coli and S. enterica, the cellulose biosynthesis machinery is encoded 
by two divergent operons, bcsEFG and bcsRQABZC (76, 79, 109) (110). BcsA and BcsB 
are the main catalytic subunits of the core enzyme complex for cellulose biosynthesis, 
while the remaining proteins enhance enzyme activity and product yield (110). Cellulose 
biosynthesis is regulated on both a transcriptional and post-transcriptional level. The bcs 
operons are expressed during biofilm formation, but the BcsAB enzyme complex exists 
in an autoinhibitory state. Allosteric binding of the PilZ domain of BcsA by the bacterial 
secondary messenger bis-(3’-5’)-cyclic dimeric guanosine monophosphate (c-di-GMP) 
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activates the enzyme complex, allowing the main substrate, UDP-glucose, to interact with 
the BcsA active site (110-112).  
 While c-di-GMP was originally described for its importance in cellulose 
biosynthesis (112), this secondary messenger molecule is now appreciated for its 
dynamic role in regulating multiple cell processes (reviewed in (113)). C-di-GMP is 
predominantly associated with regulating the lifestyle transition between motility and 
sessility (113). In general, low intracellular levels of c-di-GMP promotes virulence and 
cell motility, while high levels of c-di-GMP reduce virulence and motility and activate 
cellulose biosynthesis (97, 113). Diguanylate cyclase enzymes contain an active GGDEF 
catalytic domain that generates c-di-GMP from two molecules of guanosine triphosphate 
(GTP). In contrast, phosphodiesterase enzymes contain active EAL or HD-GYP domains 
that degrade c-di-GMP into 5’-phophoguanyl-(3’-5’)-guanosine (pGpG), which is 
subsequently degraded further into two molecules of guanosine monophosphate (GMP). 
AdrA was the first diguanylate cyclase associated with cellulose biosynthesis in 
Salmonella, and was identified based on its transcriptional activation by CsgD (108, 109). 
Since then, a total of 19 proteins has been identified with GGDEF and/or EAL domains 
(reviewed in (97)). Systematic analysis of these enzymes revealed that only one other 
diguanylate cyclase, STM1987, can activate cellulose biosynthesis independently of 
AdrA activity (114). Further, CsgD does not transcriptionally regulate the expression of 
STM1987 (76, 115, 116). C-di-GMP has also been implicated in regulating CsgD at both 
the transcriptional and post-transcriptional level. This level of regulation involves a 
separate set of diguanylate cyclases (i.e., STM2123, STM3388) (117) and 
phosphodiesterases (i.e., STM1703, STM1827), although some phosphodiesterases are 
involved in modulating the c-di-GMP pools that regulate either CsgD or cellulose 
biosynthesis (i.e., STM3611, STM4264) (114). To add to this complexity, the protein 
STM4551 contains a GGDEF domain and regulates csgD transcription, but does not 
contribute to c-di-GMP synthesis (116). The mechanisms that allow for such hierarchy in 
c-di-GMP signaling are still elusive, but likely involve several variables, including 
differential transcription of c-di-GMP metabolizing enzymes, enzyme-specific 
modulation by different environmental or intracellular signals, co-localization of the 
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enzymes with their targets (e.g., CsgD, cellulose synthase complex, or the flagellar rotor), 
and target-specific differences in binding affinity for c-di-GMP (113). 
 In addition to curli fimbriae and cellulose, CsgD has been directly linked to the 
transcriptional regulation of two other extracellular matrix components, BapA and the O-
antigen capsule. BapA is a large outer membrane surface-associated protein 
(approximately 386 kilodaltons (kDa)) with homology to a related protein involved in 
biofilm formation in the gram-positive bacteria Staphylococcus aureus (118, 119). S. 
Enteritidis bapA mutants form a weak pellicle at the air-liquid interface of broth cultures 
compared to wildtype strains, suggesting its potential role in Salmonella biofilm 
formation. Overexpression of curli fimbriae allowed for specific refortification of the 
pellicle structure in this mutant. These results led the authors to hypothesize that BapA 
strengthens cell-cell interactions within the biofilm, either through direct association of 
BapA molecules between the cells, or by strengthening curli fimbriae-mediated cellular 
associations. However, BapA has been demonstrated as nonessential for the rdar 
morphotype of Salmonella grown on agar plates (120). Therefore, further evidence is 
required to understand the role of BapA in the CsgD regulon and Salmonella biofilm 
formation. In contrast, the O-antigen capsule was identified as an additional unknown 
exopolysaccharide produced by Salmonella during rdar morphotype development on agar 
plates (78, 121). The O-antigen capsule is composed of 2300 repeating oligosaccharide 
units that are covalently linked to lipids anchored in the outer membrane (78, 122). CsgD 
was shown to indirectly activate the expression of genes for the O-antigen capsule by 
inhibiting the expression of a transcriptional repressor, yihW (78). While the O-antigen 
capsule is not directly required for the cell interactions and the rdar morphotype, it has 
been proven essential for the survival of Salmonella cells exposed to desiccation (78, 80) 
and has been shown as important for the Salmonella attachment to and biofilm formation 
on alfalfa plants (123).  Several other structural components have been suggested as 
important in certain models of Salmonella biofilm formation but have not been linked to 
regulation by CsgD, and as such fall outside the scope of this discussion (reviewed in 
(97)). 
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1.2.2 Genetic and Phenotypic Conservation  
 Several studies have used the rdar morphotype to evaluate the biofilm phenotype 
of Salmonella serovars obtained from clinical samples, animals, or from meat and 
produce. Conservation of the biofilm phenotype was highest in S. Typhimurium and S. 
Enteritidis isolates associated with gastroenteritis, with 70 to 90% of isolates exhibiting 
the rdar morphotype (76, 80, 124, 125). When studies were expanded to include all 
strains of Salmonella enterica subspecies enterica, isolates that were negative for a 
biofilm phenotype were associated with invasive diseases in different species, including 
humans (S. Typhi and S. Paratyphi A), pigs (S. Choleraesuis), chickens (S. Gallinarum, 
and pigeons (S. Typhimurium var. Copenhagen). To determine if biofilm formation is 
present across S. enterica and S. bongori, White et al. performed a screen on Salmonella 
Reference Collection C (126). Their study revealed conservation of the biofilm 
phenotype in 90% of the 80 isolates representing all 7 Salmonella groups. However, S. 
enterica subspecies arizonae was the only group where all representative isolates 
demonstrated a biofilm-negative phenotype. Isolates in this group are frequently isolated 
from the gut of reptiles and snakes, and therefore may be part of the commensal 
microflora. Conservation of the biofilm phenotype in invasive nontyphoidal Salmonella 
strains has yet to be determined by large-scale screening. However, preliminary studies of 
strains belonging to this sequence type have shown that the rdar morphotype is impaired 
or lost, providing potentially further evidence to the link between gastroenteritis and 
biofilm formation in Salmonella (127). Altogether, assessments of the biofilm phenotype 
across the genus reveal that biofilm formation is highly conserved in Salmonella 
associated with gastroenteritis, but is lost in Salmonella strains that are responsible for 
invasive disease or are adapted to life in the host. 
 Curli fimbriae are the only fimbrial type whose operons have been detected in 
almost all Salmonella isolates, suggesting that they serve an important general function in 
the lifestyle of Salmonella (126, 128, 129). Curli operons with nearly identical sequence 
similarity have also been found in other bacteria belonging to the family 
Enterobacteriaceae, including E. coli, Citrobacter, Enterobacter, and Klebsiella (89, 
130, 131). While the csg operons demonstrate significant sequence conservation across 
different enterobacteria, White et al. found that the intergenic region between the csg 
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operons has an overall sequence identity of 67% across Salmonella groups, suggesting 
significant diversity in the promoter region for either csg operon and potential differences 
in biofilm regulation across the genus (126). Indeed, the majority of mutations within the 
csg intergenic regions for the Salmonella isolates were localized to areas that are not 
adjacent to the csg promoters. Transcriptional reporter fusions for the csgD and csgB 
promoters of Salmonella isolates from all 7 subgroups revealed conserved transcriptional 
expression for both operons. Further, sequence analysis of the csg promoter regions 
revealed that the -10 and -35 regions of both csg promoters were almost entirely 
conserved across all Salmonella isolates. In comparing the csg intergenic regions between 
E. coli and Salmonella, Gerstel and colleagues found a similar pattern of sequence 
conservation, where sequence identity between the species was greatest in the promoter 
regions immediately upstream for either operon that contain pivotal regulatory binding 
sites (93). 
 In the studies reviewing phenotypic conservation of biofilm formation, some of 
the Salmonella isolates were found to have trans differences corresponding to altered 
regulation of the csg operons (124, 126). Many of these strains were found to have 
mutations affecting the rpoS allele, however, other strains were suspected of having 
mutations in other pathways involved in the regulation of csgD expression. White et al. 
found over-representation of such trans mutations in a small sub-collection of isolates 
representing the diversity of strains in the seven Salmonella groups (126). The authors 
postulated that the over-representation of trans mutations was most likely due to 
domestication of these isolates, a phenomenon that has been demonstrated in repeated 
sub-culturing of several bacteria including Salmonella, Mycobacterium bovis and E. coli 
(132-135). Subsequent work by Davidson et al. established that loss of rdar biofilm 
formation was common during laboratory passage. In their studies, they demonstrated 
that passaging S. Typhimurium cultures in stationary phase resulted in an increased 
mutation rate in the rpoS allele, while passaging during exponential phase produced other 
mutations resulting in loss of the rdar morphotype. While expression of the RpoS regulon 
aids cells by protecting against multiple stresses, expression of the RpoD regulon aids 
cells with nutrient scavenging and likely provides a competitive edge during laboratory-
based growth. 
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 The notion that expression of the csg operons is conserved across the Salmonellae 
is contradicted by rare exceptions. For S. arizonae isolates, cis mutations in the CsgD 
binding site for the csgB promoter and in conserved nucleotides for OmpR binding site 
required for csgD expression corresponded with loss of transcriptional activity and the 
biofilm phenotype (126). In S. Typhimurium var. Copenhagen isolates, the prevalent 
mutation was a G to T transversion in the -35 region, which was demonstrated to 
significantly reduce csgD promoter activity and may partially explain the loss of the 
biofilm phenotype in these invasive Salmonellae (124). For S. Typhi isolates, the 
intergenic region has conserved sequence, but multiple mutations exist within the csg and 
bcs operons, where preliminary stop codons within csgD and bcsC genes may eliminate 
the possibility for synthesis of curli fimbriae and cellulose altogether (124, 136). 
Similarly, a few mutations have been shown to correspond with increased biofilm 
biogenesis in Salmonella. For S. Enteritidis 3b and S. Typhimurium SR-11b, a specific G 
to T transversion in the activating OmpR site of the csgD promoter allows for csgD 
expression by RpoD instead of RpoS, resulting in a constitutive biofilm phenotype that is 
expressed in a growth- and temperature-independent manner (75, 77). White et al. 
hypothesized that cis mutations in the csg promoters are more likely to indicate an 
evolution in the lifestyle of Salmonella isolates (126). 
1.2.3 The CsgD Regulon 
 The integration of the CsgD regulon with other global regulatory elements shows 
its potential to exert profound changes in cellular physiology. To quantify the impact of 
CsgD-regulated extracellular matrix production on cell physiology, White et al. 
compared the metabolic and transcriptional profiles of wildtype and csgD mutant S. 
Typhimurium cells (137). The metabolites extracted from wildtype, biofilm-forming cells 
were associated with the end products of gluconeogenesis, osmoprotectants, and other 
products related to defenses against reactive oxygen species. In contrast, csgD mutant 
cells were inhibited for gluconeogenesis, as evident through elevated levels of adenine 
monophosphate (AMP), polyamines, and molecules of the upper tricarboxylic acid 
(TCA) cycle. These metabolites indicated novel physiology for wildtype biofilm cells. 
The presence of osmoprotectants indicated signals of high osmolarity for biofilm cells, 
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which was unexpected because the cells were grown in the low osmolarity conditions of 
1% tryptone media (89, 93, 137). These findings together indicated that the metabolic 
requirements for biofilm production and the presence of the mature extracellular matrix 
may indirectly influence the global gene expression within a cell (137). To determine if 
cell aggregation had a global effect on gene expression at the transcriptional level, White 
et al. generated a library of transcriptional fusion constructs for genes in pathways that 
synthesize the metabolic products identified in wildtype and csgD mutant cells. Most of 
the genes included in their reporter library were expressed in a similar temporal pattern, 
with their maximal expression beginning in sync with high activity of RpoS sigma factor 
and the expression of csgDEFG, csgBAC, and adrA promoters. In contrast, expression of 
the reporter library in csgD mutant cells had lost this ordered temporal expression. 
Altogether, these observations suggested that cells within multicellular aggregates might 
have gene expression occurring in anticipation of extracellular matrix production or 
responding to changes in the local microenvironment created by the presence of the 
biofilm superstructure (137). 
1.2.4 CsgD Bistability and Phenotypic Variation 
 Biofilm development represents an important driver of phenotypic heterogeneity 
amongst otherwise genetically identical cells (179). While some diversity arises from the 
unique niches created within the biofilm’s complex physical structure, probes into the 
genetic processes governing biofilm formation have revealed the potential for population 
heterogeneity long before synthesis of the extracellular matrix. Indeed, the complex 
interplay of environmental signaling and global transcriptional regulators creates the 
potential for cell-to-cell variation in the expression of csgD. White et al. (2008) first 
observed the presence of two populations of cells within S. Typhimurium liquid cultures 
grown under biofilm-inducing conditions (Fig 1.2c). One group of cells were aggregated 
and had high curli expression, whereas the other group of cells remained as single cells 
and had low curli expression. Grantcharova et al. examined this phenomenon at the 
molecular level (138) and were able to monitor dynamic changes in CsgD synthesis by 
generating a translational fusion of CsgD to green fluorescent protein (GFP+) and 
tracking using fluorescence microscopy and fluorescence-assisted cell sorting (FACS). 
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The authors observed a state of genetic bistability during their experiments, where unique 
subpopulations of cells with high CsgD synthesis or where CsgD synthesis was absent 
were consistently identified across three models of biofilm growth (spot cultures on agar 
plates, in static liquid cultures, or during growth in a flow cell). Cell sorting revealed that 
at maximum, 52% of cells in the total population existed in a “CsgD-ON” state after 24 
hours of growth in liquid media. The CsgD-ON cells were demonstrated to be the main 
sources of cellulose production, and were associated with other CsgD-synthesizing cells 
as multicellular aggregates that had sedimented out of the culture medium or had attached 
to an abiotic glass surface. In contrast, cells in a “CsgD-OFF” state existed as singular, 
motile planktonic cells within the bulk liquid phase of the cultures and were not 
associated with multicellular aggregates. Similarly, mutant cells lacking the csgD gene 
also existed as single cells and had 40% less cell attachment to the glass surfaces of a 
flask or flow cell compared to CsgD-ON wildtype cells. The authors concluded that this 
defect in cellulose production and attachment in the csgD mutant was due to a lack of 
activation of adrA expression, which normally contributes a significant amount to the c-
di-GMP pool that promotes cellulose biosynthesis. Overall, their findings suggest that 
csgD expression is an all-or-none event, and that variation in its expression at the single 
cell level generates disparate cell phenotypes with unique physiology in an otherwise 
isogenic population of nontyphoidal Salmonella cells. 
 One of the requirements for bistable gene expression is the presence of an auto-
regulatory loop involving the gene in question, pushing its expression past intermediate 
levels and towards an extreme “ON” state (139). While evidence for such regulation has 
yet to be proven in Salmonella, a potential auto-regulatory loop has been shown in a 
study observing biofilm formation in E. coli (140). In this study, Gualdi et al. used 
variants of the biofilm-negative E. coli strain MG1655 that were complemented for the 
biofilm phenotype in either a growth-phase dependent manner via a mutated ompR allele, 
or through constitutive, low-level csgD expression from a plasmid. After 18 hours of 
growth at 30˚C, a comparison of the proteomes of these strains with respect to the 
wildtype parental strain identified thec differential expression of several proteins encoded 
by genes belonging regulated by the stationary phase sigma factor RpoS. Constitutive 
expression of csgD was unable to change the synthesis of these proteins without the 
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presence of a functional rpoS allele. Similarly, the combination of csgD and rpoS was 
required to promote significant up-regulated transcription of an examined selection of 
genes from the rpoS regulon. Therefore, the authors reasoned that CsgD is able to affect 
the expression of rpoS-dependent genes by modulating the concentration or activity of 
the RpoS sigma factor. Previous work by the same research group had shown CsgD-
dependent up-regulation of iraP, which encodes a protein that was later demonstrated to 
stabilize the protein levels of RpoS sigma factor by inhibiting its degradation by the 
RssB-ClpXP protein complex (141, 142). Gualdi and co-workers were able to provide 
direct evidence of the link between CsgD, IraP, and RpoS sigma factor by demonstrating 
the reduced half-life of RpoS sigma factor in an iraP mutant with constitutive CsgD 
synthesis. Further, deletion of the iraP allele from the constitutive csgD strain abrogated 
the changes in protein synthesis the authors had previously shown to be connected to 
expression of csgD. Altogether, these results suggest that CsgD affects the rpoS regulon, 
of which it is a member, by indirect stabilization of the intracellular levels of RpoS sigma 
factor via iraP activation. 
1.3 Tn7 Transposition and Biotechnology 
1.3.1 Tn7 Transposition Biology 
 Transposons are mobile genetic elements that move from one position to another 
in the genome of a cell (143). These systems are broadly classified into two categories: 
retrotransposons, which rely on reverse transcription to move between segments of DNA 
via an RNA intermediate, and DNA transposons, which are mobilized directly from DNA 
to DNA (144). Tn7 is a bacterial DNA transposon that is unique due to the site-specific 
nature of its integration into the bacterial chromosome (145). This transposon is 
comprised of the genes responsible for its transposition, tnsABCDE, a variable region 
containing additional genes, and two bordering sequences at either end of the element, 
Tn7L and Tn7R (146). Tn7 was first described for its role in conferring trimethoprim 
resistance to E. coli strains associated with calves (145, 147). However, increasing 
availability of bacterial genome sequences has revealed that Tn7 and Tn7-related 
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elements are ubiquitous throughout the bacterial kingdom, with significant gene diversity 
represented in the transposon’s variable region (148). 
 One potential reason for the widespread adoption of Tn7 transposition systems 
across bacteria is the ability to target a conserved chromosomal sequence and integrate 
into the genome without affecting the host’s gene repertoire (149, 150). TnsD is the target 
specificity factor that directs site-specific integration of Tn7 into the chromosome (149). 
Research into the mechanism of Tn7 integration has shown that TnsD is a DNA-binding 
protein that recognizes a conserved sequence found in the 3’ end of the highly conserved 
glmS gene (151). Two host proteins, the acyl carrier protein (ACP) and L29 (a 
nonessential component of the ribosomal large subunit), stimulate binding of TnsD to this 
region (152). Interaction of TnsD with the target sequence induces a conformational 
change in the target DNA, which recruits an additional DNA-binding protein, TnsC 
(153). The formation of this nucleoprotein structure promotes integration of the Tn7 
element into the attTn7 site, located 25 basepairs downstream of the TnsD binding region 
(154). This site of integration exists within the transcriptional terminator sequence for the 
glmS gene (150). However, Tn7 insertion does not affect the function of the encoded 
enzyme, glucosamine-6-phosphate, which has an essential role in the biosynthesis of the 
bacterial cell wall (150). Tn7 elements have been demonstrated to integrate into the 
chromosome at a high frequency, with approximately 10-1 and 10-2 chromosomal 
insertions for each donor DNA plasmid (155). 
 In addition to its role in targeting Tn7 transposition to the attTn7 site, TnsC also 
regulates the activity of the Tn7 transposase machinery involved in transposon excision, 
TnsAB. Once the nucleoprotein complex (i.e., TnsABCD) is established downstream of 
glmS, Tn7 transposition into the chromosome occurs via a “cut and paste” mechanism 
that involves the activities of both TnsA and TnsB (156). TnsA shares structural 
similarity to a restriction endonuclease (157), and is responsible for nicking the 5’ end of 
both strands of the donor DNA molecule (156, 158, 159). In contrast, the TnsB enzyme is 
a member of the retroviral integrase superfamily, and is responsible for breaking the 3’ 
hydroxyl bonds on both strands of donor DNA (159). The cleavage of both DNA strands 
results in complete liberation of the transposon element from the donor DNA, leaving 
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behind a double-stranded DNA break that is repaired by the host’s machinery via 
homologous recombination (156).  
 TnsA and TnsB also facilitate integration of the transposon element into the target 
DNA sequence. TnsB recognizes specific binding sites found within the Tn7L and Tn7R 
regions on either end of the transposon (160, 161). It is hypothesized that differences in 
both the number and configuration of TnsB binding sites between Tn7L and Tn7R 
ensures insertion of the Tn7 element into the target DNA in a specific “left-to-right” 
orientation (reviewed in (162)). The transposon ends are then joined together by TnsA, 
forming the paired end DNA complex that is necessary for transposition (163). Following 
this complex formation, TnsB facilitates “strand transfer”, or the integration of the 3’-
hydroxyl ends of the Tn7 element into the target DNA sequence (156, 159). These end 
sequences are integrated 5 basepairs apart in the target DNA sequences, creating a single-
stranded gap on either end of the integrated transposon element (156). Reparation of 
these gaps by the host machinery results in 5-basepair duplications that flank either end 
of the transposon sequence (154, 156). 
 While TnsD-mediated Tn7 transposition facilitates vertical transfer of the 
transposon to bacterial progeny, a second targeting factor, TnsE, is important for 
horizontal dissemination of Tn7 elements across bacterial species. Unlike TnsD, TnsE-
mediated transposition relies on identifying a DNA structure instead of a specific DNA 
sequence (164). TnsE associates with sites of lagging strand synthesis during DNA 
replication, and will simultaneously bind DNA structures with a 3’ recessed end and the 
sliding processivity factor, DnaN (164, 165). This unique feature of TnsE targeting 
explains why TnsE-mediated transposition frequently results in integration of Tn7 
elements into conjugal plasmids (166). Once mobilized, these plasmids enter the new cell 
as single-stranded DNA, and are replicated by the host DNA replication machinery in a 
manner similar to lagging strand synthesis (167). TnsE recognizes the DNA structure 
associated with this synthesis and will incorporate the Tn7 element into the plasmid DNA 
sequence at random positions (166). Due to recognition of a specific DNA structure, 
TnsE can also facilitate Tn7 incorporation into the M13 bacteriophage or the bacterial 
chromosome (149, 180). However, integration into the chromosome occurs at a much 
lower frequency than integration into conjugal plasmids (162). 
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1.3.2 Tn7 Biotechnology 
 Chromosomal integration of a gene of interest overcomes many of the current 
pitfalls associated with plasmid-based gene expression. For example, single-copy 
chromosomal insertion of the gene of interest addresses the issues of plasmid copy 
number and gene dosage effects that can result in non-physiological levels of gene 
expression (150, 168). Knodler et al. demonstrated that introduction of a cloning vector 
can also result in unintended secondary effects on other bacterial cell processes, such as 
Salmonella virulence (169). Stable chromosomal integration of the gene eliminates the 
issue of plasmid loss associated with imperfect plasmid segregation (150). In some cases, 
the selection pressure required for plasmid maintenance may even be impossible or 
undesirable, such as during experiments with bacterial biofilm formation or in vivo 
studies of bacteria in animals or humans (168, 170, 171). Therefore, Tn7 transposition is 
an attractive option for generating a broadly applicable molecular tool that would 
facilitate site-specific gene insertion into the bacterial chromosome. 
 One of the earliest and most widely-adopted Tn7 biotechnologies was developed 
by Bao and colleagues in 1991 (172). Their plasmid-based system was designed to 
establish a stable chromosomal integrant, where the gene of interest would be 
permanently incorporated into the targeted chromosomal region downstream of glmS. To 
achieve this, Bao et al. devised a two-plasmid system involving a “helper” plasmid 
(pUX-BF13) carrying the Tn7 transposase genes, and a “carrier” plasmid (pUX-BF5) 
with a miniaturized Tn7 element. This mini-Tn7 element consisted of a kanamycin 
resistant cassette flanked by the Tn7L and Tn7R end sequences; researchers could use 
one of the available restriction sites to insert their gene of interest into this transposon. 
Both the carrier and helper plasmids were then simultaneously conjugated or 
electroporated into the targeted bacterial strain. One of the key features critical to this 
molecular system was to develop a “suicide vector” strategy, where both plasmids would 
be naturally lost following successful chromosomal integration of the gene of interest. To 
limit maintenance of either plasmid in the targeted bacterial strain, Bao et al. cloned the 
transposase genes and mini-Tn7 element into vectors associated with a narrow bacterial 
host range. The tnsABCDE genes were ligated to a plasmid with an R6K origin, which 
can only be replicated in host strains that carry the lambda pir gene. In contrast, the 
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carrier plasmid was based on a ColE1 vector that can only replicate in Enterobacterial 
species such as E. coli and Salmonella. 
 The Tn7 transposition system developed by Bao et al. was a significant 
advancement over the random chromosomal insertion strategy provided by existing Tn5-
based technologies. However, the use of this system was hampered by three important 
factors: (1) a lack of unique restriction sites available for cloning into the mini-Tn7 
element (173), (2) the potential for random chromosomal insertion due to the tnsE gene 
(174), and (3) the inability to use this suicide-based approach in Enterobacteriaceae due 
to the ColE1 vector backbone (168, 170, 175). Choi and colleagues addressed these 
limitations by introducing several modifications to this two-plasmid system (170). To 
ensure site-specific integration of the mini-Tn7 element, Choi et al. deleted a large 
portion of the tnsE 5’ coding sequence from pUX-BF13, resulting in a new helper 
plasmid, pTNS1. Many additional modifications affected the functionality of the carrier 
plasmid and its mini-Tn7 element. Choi et al. made it possible to use this Tn7 system in 
Enterobacteriaceae by replacing the ColE1 origin of replication with an R6K origin. 
Addition major modifications were made to the mini-Tn7 element itself. First, the 
researchers inserted T0 and T1 transcriptional terminators to the Tn7R end of the element 
to act as a replacement for the native glmS transcriptional terminator that is interrupted by 
Tn7 integration. Second, Choi et al. included an expansive multiple cloning site to 
facilitate insertion of genes of interest into the mini-Tn7 element. To further broaden the 
application of this system, Choi et al. also generated a family of pre-built mini-Tn7 
elements. These elements provided researchers with the option to select a desired 
antibiotic resistance marker, generate transcriptional fusions with lacZ or bacterial 
luciferase genes, or insert a gene into a multiple cloning site downstream of an IPTG-
inducible tac promoter. Unlike previous Tn7 systems (172, 173, 176), their mini-Tn7 
element also included FRT sites flanking the antibiotic resistance cassettes to allowing 
for excision of this cassette by yeast flippase (FLP) following chromosomal integration of 
the transposon and verification of selected bacterial clones. Altogether, the modifications 
by Choi et al. vastly improved the robustness and functionality of the original Tn7 
system. 
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 Following the release of this toolset, subsequent iterations of the Tn7 system 
focused on improving the efficiency of successful transposition events. To increase 
expression of the transposition genes, Choi et al. introduced additional helper plasmids 
where the native promoter for tnsABCD genes had been replaced by the constitutively-
expressed lac promoter (pTNS2) (170) or the P1 integron and lac promoters in tandem 
(pTNS3) (177). Despite the system’s extensive use in some bacterial species (i.e., 
Pseudomonas aeruginosa), there were only rare reports of its use in Salmonella and E. 
coli. We hypothesized that the suicide vector approach of Choi et al’s system may not 
allow for sufficient expression of the tnsABCD genes, resulting in failure to integrate the 
mini-Tn7 element prior to loss of the helper plasmid. During the course of this thesis, 
Crépin and colleagues published an alternative approach to increasing transposase 
expression with a new helper plasmid, pSTNSK (168). Their two-plasmid system 
involved the transfer of the tnsABCD genes from pTNS2 to a temperature-sensitive 
plasmid (i.e., pSC101 origin), allowing for conditional maintenance of the tns genes 
within a bacterial strain. The authors reported significant success with this system in a 
range of Enterobacterial strains, observing transposition efficiencies between 68 and 
96%. Similarly, researchers McKenzie and Craig (pGRG25) incorporated both aspects of 
improved promoter strength for the tnsABCD genes and conditional maintenance of the 
Tn7 system in their one-plasmid system, pGRG25 (150). In contrast to the system 
devised by Crépin et al., this tool positioned both the transposase genes and the mini-Tn7 
element together on a temperature-sensitive plasmid. Further, McKenzie and Craig’s 
system allowed the user to modulate expression levels of the transposition genes by 
placing them under the control of an arabinose-inducible araBAD promoter. In 
experiments with E. coli K-12, the authors demonstrated that use of their system resulted 
in a transposition efficiency of 79% (150). However, both our research group and Crépin 
et al. were unsuccessful with using this single-plasmid system in pathogenic E. coli and 
Salmonella (168, 178). These observations suggest that further improvements must be 
made to the available Tn7 systems in order to generate robust tools that allow for 
chromosomal integration across multiple bacterial species and strains. 
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2.0 RATIONALE, HYPOTHESES, AND OBJECTIVES 
2.1 Rationale and Hypotheses 
 Salmonella biofilm formation was traditionally studied at the population level as 
the rdar morphotype. The rdar morphotype was activated by environmental conditions, 
such as nutrient limitation, low temperatures, and low osmolarity, and was shown to 
enhance the survival and persistence of Salmonella cells. Cells within a biofilm retained 
the ability to cause an infection, even after exposure to environmental conditions (i.e. 
desiccation and starvation) for a long period of time – on the order of years. However, it 
was still viewed primarily as a survival adaptation, and not a virulence trait. A 
comparison of biofilm-positive and biofilm-negative colonies revealed a shift in the 
expression of multiple genes associated with metabolism during biofilm formation. Many 
of these changes did not appear to have a direct relationship to CsgD, which suggested 
that biofilm formation could represent a developmental program. 
 The paradigm of Salmonella biofilm formation as a population-level phenotype 
was shifted by the discovery that CsgD expression varies between cells. The ON-OFF 
nature of CsgD bistability results in two different cell types – multicellular aggregates 
and planktonic cells. These subpopulations are genetically clonal, but are distinct at the 
phenotypic level. Thus, in my Ph.D. research we set out to perform a detailed comparison 
between multicellular aggregates and planktonic cells to better understand the potential 
role of CsgD bistability in Salmonella biology. We hypothesized that multicellular 
aggregates would have a similar gene expression profile to Salmonella rdar morphotype 
cells. In contrast, we predicted that planktonic cells would have a novel gene expression 
profile (i.e., their gene expression would not match the expression that has been 
characterized for Salmonella rdar morphotype cells). 
 For the last section of my thesis, we investigated the biofilm-forming capacity of 
invasive nontyphoidal Salmonella isolates. Most nontyphoidal Salmonella isolates are 
associated with gastroenteritis, are transiently associated with the human host, and are 
positive for the biofilm phenotype. In contrast, host-restricted typhoidal Salmonella 
isolates are associated with an invasive systemic infection, can persist asymptomatically 
within humans, and are biofilm-negative. The invasive nontyphoidal isolates represent a 
 50 
phylogenetically distinct set of nontyphoidal Salmonella strains that are associated with a 
typhoid-like illness, primarily in sub-Saharan Africa. Invasive NTS strains can be 
isolated from asymptomatic persons, and have yet to be isolated from an environmental 
reservoir. Due to their apparent similarities to typhoidal strains, we hypothesized that 
invasive nontyphoidal Salmonella strains would be negative for the biofilm phenotype. 
2.2 Objectives 
The original objectives of my research project included the following: 
i. Generate a csgD-complemented Salmonella strain for use as a control strain in 
experiments (Chapter 3). 
ii. Develop a method for efficient chromosomal integration in Salmonella 
(Chapter 3). 
iii. Use csgD and csgB promoter expression to identify time points corresponding 
to important stages of Salmonella biofilm development during growth in 
liquid culture (Chapter 4). 
iv. Develop a procedure for separating multicellular aggregates from planktonic 
cells (Chapter 4). 
v. Develop a method for reproducible RNA extraction from multicellular 
aggregates and planktonic cells (Chapter 4). 
vi. Develop a method for the robust quantitation and enumeration of cells within 
multicellular aggregates (Chapter 4). 
Based on the results from our experiments, additional objectives were defined: 
vii. Determine if increased SPI-1 and SPI-2 type three secretion system expression 
in planktonic cells was reflected in corresponding increases in protein 
synthesis (Chapter 4). 
viii. Compare the virulence and survival properties of multicellular aggregates and 
planktonic cells (Chapter 4). 
ix. Evaluate iNTS strains for the ability to form a biofilm phenotype (Chapter 5). 
x. Evaluate the biofilm regulatory network in iNTS strains compared to known 
biofilm-positive and biofilm-negative Salmonella strains (Chapter 5). 
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3.1 Interface 
 This chapter presents the modifications we introduced to the existing Tn7 
transposition system designed by Choi et al. (12). The genetic changes we introduced to 
this Tn7 system facilitated integration of antibiotic resistance genes and bioluminescent 
or fluorescent reporter markers into the chromosome of Salmonella. This tool for 
chromosomal tagging allowed us to track isogenic Salmonella strains (i.e., wildtype and 
∆csgD strains of Salmonella) or Salmonella subpopulations (i.e., multicellular aggregates 
and planktonic cells). The marked Salmonella strains were used to validate the results of 
our transcriptomic analysis (presented in Chapter 4) by facilitating comparative 
physiological assays, such as in vitro fitness experiments or in vivo competitive infection 
assays. 
3.2 Abstract 
 Our goal was to develop a robust tagging method that can be used to track 
bacterial strains in vivo. To address this challenge, we adapted two existing systems: a 
modular plasmid-based reporter system (pCS26) that has been used for high-throughput 
gene expression studies in Salmonella and E. coli, and Tn7 transposition. We generated 
kanamycin- and chloramphenicol-resistant versions of pCS26 with bacterial luciferase, 
GFP and mCherry reporters under the control of σ70-dependent promoters to provide 
three different levels of constitutive expression. We improved upon the existing Tn7 
system by modifying the delivery vector to accept pCS26 constructs and moving the 
transposase genes from a non-replicating helper plasmid into a temperature-sensitive 
plasmid that can be conditionally maintained. This resulted in a 10 to 30-fold boost in 
transposase gene expression and transposition efficiencies of 10-8 to 10-10 in Salmonella 
serovar Typhimurium and E. coli APEC O1, whereas the existing Tn7 system yielded no 
successful transposition events. The new reporter strains displayed reproducible signaling 
in microwell plate assays, confocal microscopy, and in vivo animal infections. We have 
combined two flexible and complementary tools that can be used for a multitude of 
molecular biology applications within the Enterobacteriaceae. This system can 
accommodate new promoter-reporter combinations as they become available and can 
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help to bridge the gap between modern, high-throughput technologies and classical 
molecular genetics.  
3.3 Introduction 
 The ability to generate recombinant strains of Escherichia coli and Salmonella 
enterica has facilitated insight into their ecology and pathogenic mechanisms. In recent 
years, strain collections have been assembled consisting of single gene knockouts of the 
entire genomes of E. coli K-12 (1) and S. enterica serovar Typhimurium 14028 (2). These 
collections can be used for finely-tuned analysis of gene function, host-pathogen 
interactions, as well as for strain fitness and competition experiments (3). There are also a 
wide array of reporter systems available to analyze gene expression in detail, for the 
ordering of hierarchical gene circuits (4), a deeper understanding of metabolism (5) or the 
development of biosensors (6). The use of these systems, coupled with next generation 
sequencing approaches that have facilitated functional genomics (7, 8), allows for 
unprecedented access to and understanding of the inner workings of the microbial cell.  
 Despite these recent advances in molecular tools, there is a need for improved in 
vivo analysis of bacterial pathogens (9). It is necessary to validate the expression of 
individual genes identified by next generation sequencing applications, such as Tn-seq 
(10), or to complement in vivo – specific genetic techniques, such as IVET (11). 
Chromosomal integration is desirable because it provides improved stability and more 
stoichiometric expression as compared to plasmid-based expression. Since original 
publication of the miniTn7 transposition method in 2005 (12), it has proven to be an 
incredibly useful system for integrating genes into bacterial chromosomes, particularly 
with Pseudomonas species (13). Tn7 transposition is ideal because it is directional (14), 
highly-specific for attTn7 sites (15), and results in single copy insertion in most bacterial 
species (13). For Salmonella and E. coli, the single attTn7 site lies near the conserved 
glmS gene (16). Modifications have been made in an attempt to improve the flexibility of 
the Tn7 system, such as through the generation of new helper plasmids (17), helper 
plasmid and delivery plasmid hybrids (18), arabinose inducible gene expression (19), and 
luciferase integration (20, 21). Unfortunately, the Tn7 system (12, 18) did not work in our 
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hands for Salmonella. We speculated that this was due to low expression of the tnsABCD 
genes that are necessary for transposition to occur.  
 In this manuscript, we describe a modified miniTn7 system that is amenable for 
use in the Enterobacteriaceae and provides the means necessary to combine modern, 
high-throughput technologies with classical molecular genetics. We built a replication-
proficient Tn7 helper plasmid based on a temperature-sensitive replicon and demonstrate 
that tnsABCD expression is boosted 10-30 times as compared to the original helper 
plasmids (12). Furthermore, we incorporated the pCS26 vector system, which was 
designed to be modular and has a long history of use in gene expression experiments (4, 
22-24). This gives unprecedented control over promoter and reporter combinations, 
which can be tested in vitro and are only two steps away from chromosomal integration. 
We generated reporter strains of S. Typhimurium and E. coli with luminescent and 
fluorescent reporters and kanamycin or chloramphenicol antibiotic selection and describe 
synthetic σ70-dependent promoters that provide constitutive expression at three different 
levels of expression. Further, we showcase the effectiveness of gene complementation 
using this system, an important requirement for the robust validation of gene function 
discovery. This system is amenable for use in the Enterobacteriaceae and provides the 
means necessary to combine classical molecular genetics with modern, high-throughput 
technologies in both in vitro and in vivo settings. 
3.4 Materials and Methods 
3.4.1 Bacterial strains, media, and growth conditions. 
 Salmonella enterica serovar Typhimurium strain ATCC 14028 (American Type 
Culture Collection, Manassas, VA) and E. coli APEC O1 (25) were used as the parental 
strains in this study. The isogenic S. Typhimurium ∆csgD strain, formerly named ∆agfD, 
has been described previously (26). All cloning experiments were performed in E. coli 
DH10B (pCS26, pHSG415 and pACYC184) or E. coli CC118 (lambda pir) (27) 
(pUC18R6K-mini-Tn7T). All oligonucleotides used are listed in Table 3.1. Prior to 
plasmid purification, cloning and analysis, strains were inoculated from frozen stocks 
onto Luria agar (Luria broth + 1.5% agar) supplemented with the appropriate antibiotics 
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(Kanamycin; Kn 50 µg mL-1; Chloramphenicol; Cm 10 µg mL-1) and grown for 20 h at 
37˚C. One isolated colony was used to inoculate 5 mL LB broth cultures.  
 For bioluminescence assays, overnight cultures of S. Typhimurium or E. coli 
strains carrying pCS26-derivatives (luxCDABE, GFP or mCherry reporters) were diluted 
1 in 600 in 1% tryptone broth or LB supplemented with 50 µg ml-1 Kn or 10 µg ml-1 Cm 
to a final volume of 150 mL in 96-well clear-bottom black plates (9520 Costar; Corning 
Inc.). pCS26 bacterial luciferase (lux) operon fusion plasmids containing csgDEFG, 
csgBAC, and adrA promoters have been described previously (26). The RpoS-dependent 
reporter plasmid, sig38H4, contains a promoter that was designed based on alignment of 
numerous RpoS-controlled promoters, driving expression of the lux operon (26, 28). For 
E. coli or S. Typhimurium strains with reporters integrated into the genome, final dilution 
was performed into media without antibiotics. The cultures in each well were overlaid 
with 50 mL of mineral oil prior to starting the assays. Cultures were assayed for 
absorbance (590-600 nm, 0.1s), luminescence (1s, counts per second (CPS)) or 
fluorescence (GFP; excitation 485nm, emission 535nm; mCherry: excitation 555 ±38 nm, 
emission 632 ±45 nm) every 30 min during growth at 37ºC with agitation in a Victor X3 
multilabel plate reader (Perkin-Elmer).  
 Strains used in murine infection experiments were inoculated from frozen stocks 
onto Luria agar supplemented with 50 µg mL-1 Kn or 10 µg mL-1 Cm. Isolated colonies 
were selected and grown for 16 hours in LB broth at 37° C, shaking at 200 rpm. These 
cultures were used to generate the bacterial challenge solutions used to infect mice.  
3.4.2 Generating a CmR pCS26 plasmid 
 The Kn-resistant (KnR) reporter plasmid pCS26 containing the promoter-less 
luxCDABE operon from Photorhabdus luminescens has been previously described (22). 
The lux gene products from P. luminescens are more thermostable than those from Vibrio 
species, and thus are more suitable for gene expression experiments (29, 30). To generate 
a chloramphenicol-resistant (CmR) version of pCS26, inverse PCR was performed using 
primers pCS26-Eco and pCS26-Pst to remove the aph gene coding for KnR. The linear 
PCR product was digested with EcoRI and PstI (New England Biolabs). The cat gene 
coding for CmR was part of a 1.1 kb blunt-ended insert from a PCR Script AMP cloning 
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Table 3.1. Oligonucleotides used in this study. 
Primer name Sequence (5’-3’)a Purpose 
pCS26-Eco GCCGAATTCCGGCAAGAAAGCCATCCAGTTTACTT To generate CmR-pCS26 
pCS26-Pst GCCCTGCAGGCGGGACTCTGGGGTTCGAGAGCTCGCTTGG
ACTCC 
To generate CmR-pCS26 
Bam_out_Pst   GCCCTGCAGGTCGACTCTAGACGATCCCC To generate CmR-pCS26 
Pst_to_terminator CGGGACTCTGCAGTTCGAGAGCTCGCTTGGACTCCTG To generate CmR-pCS26 
sig70-16_sense TCGAGAATAATTCTTTACATTTATGCTTCCGGCTCGTATTC
TACGTGCAATTG 
sig70_16 promoter 
sig70-16_antisense GATCCAATTGCACGTAGAATACGAGCCGGAAGCATAAAT
GTAAAGAATTATTC 
 
sig70_16-10c2F TCGAGAATAATTCTTTACATTTATGCTTCCGGCTCGTATAA
TACGTGCAATTG 
sig70c10 promoter 
sig70_16-10c2R GATCCAATTGCACGTATTATACGAGCCGGAAGCATAAATG
TAAAGAATTATTC 
 
sig70_16-35c2F TCGAGAATAATTCTTGACATTTATGCTTCCGGCTCGTATTC
TACGTGCAATTG 
sig70c35 promoter 
sig70_16-35c2R GATCCAATTGCACGTAGAATACGAGCCGGAAGCATAAAT
GTCAAGAATTATTC 
 
pZE05rev TCACCGACAAACAACAGATA Amplify mCherry 
TNS2forEco GATCGAATTCATGCTGTGAAAAAGCATACTGGACT Amplify tnsABCD from pTNS2 
TNS2revXma GATCCCCGGGATTTTGGCTCGTTGAAGATCCGATG  
Sac_Pac_Kpn1 CTTAATTAAGGTAC PacI polylinker inserted in pUC18R6K-
mini-Tn7T 
Sac_Pac_Kpn2 CTTAATTAAGAGCT  
mCherry-check TGCGTGGTACTAATTTTCCA To verify chromosomal insertion of 
mCherry 
GFP-check TACATCATGGCAGACAAACA To verify chromosomal insertion of GFP 
Lux-check TCAACACTTGTTTCTTTGAGG To verify chromosomal insertion of 
luxCDABE 
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glmSdetectFor AACCACCCGTTCAGGCTGGCTA To verify chromosomal insertion at glmS 
site 
glmSdetectRev ACGTTGACCAGCCGCGTAAC  
Cm-check CCCCGTGGAGGTAATAATTG To verify chromosomal insertion of CmR 
marker 
Kn-check TACCCGTGATATTGCTGAAG To verify chromosomal insertion of KnR 
marker 
csgDcompFor2 GATTCTCGGGCATCATAAATAACAATTTGT To generate csgD-cat construct 
csgDcompREV GTTCGAATTCCCTTACCGCCTGAGATTATC  
csgDFOR_Bam GGCCGGATCCCATCATAAATAACAATTTGT  
glmScsgDREV_Pst GGCCCTGCAGGGCCGTCGATAGACGGCCTTTTTTTGTGCG
CCGTGACAGGCGCTGTTCTTCCTTACCGCCTGAGATTATC 
 
glmSCAMfor_Eco GGCCGAATTCAGCGCAGGTAGGCGTAGCACCTCTTAGTCG
CTCTTCAGCCACCATAGAGAGTGTAGGCTGGAGCTGCTTC 
 
CAMrev_Bam GGCCGGATCCATATGAATATCCTCCTTA  
CAMfor_Eco GGCCGAATTCGTGTAGGCTGGAGCTGCTTC  
csgDREV_Kpn GGCCGGTACCCCTTACCGCCTGAGATTATC  
tnsA-for ATACGAGCCTTAACCGCAAA qRT-PCR for tnsA 
tnsA-rev CGCAACTCCTCCATATTCAC  
tnsB-for TGCCACGATTGCTGATATTT qRT-PCR for tnsB 
tnsB-rev GCCACCACATAAGACGGATT  
tnsC-for CGCATTGCTCGTTATTCTGA qRT-PCR for tnsC 
tnsC-rev TGACGCTGATCTTCGGTATC  
tnsD-for AATGCTAGGAGTCGCTGCTT qRT-PCR for tnsD 
tnsD-rev TACCAATCTCGTTGCCAAAA  
fabG1 CAGCGTGCGGGTATCCTGGC qRT-PCR – control gene 
fabG2 CCGCCGTTGACGTGCAGAGT  
groEL1 CGTTGCGCTGATCCGCGTTG qRT-PCR – control gene 
groEL2 GACGGCTCTTCGCCGCAGTT  
 
a  Nucleotide sequences corresponding to restriction enzyme sites are underlined. 
  59 
kit (Agilent Technologies, Santa Clara, CA) that was cloned into SmaI-digested pUC18 
and excised by digestion with EcoRI and PstI. The inverse PCR product and the CmR 
fragment were ligated using T4 DNA ligase (New England Biolabs). To remove a second 
BamHI site that was introduced as part of the CmR fragment, inverse PCR was performed 
using primers Bam_out_Pst and Pst_to_terminator. The product of inverse PCR was 
digested with PstI and ligated using T4 DNA ligase to generate the final pCS26-Cm 
vector.  
3.4.3 Generation of sig70_16, sig70c10 and sig70c35 promoter constructs 
 sig70_16 is a derivative of pCS26 that contains a synthetic, σ70-dependent 
promoter controlling luxCDABE expression(31). To generate a sig70_16 version of 
pCS26-CmR, oligonucleotides sig70-16_sense and sig70-16_antisense were 
phosphorylated using T4 polynucleotide kinase (NEB) at 37ºC for 1 h in buffer 
containing 50mM Tris pH 8, 10mM MgCl2, 5mM DTT, 1 mM ATP, and 1.5 mg of BSA.  
The phosphorylated oligonucleotides were mixed, heated to 80ºC for 7 min and allowed 
to cool slowly to 30ºC, and the annealed product was ligated into XhoI/BamHI-digested 
pCS26-CmR. To generate sig70c10 and sig70c35 promoter variants, oligonucleotides 
sig70_16-10c2F and sig70_16-10c2R, and sig70_16-35c2F and sig70_16-35c2R were 
phosphorylated and annealed as above, then ligated into XhoI/BamHI-digested pCS26-
KnR or -CmR vectors. Clones were screened for light production using an IVIS Lumina II 
in vivo imaging system (Perkin Elmer). DNA sequencing (Eurofins MWG Operon) was 
performed on all constructs using primers pZE05 and pZE06 (22). 
3.4.4 Generation of GFP and mCherry pCS26 reporter plasmids. 
 pCS26-KnR and -CmR containing sig70_16, sig70c10 and sig70c35 promoters 
were digested with NotI and the 7300 bp luxCDABE-containing fragment was removed. 
GFP-containing fragments were PCR amplified from pCS21 (22) and mCherry-
containing fragments were PCR amplified from PadrA-mCherry (32) using primers 
pZE05 (22) and pZE05rev. Phusion High-Fidelity DNA polymerase (Fisher Scientific) 
was used and reaction conditions were as outlined by the manufacturer. The resulting 
products were digested with NotI, ligated into the pCS26 vectors and transformed into E. 
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coli DH10B. Potential clones were selected on Luria agar supplemented with the 
appropriate antibiotics and screened for fluorophore production on the IVIS Lumina II 
imaging system, as above. Proper orientation of reporter constructs was confirmed by 
plasmid purification followed by restriction digestion.  
3.4.5 Modification of the Tn7 delivery and helper plasmids. 
 The tnsABCD operon was PCR-amplified from pTNS2 (12) with Phusion DNA 
polymerase using primers TNS2forEco and TNS2revXma. The tnsABCD PCR product 
was digested with EcoRI and XmaI and ligated into EcoRI/XmaI-digested pHSG415 (33). 
By cloning into this region of pHSG415, tnsABCD expression would be partly controlled 
by the existing cat promoter. To facilitate cloning of pCS26-based vector fragments into 
the pUC18R6K mini-Tn7T plasmid (12), a poly-linker containing a PacI restriction site 
was inserted. Oligonucleotides Sac_Pac_Kpn1 and Sac_Pac_Kpn2 were phosphorylated 
and annealed as above and ligated into SacI/KpnI-digested pUC18R6K-mini-Tn7T. The 
pUC18R6K-mini-Tn7T-PacI vector was used for all subsequent experiments. 
3.4.6 Integration into the E. coli and S. Typhimurium chromosome.  
 pCS26-KnR and -CmR constructs were digested with PacI to remove the pSC101-
based origin of replication and ligated into PacI-digested pUC16R6K mini-Tn7T PacI 
vector. Potential clones in E. coli CC118 (lambda pir) were selected by growth on LB 
agar supplemented with 100 µg mL-1 Ap and 10 µg mL-1 Cm or 50 µg mL-1 Kn. To 
confirm that constructs were ligated in the desired orientation, plasmid purifications were 
performed, followed by restriction digestion. The resulting mini-Tn7T-pCS26 plasmids, 
18 in total, were purified using Plasmid Midi kits (Qiagen). DNA sequencing was 
performed with primers pZE05 and pZE06 (Lux), pZE05 and mCherry-check (mCherry), 
or pZE05 and GFP-check (GFP) (Table 3.1). 
 Chromosomal integration was achieved by electroporation of 100 ng of the 
appropriate pUC18R6K-mini-Tn7T-pCS26 vector into competent cells of S. 
Typhimurium 14028 ∆csgD or E. coli APEC O1 containing pHSG415-tnsABCD. 
Competent cells were prepared by growing for 3-4 h at 28ºC, with agitation in LB 
supplemented with 100 µg mL-1 ampicillin. Cells were allowed to recover in SOC media 
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for 2 h at 30°C prior to plating on Luria agar supplemented with 50 µg mL-1 Kn or 10 µg 
mL-1 Cm. Final plates were incubated overnight at 37°C, to ensure loss of the 
temperature-sensitive pHSG415-tnsABCD plasmid. To test the existing Tn7 method, 100 
ng of pTNS2 (12) or pTNS3 (34) were co-electroporated with 100 ng of miniTn7T-
pCS26 plasmid into S. Typhimurium or E. coli competent cells. These plasmids do not 
replicate in Salmonella and E. coli; Tn7 transposition was unsuccessful in these 
experiments.   
 Chromosomal integration of reporter fragments into the attTn7 site downstream 
of the glmS gene of S. Typhimurium or E. coli was confirmed by PCR using the 
following primer sets: Reaction (1) glmSdetectFor + Lux-check, mCherry-check or GFP-
check, Reaction (2) glmSdetectRev  + Cm-check or Kn-check (Table 3.1). PCR products 
were purified using QIAquick PCR purification kits (Qiagen) and DNA sequencing was 
performed (Eurofins MWG Operon). To ensure the absence of secondary mutations in 
Salmonella reporter strains that were used for murine infection experiments, the reporter 
fragments (~3800 – 8800 bp) were moved from S. Typhimurium ∆csgD into the S. 
Typhimurium 14028 wild-type strain by P22 phage transduction (35). These P22 phage 
lysates are also available upon request. 
3.4.7 Determination of tnsABCD transcript levels  
 RNA was isolated using an RNeasy Mini Kit (Qiagen) from S. Typhimurium 
14028 ∆csgD cells transformed with pHSG415-tnsABCD, pTNS2 or pTNS3 and allowed 
to recover for 1h or 2h at 30ºC in SOC (as described in previous section). The quantity 
and purity of RNA was verified using a NanoDrop ND-1000 spectrophotometer (Fisher 
Scientific) and integrity verified on a Agilent 2100 Bioanalyzer with a Prokaryote Total 
RNA Nano chip NanoDrop ND-1000 (Thermo Fisher Scientific). A total of 2ug RNA 
was then reverse transcribed using the High Capacity cDNA Reverse Transcription Kit 
(Thermo Fisher Scientific). Real time PCR reactions specific for tnsA, tnsB, tnsC or tnsD 
(primers listed in Table 3.1) were performed on 20ng equivalent cDNA using KAPA 
SYBR FAST qPCR mastermix (D-Mark Biosciences) on a Step-One-Plus Real-Time 
PCR system (Thermo Fisher Scientific).  Analysis was conducted using the 2-ΔΔCT 
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method(36) with normalization against the geometric mean of two housekeeping genes, 
fabG and groEL. 
3.4.8 Murine Infections with S. Typhimurium reporter strains.  
 Female C57BL/6 mice (6 to 8 weeks old) were purchased from Jackson 
Laboratory (Bar Harbor, ME) and housed in the VIDO animal facilities in direct 
accordance with guidelines drafted by the University of Saskatchewan’s Animal Care 
Committee and the Canadian Council on the Use of Laboratory Animals. For competitive 
index (CI) experiments, two groups of six mice were assigned to groups using a 
randomization table prepared in Microsoft Excel; individual mice were marked with ear 
notches. Mice were infected by oral gavage with a mixed inoculum containing a 1:1 ratio 
of KnR and CmR S. Typhimurium 14028 strains containing the sig70_16-luxCDABE 
construct. An inoculum of 1.1 × 107 CFU, containing 5.3 × 106 KnR cells and 5.7 × 106 
CmR cells, was delivered to each mouse in 100 µL of 100 mM HEPES pH 8. Infected 
mice were weighed daily and mice that had a >20% drop in weight, typically 4-7 days 
post-infection, were humanely euthanized. Spleen, liver, mesenteric lymph nodes (MLN), 
and cecum were collected from each mouse, placed in a 2mL Eppendorf Safe-Lock tube 
containing 1 mL of PBS and a 5mm steel bead (Qiagen product #69989) and were 
homogenized using a MM400 high-speed mixer mill (Retsch). For determination of total 
Salmonella CFU, organ homogenates were serially diluted in PBS and plated on Luria 
agar supplemented with 50 µg mL-1 Kn or 10 µg mL-1 Cm. The CI values were calculated 
as [CFU planktonic/CFU biofilm]output/[CFU planktonic/CFU biofilm]input.  
 For whole animal imaging experiments performed to compare light production 
between different reporter strains, groups of (n=4) C57BL/6 mice were pre-treated with 
an oral dose of 20 mg streptomycin 24 h prior to challenge (37) with 1 × 107 CFU of 
individual reporter strains: CmR sig70_16-, sig70c10- and sig70c35-luxCDABE or KnR-
sig70c35-luxCDABE. Post-infection monitoring was performed as described above. Mice 
were imaged daily using the IVIS Lumina II (Perkin Elmer) and final tissue images were 
obtained after euthanization.  
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3.4.9 Complementation of S. Typhimurium 14028 ΔcsgD mutant 
 For plasmid-based complementation, the region of DNA including the csgD ORF 
and intergenic region between the divergently transcribed csgBAC and csgDEFG operons 
was PCR amplified from S. Typhimurium 14028 genomic DNA using primers 
csgDcompFor2 and csgDcompREV. The resulting PCR product was purified and 
digested with EcoRI and AvaI and ligated into EcoRI/AvaI-digested pACYC184 (38) to 
generate pACYC-csgD. Product 1, consisting of csgD and corresponding intergenic 
region, was PCR-amplified from pACYC-csgD using primers csgDFOR_Bam and 
glmScsgDREV_Pst. Product 2, containing the chloramphenicol acetyltransferase (cat) 
gene and flanking Flp recombinase target (FRT) sites, was PCR-amplified from 
pKD3(39) using primers glmSCAMfor_Eco and CAMrev_Bam. Phusion High-Fidelity 
DNA polymerase was used for all PCR reactions (ThermoFisher Scientific). 
EcoRI/BamHI-digested product 2 and BamHI/PstI-digested product 1 were sequentially 
ligated into EcoRI-BamHI-PstI-digested pTZ18U (Sigma-Aldrich). The cat-csgD product 
was PCR-amplified from pTZ18U using primers CAMfor_Eco and csgDREV_Kpn, 
digested with EcoRI and KpnI and ligated into EcoRI/KpnI-digested pUC18R6K-mini-
Tn7T. The resulting vector was electroporated into S. Typhimurium ∆csgD cells 
containing the pHSG415-tnsABCD helper plasmid. Chromosomal insertion strains were 
selected by growth on Luria agar supplemented with 10 µg mL-1 Cm; final confirmation 
was performed by PCR using primers glmSdetectFor and glmSdetectRev followed by 
DNA sequencing.  
3.4.10 Statistical Analysis 
 Maximum luciferase, mCherry or GFP expression values from E. coli or S. 
Typhimurium strains harboring pCS26 plasmids, or from E. coli APEC O1 or S. 
Typhimurium 14028 reporter strains, were compared between KnR or CmR, or sig70_16, 
sig70c10 or sig70c35 groups using unpaired t Tests with Welch’s correction, which does 
not assume that groups have equal standard deviations. Competitive index values 
calculated from the organs of all 12 mice were first analyzed using a Shapiro-Wilk 
normality test, which determined that the data were not normally distributed. Wilcoxon 
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signed rank tests determined that the CI values for each organ were not statistically 
different (p >0.05) from a theoretical value of 1.0. All analyses were performed using 
GraphPad Prism v6.0. 
3.5 Results 
3.5.1 Modular pCS26 vectors with synthetic, σ70-dependent promoters  
 The pCS26 vector, originally developed in the laboratory of Dr. Michael Surette 
(22) (http://www.surettelab.ca/lab/), has been used for several large-scale gene expression 
experiments (4, 22-24). pCS26 offers flexibility in both the promoters and reporters that 
can be incorporated (Fig. 3.1A). We generated versions of pCS26 containing either 
mCherry or GFP reporters, in addition to the base plasmid containing the luxCDABE 
operon from Photorhabdus luminescens. To increase the utility of the pCS26 reporter 
system and enable experiments where strains can be combined, such as competitive 
infections or fitness assays, we generated a version of pCS26 with chloramphenicol-
resistance as a selectable marker (see Materials and Methods). We incorporated 
promoters of increasing strength based on a constitutive, σ70-dependent promoter named 
sig70_16 (40). This promoter was designed based on the consensus sequence of different 
σ70–controlled promoters in E. coli, with degenerate positions in the -10 and -35 regions 
to introduce variability in promoter strength (K. Pabbaraju and MG Surette, unpublished 
data). We reasoned that restoring the sig70_16 sequence back to the consensus -10 or -35 
sequence would boost the promoter strength. We named these new promoters sig70c10, 
with the -10 sequence restored to consensus, and sig70c35, with the -35 sequence 
restored to consensus (Fig. 3.1A). Luciferase expression from these plasmids was 
monitored in E. coli DH10B and S. Typhimurium 14028 during a 48-hour growth period 
(Fig. 3.2). In general, the profiles differentiated into three distinct groups with the sig70-
16 promoter having the lowest expression, sig70c10 with intermediate levels and 
sig70c35 with the highest expression. There was very little difference in expression 
between the KnR and CmR plasmids, except in Salmonella where the CmR sig70c35 
plasmid construct had a lower maximum expression level (Fig. 3.2).  
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Figure 3.1. Use of modular pCS26 plasmids in a modified Tn7 transposition system. 
(A) Choose the antibiotic resistance marker (KnR or CmR), sig70 promoter (or new promoter cloned with XhoI/BamHI) and 
luxCDABE, mCherry, or GFP (or new reporter cloned with NotI/NotI) in the modular pCS26 plasmid. The synthetic, σ70-dependent 
promoters (shown in magenta) allow for constitutive expression at differing strengths; the nucleotide differences are outlined, and -35 
and -10 regions are recognized by σ70. (B) pCS26 constructs are digested with PacI and ligated into the pUC18R6K-miniTn7T-PacI 
delivery plasmid. pHSG415-tnsABCD is a new helper plasmid that is replication proficient and can be conditionally maintained in 
most Enterobacteriaceae strains. The tnsABCD operon is expressed under control of the pre-existing cat promoter, leading to elevated 
expression; two black arrows represent truncated aph (KnR) and cat (CmR) genes. (C) 100 ng of miniTn7T-pCS26 delivery plasmid is 
transformed into cells containing pHSG415-tnsABCD, resulting in orientation-specific integration of KnR or CmR-promoter-reporter 
constructs into the attTn7 site (shown as a black box) present in the chromosome of Salmonella and E. coli, downstream of the glmS 
gene. The details of Tn7 transposition were adapted from (16). Chromosomal insertion can be verified by PCR, followed by growth at 
37ºC to cure the pHSG415 helper plasmid. All plasmid maps were generated using Geneious v. 9.0.4 (www.biomatters.com).  
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3.5.2 Modifying the Tn7 transposition system for chromosomal integration of luxCDABE 
constructs. 
 Plasmid stability is a significant issue when it comes to in vivo studies of 
microbial pathogenesis within a host. To expand the spectrum of uses for the modular, 
pCS26 reporter system, we wanted to develop a chromosomal integration strategy based 
on Tn7 transposition. The original Tn7 system, first described by Choi et al. (12) consists 
of two replication-sensitive vectors that are used to carry: (1) the gene(s) of interest and 
(2) the transposase machinery required for chromosomal integration. The first 
modification we made to the existing Tn7 system was to insert a PacI polylinker into the 
multiple cloning site of the pUC18R6K miniTn7T delivery plasmid (Fig. 3.1B). This 
enabled cloning of the promoter, reporter and antibiotic resistance cassettes from pCS26-
KnR or -CmR. We attempted to integrate the pCS26-luxCDABE constructs into the 
chromosome of Salmonella using one of the original helper plasmids, pTNS2(12) or 
pTNS3 (34), but the experiments were unsuccessful (Table 3.2). Since pTNS2 and 
pTNS3 do not replicate in Salmonella, we reasoned that tnsABCD expression might not 
reach high levels during the transformation process; this was subsequently confirmed by 
qRT- PCR (Table 3.2). Therefore, the second modification we made was to generate 
pHSG415-tnsABCD, a replication-proficient helper plasmid that contains a temperature-
sensitive origin of replication to allow for curing of cells. Use of this plasmid, with 
tnsABCD genes cloned under partial control of the chloramphenicol promoter (Fig. 3.1B), 
resulted in 10-30 fold enhanced gene expression as measured by qRT-PCR (Table 3.2). 
We achieved Tn7 transposition of the sig70-luxCDABE reporter constructs into the 
genome S. Typhimurium 14028 (Fig. 3.1C) at high efficiency (Table 3.2). Since ligation 
of PacI-digested pCS26 reporter constructs into the miniTn7T delivery vector resulted in 
two possible insert orientations, we used the orientation that had slightly stronger 
expression (Fig. 3.3). For E. coli APEC O1, transposition with pHSG415-tnsABCD was 
even more efficient than in Salmonella, ranging from 2.2 x 10-8 to 1.4 x 10-10. In contrast, 
the use of pTNS2 or pTNS3 did not result in any successful transposition events.  
 We analyzed the S. Typhimurium 14028 and E. coli APEC O1 luxCDABE 
reporter strains during growth in liquid culture at 37ºC. Expression profiles clustered into  
  
68 
Table 3.2. tnsABCD expression from different Tn7 helper plasmids and resulting transposition frequencies in S. Typhimurium 
14028. 
 tnsABCD expressionb Transposition frequencyc 
Helper plasmida 1 h 2 h luxCDABE mCherry GFP 
pTNS2 1.0 ±0.1 1.9 ±0.5 0 0 0 
pTNS3 2.4 ±1.0 4.2 ±1.2 0 0 0 
pHSG415-tnsABCD 31.9 ±3.8 33.5 ±3.6 6.0 ×10-9 to 3.8×10-10 5.6 ×10-9 to 3.8×10-10 6.0 ×10-9 to 7.5×10-10 
 
a 100ng of pTNS2 or pTNS3 were electroporated into S. Typhimurium 14028 competent cells. For pHSG415-tnsABCD, 
competent cells were prepared containing this helper plasmid.  
b Total RNA was isolated from each competent cell / helper plasmid combination after recovery in SOC medium at 30ºC for 
1 h or 2 h. Expression levels were calculated individually for tnsA,B,C and D as described in the Materials and Methods; 
values represent the average fold-change for all four genes measured from four biological replicate samples, plus or minus 
the standard deviation. 
c For each reporter type, 100ng of pUC18R6K-mini-Tn7T-pCS26 delivery plasmid, containing one of six different 
constructs (KnR or CmR with sig70_16, sig70c10 or sig70c35 promoters), was electroporated into S. Typhimurium 14028 
cells containing the different helper plasmids. The values represent the range of transposition frequencies calculated based 
on the number of luminescent or fluorescent KnR or CmR colonies obtained from a total number of 2.7 × 109 competent cells. 
No colonies were obtained using pTNS2 or pTNS3 helper plasmids. 
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Figure 3.2. Plasmid-based luciferase expression in E. coli and S. Typhimurium. 
pCS26 plasmids expressing luxCDABE under the control of synthetic, σ70-dependent 
promoters were transformed into E. coli DH10B (A) or S. Typhimurium 14028 (C) and 
luciferase expression (counts per second; CPS) was measured during growth in LB at 
37ºC for 48 h. (B and D) Bars show the mean and standard deviation of the maximum 
expression values corresponding to the CmR and KnR plasmids within each sig70 
promoter group. Statistical significance (*) between CmR and KnR groups was 
determined using multiple t tests, corrected for multiple comparisons using the Holm-
Sidak method (alpha = 5%). The CmR-sig70c35 pCS26 plasmid had low expression in S. 
Typhimurium even when strains were grown in the presence of less chloramphenicol 
(i.e., 5, 7, or 9 µg mL-1; data not shown).  
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three distinct groups based on promoter strength (Fig. 3.4A, D). For S. Typhimurium 
14028, the peak expression values were 8,000 counts per second (CPS) for sig70_16, 
30,000 CPS for sig70c10, and 62,000 CPS for sig70c35, which represented step-wise 
increases of 3.6x and 8.2x (Fig. 3.4B). For E. coli APEC O1, the increase between 
sig70_16 and sig70c10 was 2.4x and between sig70c10 and sig70c35 was 5.6x (Fig. 
3.4E). For both S. Typhimurium and E. coli, there were only small expression differences 
between the KnR and CmR constructs (Fig. 3.4C, F). These results confirmed that the 
modularity of the pCS26 vector system was conserved upon integration into the 
chromosome.  
3.5.3 Generating fluorescent S. Typhimurium and E. coli reporter strains. 
 Fluorescent reporters can be used to visualize bacterial cells by microscopy after 
tissue sectioning or in in vitro experiments. To this end, we generated mCherry- and 
GFP-expressing S. Typhimurium reporter strains at high efficiency (Table 3.2). 
Expression from these strains was measured after 24 h growth at 37 ºC on Luria agar 
(Fig. 3.5A). Increasing levels of expression with the sig70_16, sig70c10 and sig70c35 
promoters could be measured for each reporter (Fig. 3.5B). The dynamic range of GFP 
and mCherry was reduced compared to luciferase, however, a more observable difference 
between promoters was measured during growth in liquid culture (Fig. 3.6). Importantly, 
only minor background fluorescence for GFP-expressing strains was detected in the 
mCherry channel and vice versa (Fig. 3.5A). A confocal microscopy image was 
generated for the KnR S. Typhimurium sig70_16-GFP reporter strain, which 
demonstrated that individual cells within the population were expressing similar levels of 
GFP (Fig. 5.3C). Similar images were generated for the S. Typhimurium mCherry 
reporter strains (data not shown). 
 mCherry- and GFP-reporter strains were also generated for E. coli APEC O1 at 
efficiencies as high as 2.2 x 10-8 (data not shown). As in S. Typhimurium, the expression 
profiles of the σ70-dependent promoters were distributed into three distinct groups during 
growth in liquid culture (Fig. 3.7). Fluorescent APEC O1 cells were also visualized by 
confocal microscopy (Fig. 3.7).  
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Figure 3.3. The influence of construct orientation on luciferase expression in S. 
Typhimurium.  
Ligation of PacI-digested pCS26 reporter constructs into the pUC18R6K miniTn7T-PacI 
delivery vector resulted in two possible insert orientations: what we termed forward 
(Tn7L-KnR/CmR-promoter-luxCDABE-Tn7R) and reverse (Tn7L-luxCDABE-promoter-
KnR/CmR-Tn7R). Since Tn7 transposition is orientation-specific, this lead to the 
generation of two final strain possibilities. We wanted to determine if construct 
orientation in the Salmonella chromosome affected luxCDABE expression. (A) 
Luciferase expression (counts per second; CPS) and (B) optical density at 590 nm were 
measured every 30 min during growth of S. Typhimurium KnR or CmR reporter strains 
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containing the sig70_16-luxCDABE construct integrated in the forward (Red) or reverse 
(Grey) orientations. Each line represents the mean luciferase expression at each time 
point from one individual clone grown in triplicate. Four forward orientation clones and 
18 reverse orientation clones were assayed. 
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Figure 3.4. Chromosome-based expression of luciferase in S. Typhimurium and E. coli.  
Synthetic, σ70-dependent promoter - luxCDABE operon fusions were integrated into the chromosomes of S. Typhimurium 14028 
∆csgD or E. coli APEC O1 using the modified Tn7 transposition system. (A and D) Luciferase expression from each strain was 
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measured during growth at 37ºC for 48 h; each line represents the expression curve from one individual reporter strain. (B and E) Box 
plots show the mean and range of maximum expression values for the different chromosomal reporter strains. Numerical values above 
the boxes represent the step-wise increase in mean expression levels between promoters. Statistical significance was calculated using 
unpaired t tests with Welch’s correction (***, p <0.001). (C and F) Maximum expression values for CmR and KnR strains within each 
sig70 promoter group are shown with histogram bars representing the mean and error bars representing the standard deviation. 
Statistical significance (*) was determined using multiple t tests, corrected for multiple comparisons using the Holm-Sidak method 
(alpha=5%).  
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Figure 3.5. Fluorescent reporter strains of Salmonella serovar Typhimurium 14028.  
(A) S. Typhimurium reporter strains with sig70_16, sig70c10, or sig70c35 promoters 
controlling luxCDABE, mCherry or GFP expression were grown on Luria agar at 37°C. 
Expression from the different strains was visualized using a IVIS Lumina II whole 
animal imaging system (Perkin-Elmer). B) Peak luciferase (CPS) or fluorescence (radiant 
efficiency) was measured using the region of interest (ROI) module in Living Image 
software ver. 4.2 (Perkin Elmer). C) Cells of the KnR sig70_16 GFP reporter strain were 
visualized on a Leica TCS SP5 Confocal microscope, using the 63x oil immersion 
objective with the 180 laser operating at 488 nm. The scale bar is displayed in the bottom 
right corner. 
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3.5.4 Use of luciferase-expressing S. Typhimurium reporter strains in vivo. 
 S. Typhimurium is a well-established pathogen capable of causing disease in 
susceptible mouse strains (41). We wanted to assess the virulence of the bacterial 
luciferase reporter strains, and determine if the antibiotic resistance markers would have 
any influence. To ensure that KnR and CmR strains would be recovered with equal 
efficiencies, we tested their plating efficiencies on Luria agar supplemented with 7, 10 or 
15 µg mL-1 of Cm or 50 or 100 µg mL-1 of Kn. Similar CFU values were detected for the 
strains on all media used, indicating that the antibiotic concentration did not affect their 
recovery (Table 3.3). C57BL/6 mice were challenged with a 1:1 ratio of KnR and CmR 
sig70_16-luxCDABE reporter strains. At 4-7 days post-infection, infected mice were 
euthanized and the bacterial loads were determined for the spleen, liver, cecum and 
mesenteric lymph nodes (Fig. 3.8). In some individual mice, the KnR reporter strain 
(black bars) was recovered at higher levels while in other mice the CmR reporter strain 
(grey bars) was recovered at higher levels. Typically, the same strain was recovered at 
higher levels in all organs from a single mouse, suggesting that the outcome of the 
competition between the strains was decided early on during infection. The competitive 
index (CI) values were calculated from each individual mouse; for each organ, the values 
were not significantly different than 1 (Fig. 3.8E). Based on this experiment, we 
concluded that the KnR and CmR S. Typhimurium reporter strains were equally virulent in 
this model.  
 In a separate trial, C57BL/6 mice were orally infected with individual S. 
Typhimurium sig70_16, sig70c10 and sig70c35 luciferase reporter strains and visualized 
using a whole animal imager. Each reporter strain produced a luciferase signal that was 
detectable within whole mice at day 1 post-infection and in their internal organs after 3-6 
days post-infection (Fig. 3.9). Similar to the in vitro experiments, there were step-wise 
increases in expression between the three promoters and the sig70c35 reporter strain had 
the highest levels of light production (Fig. 3.9C, F). Luciferase production was also 
detected from S. Typhimurium cells shed into the fecal pellets (data not shown).  
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Table 3.3. Plating efficiency of S. Typhimurium reporter strains on various media. 
 Number of CFU obtained on each media typea 
Strainb No Ab Cm7 Cm10 Cm15 Kn50 Kn100 
WT KnR 3.75×108 0 0 0 3.88×108 3.21×108 
WT CmR 4.42×108 4.17×108 4.75×108 4.79×108 0 0 
WT KnR/WT CmR 3.83×108 2.42×108 2.42×108 2.33×108 1.71×108 1.71×108 
 
a Inocula were planted on various media and the recovery of each strain was calculated. 
The values represent the mean CFU calculated from each inoculum; serial dilutions and 
plating performed using the drop dilution method. Media consisted of Luria agar with no 
antibiotic (No Ab) or supplemented with 7, 10 or 15 µg mL-1 chloramphenicol or 50 or 100 
µg mL-1 kanamycin. 
b S. Typhimurium 14028 reporter strains contained the KnR or CmR sig70_16-luxCDABE 
reporter construct integrated into the genome. Inocula consisted either of an individual 
strain or the strains combined at a 1:1 ratio. 
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Figure 3.6. The influence of antibiotic resistance marker and promoter strength on 
mCherry and GFP expression in S. Typhimurium.  
Peak fluorescence (relative fluorescent units, RFU) was measured from pCS26 plasmids 
containing the sig70-16, sig70c10 or sig70c35 promoters and mCherry (A) or GFP (B) 
reporters in S. Typhimurium 14028 or from constructs that were integrated into the 
chromosome of S. Typhimurium 14028 ΔcsgD. Bars represent the mean and standard 
deviation from at least three biological replicates. Statistical significance (*) between 
CmR and KnR strains was determined using multiple t tests, corrected for multiple 
comparisons using the Holm-Sidak method (alpha of 5%). (C and D). 48 h expression 
profiles for S. Typhimurium reporter strains with mCherry or GFP constructs integrated 
into the chromosome. Each line represents the mean luciferase expression at each time 
point from one individual clone grown in triplicate. All strains were grown in LB at 37° 
C for 48 h. 
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Figure 3.7. Chromosomal mCherry and GFP reporters in E. coli APEC O1. 
Peak fluorescence (relative fluorescent units, RFU) was measured from E. coli APEC O1 
reporter strains containing sig70-16, sig70c10 or sig70c35 promoters and mCherry (A) or 
GFP (B) reporters integrated into the genome. Box plots show the range of expression 
from multiple biological replicates with the mean represented by the horizontal line 
within each box. Statistical significance between each promoter group was determined 
using unpaired t tests with Welch’s correction (**, p <0.01; ***, p <0.001). (C and D) 
Cells of the sig70c10-mCherry or sig70c10-GFP CmR reporter strains were visualized on 
a Leica TCS SP5 Confocal microscope, using the 63x oil immersion objective with the 
180 laser operating at 488 nm. The scale bar is displayed in the bottom right corner of 
(C). 
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Figure 3.8. Bacterial counts and competitive indices from C57BL/6 mice after oral 
infection with S. Typhimurium sig70_16 lux operon fusion strains.  
The spleen (A), liver (B), cecum (C), and MLN (D) were collected from euthanized mice, 
homogenized and plated on Luria agar supplemented with 50 µg mL-1 Kn or 10 µg mL-1 
Cm to determine the levels of each strain present (measured as CFU per whole organ). E) 
Competitive index (CI) values were calculated for each mouse in each organ: CI= ([CFU 
KnR OUT/CFU CmR OUT]/[CFU KnRIN/CFU CmRIN]). A CI value of 1.0, which 
indicates equal virulence, is represented by a horizontal dotted line. Statistical 
significance from a value of 1 was determined using a Wilcoxon Signed Rank Test (ns; 
not significant, p > 0.05). 
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3.5.5 Chromosomal complementation of a S. Typhimurium ∆csgD mutant strain. 
 We predicted that we could use the modified Tn7 system to complement a S. 
Typhimurium ∆csgD strain at near stoichiometric expression levels. Regulation of csgD 
expression is known to be complex, involving multiple transcriptional regulatory 
proteins, sRNAs and histone-like proteins, such as H-NS and IHF (42). With csgD and its 
native promoter inserted downstream of glmS in the chromosome, the resulting csgD+ 
strain was compared to the ∆csgD strain complemented from a plasmid (i.e., pACYC-
csgD).  
 CsgD is the central regulator of biofilm development in Salmonella and it controls 
several multicellular behaviors that have been collectively termed the red, dry and rough 
(rdar) morphotype (43). Rdar morphotype colonies are adhesive, patterned colonies that 
can be lifted intact off the agar surface after 48h of growth (26, 43). As expected, the WT 
S. Typhimurium 14028 strain formed rdar colonies, whereas the ΔcsgD mutant strain 
formed mucoid colonies (Fig. 3.10A). Colony morphology of the csgD+ strain closely 
matched the WT strain (Fig. 3.10A), which was consistent with production of curli 
fimbriae and cellulose, two of the extracellular matrix components that are regulated by 
CsgD (44). The pACYC-csgD strain yielded colonies that were larger and had a flatter 
appearance at 30ºC (Fig. 3.10A) and were rdar-like at 37ºC, which was consistent with 
over-production of curli and cellulose (43). We also observed the phenotypes of each 
strain grown in liquid culture under biofilm-inducing conditions; cells are known to 
differentiate into multicellular aggregates (CsgD-ON state) and planktonic cells (CsgD-
OFF state) (45, 46). Multicellular aggregates were formed in WT cultures and were 
notably absent in the ΔcsgD strain (Fig. 3.10B). Aggregates were visible in the csgD+ 
and pACYC-csgD strains, demonstrating that CsgD expression had been restored. 
However, the pACYC-csgD cultures appeared almost entirely devoid of planktonic cells 
(Fig. 3.11).  
 To quantitate the degree of CsgD complementation in each strain, we measured 
the expression of csgD and csgB, coding for curli fimbriae production, and adrA, coding 
for a regulator of cellulose production, using promoter-lux operon fusion plasmids. In 
addition, the activity level of RpoS, a sigma factor that is known to regulate csgD 
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Figure 3.9. S. Typhimurium reporter strains have varying levels of luciferase 
expression in vivo.  
C57BL/6 mice were pre-treated with streptomycin then challenged with S. Typhimurium 
luxCDABE reporter strains containing promoters sig70_16 (A,D), sig70c10 (B,E) or 
sig70c35 (C,F). Mice were visualized on a whole animal imager at one day post-infection 
(A, B, C). At 4-5 days post-infection, mice were euthanized and their organs (spleen, 
liver, GI tract (stomach, intestine, cecum, and colon) and MLN) were recovered and 
imaged (D, E, F). Peak luciferase values are indicated (measured in CPS).  
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Figure 3.10. Chromosome-based complementation of a S. Typhimurium ΔcsgD 
mutant strain. 
S. Typhimurium ATCC 14028 (WT), ∆csgD, csgD+, and pACYC-csgD were grown on 
1% tryptone agar at 28ºC or 37ºC (A) or in 1% tryptone broth at 28ºC (B). (C) csgDEFG, 
csgBAC, and adrA expression was measured during growth using promoter-luciferase 
(luxCDABE) fusion plasmids, designed to measure gene expression by light production 
(counts per second, CPS). RpoS activity was measured using the sig38H4::lux reporter 
plasmid that contains a synthetic, RpoS-dependent promoter (26). Each line represents 
the expression curve from one biological replicate culture performed in triplicate, where 
CPS was measured at half hour intervals during growth. Cells were grown in 1% tryptone 
broth at 28ºC with agitation; expression was measured in a Victor X3 multi-label plate 
reader (Perkin-Elmer).  
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expression and several downstream components, was monitored using a synthetic, RpoS-
responsive promoter (26, 28). RNA-seq transcriptome analysis indicated that the presence 
of a luxCDABE fusion plasmid only has a minor effect on cell physiology (Fig. 3.12), 
therefore, these plasmids provide a good measure of real-time gene expression. 
Expression of csgD and the RpoS-responsive promoter matched closely between the WT 
and csgD+ strains during growth at 28ºC (Fig. 3.10C). In contrast, the plasmid-
complemented strain had a different csgD expression profile and the RpoS activity was 
approximately three times higher (Fig. 3.10C, blue lines). Expression of csgB and adrA 
was similarly elevated in the pACYC-csgD strain (i.e., 2x higher for csgB and 10x higher 
for adrA) as compared to the WT. In the csgD+ strain, csgB and adrA were expressed at 
lower levels, but the temporal profiles were similar to the WT strain (Fig. 3.10C). From 
this collection of experiments, we concluded that the chromosomally complemented 
strain had more stoichiometric CsgD expression than the plasmid-complemented strain.  
3.6 Discussion 
 We developed a more efficient Tn7 transposition system for use in Salmonella, E. 
coli and other Enterobacterial strains. Transposition was successful in 40 separate 
experiments when using our pHSG415-tnsABCD helper plasmid. In comparison to the 
pre-existing Tn7 system, we did not achieve a single transposition event when using the 
non-replicating, helper plasmids pTNS2 (12) or pTNS3 (34). While these plasmids may 
still work if transformed via mating (47, 48), transposition is undoubtedly a rare event. 
Use of our helper plasmid resulted in 10-30x boosted tnsABCD expression compared to 
pTNS2 or pTNS3 and transposition frequencies ranging from 10-8 to 10-10. pHSG415 is 
particularly useful because it is unstable in the absence of selection pressure (49), 
therefore growth at 37ºC without antibiotic should result in loss of plasmid from 100% of 
cells. We also tested a helper and delivery combination plasmid that was specifically 
designed for use in Salmonella (i.e., pGRG25) (18). Presumably due to the large 12.5 kb 
size of this vector, we found it difficult to clone into and we also did not achieve a single 
transposition event after 20 attempts. The only problem we encountered with pHSG415-
tnsABCD was with an antibiotic-resistant E. coli poultry isolate that we were unable to 
transform (A. Dar and B. Allan, unpublished data). Strain resistance could be overcome 
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Figure 3.11.  Comparison of wildtype S. Typhimurium 14028 and a plasmid-
complemented ΔcsgD strain in an in vitro flask model of biofilm development. 
Strains were grown for 18 h in 1% tryptone broth at 28ºC with agitation. The media in the 
WT culture appears cloudy and contains the planktonic cell fraction, whereas the media 
in the pACYC-csgD strain is mostly clear. 
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Figure 3.12.  Scatterplot to compare RNA-seq transcriptome data from S. 
Typhimurium 14028 with and without a csgD-luxCDABE operon fusion plasmid.  
RNA samples were purified from multicellular aggregates and planktonic cells isolated 
after 18 h growth in an in vitro flask model of biofilm development. Libraries were 
prepared and sequencing was performed on three biological replicate cultures. (A) For 
each gene, the average log10 read counts per million (CPM) values from S. Typhimurium 
14028 cultures were plotted against the values obtained from S. Typhimurium 14028 + 
PcsgD::luxCDABE cultures. The red line is the 45 degree line. The left panel represents 
multicellular aggregate samples and the right panel represents planktonic cell samples; 
the datasets are deposited in the SRA database (SRX976474 vs. SRX976343 for 
aggregates; SRX976470 vs. SRX976336 for planktonic cells). (B) This graph was 
included as a control to demonstrate a large difference between two sets of samples. For 
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each gene, the average log10 read CPM values obtained from multicellular aggregate 
samples vs. planktonic cell samples, prepared from S. Typhimurium 14028 cultures, are 
plotted. See reference 46 (MacKenzie et al., 2015) for a full description of this RNA-seq 
experiment, including data analysis. (A and B) R2 values correspond to the two-tailed 
Pearson correlation coefficients. The bolded numbers in parentheses represent the total 
number of differentially expressed genes between the two datasets being compared (p 
<0.05).
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by introducing a new antibiotic resistance marker in pHSG415, or perhaps through use of 
an alternative helper plasmid (17). Our modified Tn7 system was recently used to 
generate luxCDABE expressing strains of S. enterica serovar Enteritidis (S. Lam and W. 
Koester, unpublished) and E. coli K-12 (S. Bernier and M. Surette, unpublished), within 
one month of receipt of the plasmids. In theory, the use of the pHSG415-tnsABCD helper 
plasmid should allow for efficient Tn7 transposition in any bacterial species that can 
support replication of pSC101-based plasmids.  
 Reporter strains of E. coli and S. Typhimurium expressing bacterial luciferase or 
red or green fluorescent reporters were tested in combination with three synthetic, σ70-
dependent promoters. Due to the ubiquity of σ70 during growth (50), expression was 
constitutive and each promoter had similar temporal patterns that differed only in 
strength. The S. Typhimurium luciferase reporter strains provided stable expression 
throughout the infection of mice and three different levels of expression were observed. 
However, we were unable to detect Salmonella during the middle stages of infection (i.e., 
Day 2-4). It is possible that a stronger σ70-dependent promoter, perhaps with both -10 and 
-35 consensus sequences (51), will allow visualization at lower cell numbers. The three 
levels of expression provide flexibility to ensure that the proper balance between reporter 
signal and minimal impact on biological processes can be achieved. It should be noted 
that there is a published method using Tn7 to generate bioluminescent Salmonella strains, 
and these authors demonstrated that luciferase output was proportional to cell number 
(21); however, their system does not provide for same flexibility that the pCS26-based 
system does. We have used pCS26 in the past to track the expression of various genes in 
vivo (32), but plasmid instability was a problem. The stochasticity of plasmid loss makes 
it difficult to form strong conclusions about the expression of different genes or to 
correlate with a specific number of bacterial cells. Now, with a system to easily integrate 
pCS26 constructs into the chromosome, expanded in vivo gene tracking experiments can 
be performed.  
 The E. coli and S. Typhimurium strains expressing fluorescent reporters were 
designed for future single cell applications, for example to analyze the dynamics within 
bacterial populations (52) or to study host-pathogen interactions (53). We demonstrated 
that these reporter strains could be detected with a 96-well plate reader, on solid media 
  89 
using a whole animal imager and by confocal microscopy. Although there was 
differentiation between the σ70-dependent promoters, the dynamic range of the 
fluorescent reporters was far less than luciferase, which is consistent with previous 
studies comparing these reporters (54). GFP and mCherry can be used for whole animal 
imaging experiments, but the autofluorescence from tissue and absorbance from specific 
cell molecules (i.e., hemoglobin) makes detection difficult (55). As a result, there has 
been a continual push to generate fluorescent reporters that have a lower background for 
whole animal imaging, such as those that emit signals in the near infrared range (i.e., 
>700nm (56)). If new reporters do become available (9), they can easily be incorporated 
into the pCS26 system and used to generate new chromosomal reporter strains.  
 The use of both kanamycin and chloramphenicol resistance markers facilitates 
competition experiments between Salmonella or E. coli strains or between different 
bacterial species. We had initial concerns with use of the kanamycin marker for infection 
experiments, due to the potential overgrowth of normal flora isolates upon recovery, but 
we did not encounter any problems. If a researcher does encounter low-level resistance, 
our tests showed that the KnR and CmR strains could be recovered equally well at higher 
antibiotic concentrations. We also generated a tetracycline-resistant pCS26 derivative, 
but luciferase expression was much higher and appeared to be unregulated (D.J. Shivak 
and A.P. White, unpublished data). It is assumed that insertion of transcriptional 
terminators upstream and downstream of the tetC gene would correct this problem, but 
we did not investigate this further.  
 Since the original publication of the Tn7 transposition method (12), it has proven 
to be an incredibly useful system. Modifications have been made in an attempt to 
improve the flexibility of the system (as described in the Introduction) and to incorporate 
new aspects of gene expression analysis (57). The work we have described will add to the 
microbiologist toolbox for researchers who study bacterial species within the 
Enterobacteriaceae, by providing great flexibility and the ability to combine with high-
throughput expression experiments. The tnsABCD helper and miniTn7T delivery 
plasmids that we have generated will allow the development of chromosomal reporter 
strains in as little time as 2-4 weeks. These plasmids can be easily modified and are freely 
available upon request. 
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4.1 Interface 
 This chapter presents our molecular and phenotypic analysis of the multicellular 
aggregates and planktonic cells that arise due to bistable expression of csgD. The results 
presented in this chapter provided the first published characterization of these 
subpopulations. Our focus was to understand the consequences of the CsgD bistability 
phenomenon that was previously described in the literature. As such, we designed our 
experiments to directly compare the subpopulations of multicellular aggregates and 
planktonic cells. We determined that the multicellular aggregates have a gene expression 
profile consistent with cell survival, whereas planktonic cells express multiple genes 
associated with virulence. The kanamycin- and chloramphenicol-resistant Salmonella 
strains generated using the Tn7 transposition system in the previous chapter allowed us to 
directly compare the relative fitness of the subpopulations in assays of virulence and 
persistence and provided powerful functional validation of the gene expression profiles 
that we had identified for multicellular aggregates and planktonic cells. 
4.2 Abstract 
 Pathogenic bacteria often need to survive in the host and the environment, and it 
is not well understood how cells transition between these equally challenging situations. 
For the human and animal pathogen Salmonella enterica serovar Typhimurium, biofilm 
formation is correlated with persistence outside a host but the connection to virulence is 
unknown. In this study, we analyzed multicellular aggregates and planktonic cell 
subpopulations that co-exist when S. Typhimurium is grown under biofilm-inducing 
conditions. These cell types arise due to bistable expression of CsgD, the central biofilm 
regulator. Despite being exposed to the same stresses, the two cell subpopulations had 
1856 genes that were differentially expressed, as determined by RNA-seq. Aggregated 
cells displayed the characteristic gene expression of biofilms, whereas planktonic cells 
had enhanced expression of numerous virulence genes. Increased type three secretion 
synthesis in planktonic cells correlated with enhanced invasion of a human intestinal cell 
line and significantly increased virulence in mice as compared to the aggregates. 
However, when these same groups of cells were exposed to desiccation, the aggregates 
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survived better and the competitive advantage of planktonic cells was lost. We 
hypothesize that CsgD-based differentiation is a form of bet hedging, with single cells 
primed for host cell invasion and aggregated cells adapted for persistence in the 
environment. This would allow S. Typhimurium to spread the risks of transmission and 
ensure a smooth transition between the host and the environment. 
4.3 Introduction 
 Salmonella persistence, or the ability of cells to survive in stressful conditions, 
has traditionally been studied separately from virulence. The continued success of these 
pathogens, however, dictates that both traits must be inherently connected. Most of the 
>2000 serovars of Salmonella collectively account for approximately 94 million annual 
cases of human gastroenteritis (1), a disease characterized by intestinal inflammation and 
diarrhea (2). The gastroenteritis-causing serovars are collectively referred to as non-
typhoidal Salmonella (NTS), and serovar Typhimurium is one of the most commonly 
isolated in the world. Most NTS isolates are considered to be host-generalists with a 
cyclical lifestyle involving exposure to the environment in between host colonization 
events (3). This is in contrast to typhoidal Salmonella serovars (i.e., Typhi and Paratyphi 
A), which are human-restricted (4, 5). Despite their differences, both NTS and typhoidal 
Salmonella rely on type three secretion systems (T3SS) to stimulate invasion, uptake and 
survival within human epithelial cells and macrophages (6). While we have an improving 
understanding of pathogenesis, less is known about the strategies that pathogenic 
Salmonella strains employ to survive outside the host (7, 8). It is generally assumed that 
people become infected with Salmonella through ingestion of contaminated food and 
water, but there are also numerous examples of sporadic human cases where the causative 
source is unknown (9). 
 One strategy for bacterial survival is through the formation of biofilms, where 
cells aggregate and become embedded in a self-produced extracellular matrix, usually in 
contact with a surface. This has been described in Salmonella as the rdar (red, dry and 
rough) morphotype (10, 11). The extracellular matrix surrounding rdar-positive cells is 
comprised of protein polymers (curli fimbriae) and extracellular polysaccharides 
(cellulose and an O-antigen capsule) that physically link cells together (10-13). The genes 
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coding for these polymers are conserved throughout Salmonella (14, 15) and Escherichia 
coli (16, 17). Comparisons between rdar-positive and rdar-negative S. Typhimurium and 
E. coli strains have shown that embedded cells have enhanced persistence upon exposure 
to conditions of starvation, desiccation and treatment with disinfectants (15, 18-21), as 
well as an increased ability to adhere to both biotic and abiotic surfaces (22, 23). Rdar-
positive cells can also cause infections after long time periods (24), but do not appear to 
be specifically adapted for virulence (25). Rdar-negative Salmonella and E. coli isolates 
tend to cause more invasive forms of disease (26, 27).  
 Most NTS isolates are rdar-positive and most typhoidal Salmonella isolates are 
rdar-negative (21, 25, 26). One possible explanation for this correlation is that the rdar 
morphotype is an adaptation necessary for life outside the host. However, there have been 
recent links between the rdar morphotype, immune stimulation and invasion (28, 29), 
making it difficult to fully understand this physiology. Although they are informative, a 
potential problem with strain-to-strain comparisons is that they could miss fluctuations 
that exist within individual populations of cells. It was recently demonstrated that when 
S. Typhimurium is grown under biofilm-inducing conditions in liquid media, the 
population of cells in the fluid phase differentiates into large, multicellular aggregates 
and single (planktonic) cells (25, 30). This bifurcation is caused by the bistable synthesis 
of CsgD, the central transcriptional regulator of the rdar morphotype (31). Aggregated 
cells are in a CsgD-ON state, whereas the non-aggregative planktonic cells are primarily 
in a CsgD-OFF state. The multicellular aggregates can be thought of as non-canonical 
biofilms, as the cells highly express extracellular matrix components (25, 30), but are not 
in direct contact with a surface. While it is assumed that the aggregates retain the 
resistance properties of classic adherent biofilms, the planktonic cells that result from 
CsgD bistability have never been analyzed in detail and it is unclear what role they may 
have in S. Typhimurium physiology.  
 In this study, we have isolated and examined these two groups of cells and 
demonstrate for the first time that they could represent a critical link between the 
virulence and persistence of Salmonella. Bistability and the formation of specialized cell 
types are predicted to contribute to S. Typhimurium transmission success, with single 
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cells adapted for host cell invasion and multicellular aggregates adapted for persistence in 
the environment. 
4.4 Materials and Methods 
4.4.1 Bacterial strains, media, and growth conditions. 
 Salmonella enterica serovar Typhimurium strain ATCC 14028 was the wildtype 
strain in this study. In general, strains were inoculated from frozen stocks onto LB agar 
and grown for 20 h at 37˚C. One isolated colony was used to inoculate 5 mL LB broth 
(containing 1% NaCl) and the culture was incubated for 12 h at 37˚C with agitation at 
200 rpm. To analyze growth under biofilm-inducing conditions, approximately 4 x 109 
CFU were inoculated into 400 mL of 1% tryptone pH 7.4 and the culture was distributed 
in 100 mL volumes into four 250 mL flasks that were incubated at 28˚C for 8h, 13h, 18 h, 
or 32 h with agitation at 200 rpm. The csgD promoter (PcsgD) luxCDABE fusion plasmid 
used for bioluminescence assays has been previously described (21). To measure 
luminescence, 200 µl aliquots of culture were removed at hourly intervals in triplicate 
using a wide-bore pipette, transferred into individual wells of a 96-well clear-bottom 
black plate (Product #9520, Corning Life Sciences), and assayed on a Victor 
X3 multilabel plate reader (Perkin-Elmer Life Sciences). 
4.4.2 Generation of S. Typhimurium 14028 ΔcsgD and ΔSPI-1 mutant strains. 
 ∆csgD and ∆SPI-1 strains were generated using the lambda red recombinase 
knockout procedure (32). Primers containing a 50 nucleotide sequence on either side of 
the entire SPI-1 region (SPI-1F and SPI-1R) (33) or csgD (csgDko sense; 
GCAGCTGTCAGATGTGCGATTAAAAAAAGTGGAGTTTCATCATGTTTAATGT
GTAGGCTGTAGCTGCTTC and csgDko antisense; CTCTGCTGCTACAATCCAGG 
TCAGATAGCGTTTCATGGCCTTACCGCCTGCCTCCTTAGTTCCTATTCCG) were 
used to amplify the cat gene from pKD3 using Phusion High-Fidelity DNA polymerase 
(New England Biolabs). PCR products were purified (AxyPrep Mag PCR clean-up kit; 
Axygen) and electroporated into S. Typhimurium 14028 cells containing pKD46. Mutant 
strains were first selected by growth at 37°C on LB agar supplemented with 7 µg mL-1 
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Cm, before re-streaking onto LB agar containing 30 µg mL-1 Cm. Mutations were moved 
into clean wild-type backgrounds by transduction with P22 phage (34). The cat gene was 
resolved from the chromosome using pCP20 (32). DNA sequencing of PCR products 
amplified from the chromosome of ∆csgD or ∆SPI-1 strains confirmed the loss of the 
majority of csgD or SPI-1, respectively.  
4.4.3 Generation of KnR or CmR-resistant S. Typhimurium strains.  
 sig70-16 is a reporter plasmid that contains a synthetic, σ70-dependent promoter 
driving luxCDABE expression (35). A chloramphenicol-resistant (CmR) version of the 
sig70-16 plasmid was generated, and the sig70_16-KnR or -CmR fragments were used for 
Tn7 integration (36) into the S. Typhimurium ATCC 14028 chromosome, using a 
modified protocol (D. Shivak, K. MacKenzie, B. Jones and A. White, submitted for 
publication). To confirm that the fragments had been properly inserted into the attTn7 
site downstream of the glmS gene of S. Typhimurium, the chromosomal region was PCR 
amplified and the resulting products were sequenced. To ensure the absence of secondary 
mutations, the KnR and CmR sig70_16 fragments were moved into a clean wild-type or 
ΔcsgD background by P22 transduction.  
4.4.4 Isolation of multicellular aggregates and planktonic cell subpopulations.  
 S. Typhimurium biofilm cultures were transferred into 15 mL conical tubes and 
subjected to slow-speed centrifugation (210 x g, 2 min, 4°C). The supernatant fractions 
were transferred into new 15 mL tubes, and the cell aggregates were transferred into 1.5 
mL tubes using a sterile loop. After brief centrifugation (10,000 x g, 30 s), culture media 
was removed and the wet weight of the aggregates was determined. Aggregates were 
resuspended in 1 mL of PBS (for direct counting) or 1 mL cell-free 1% tryptone culture 
supernatant (for subsequent applications) and homogenized for approximately 30 s (25 
dounces) with a glass tissue grinder (Product #7727-2, Corning Life Sciences). For CFU 
determination, serial dilutions of planktonic cells or homogenized aggregates were plated 
in 4 µL drops onto LB agar, prior to incubation overnight at 37°C.  
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4.4.5 Visualizing the homogenization of multicellular aggregates 
 Multicellular aggregates were harvested from a S. Typhimurium 14028 reporter 
strain containing a csgBAC promoter - GFP fusion (25) grown for 13 h (TP2). 10 mg of 
aggregates were resuspended in 1 mL of cell-free culture supernatant, homogenized in a 
tissue grinder, and two successive 1 in 10 dilutions were used to prepare a solution of 1.2 
x 107 CFU/mL. Ten 200 mL aliquots were individually concentrated onto the surfaces of 
3 inch x 1 inch x 1.0 mm glass slides (Fisher Scientific #12-550-343) using a Cytospin-4 
cytocentrifuge (Thermo Shandon, Asheville, NC). Samples were centrifuged at 500 rpm 
for 5 min with low acceleration. 5 mL of Mowiol mounting medium (Sigma-Aldrich # 
81381) was added to the cells on each slide and each mixture was topped with a #1 ½ 
micro-cover glass (12 mm diameter) (Electron Microscopy Sciences #72230-01). Slides 
were air-dried overnight prior to visualization on a Leica TCS SP5 Confocal microscope, 
using the 63x oil immersion objective with the laser operating at 488 nm.  
4.4.6 SDS-PAGE and western blotting.  
 Planktonic cells were sedimented (11,000 x g, 10 min, 4°C) to concentrate the 
samples, before suspending in 1 mL of SDS-PAGE sample buffer (without 2-
mercaptoethanol and bromophenol blue). 100 mg samples of multicellular aggregates 
were resuspended in 1 mL of water and homogenized with a glass tissue grinder. Cell 
material was sedimented (10,000 x g, 1 min) before resuspending in 1 mL of SDS-PAGE 
sample buffer and boiling for 5 min. Protein concentrations were determined using the 
DC protein assay kit (BioRad Laboratories), and samples were normalized to 30 mg of 
total protein per lane and Bromophenol blue (0.0002% final conc.) and 2-
mercaptoethanol (0.2% final conc.) were added. SDS-PAGE was performed with a 5% 
stacking gel and a 12% resolving gel or with 10%, 12% or 4-15% pre-cast Mini-
PROTEAN TGX™ gels (Bio-Rad Laboratories). For immunoblots, proteins were 
transferred to nitrocellulose for 40 min at 25 V using a Trans-Blot SD semi-dry transfer 
cell (Bio-Rad Laboratories) in buffer recommended by the manufacturer. For detection of 
curli fimbriae, cell samples were boiled for 5 min in SDS-PAGE sample buffer with 2-
mercaptoethanol, the cell debris was sedimented (14,000 x g, 2 min), washed twice in 
  104 
500 mL of distilled water, before suspending in 250 mL of 90% formic acid, freezing at -
80°C and lyophilization (10). Dried samples were resuspended in SDS-PAGE sample 
buffer and loaded directly, without boiling, into each gel lane prior to electrophoresis.  
 CsgD was detected using the monoclonal antibody described below. CsgA, the 
major subunit of curli fimbriae, was detected using rabbit polyclonal immune serum 
raised to whole purified curli (10). GroEL was used as a protein-loading control and was 
detected with rabbit polyclonal immune serum used at a 1 in 10,000 dilution (Sigma-
Aldrich, G6532). SPI-1 TTSS proteins (InvG, SipD, SopE2, and SopB) were detected 
with rabbit polyclonal immune sera generated against each of the individual proteins 
(33). Secondary antibodies were goat anti-rabbit immunoglobulin G (IgG)- or human-
adsorbed, goat-anti-mouse IgG-alkaline phosphatase conjugates (KPL; www.kpl.com). 
Proteins were detected by dye precipitation using the substrate 5-bromo-4- chloro-3-
indolylphosphate and 4-nitroblue tetrazolium chloride (Sigma-Aldrich) as an enhancer. 
4.4.7 Generation of CsgD-specific monoclonal antibodies. 
 csgD was PCR-amplified from S. Typhimurium 14028 genomic DNA using 
Phusion High-Fidelity DNA polymerase (New England Biolabs) and primers 
csgD_expFOR (GGCTCATATGTTTAATGAAGTCCATAG) and csgD_expREV2 
(ATTTCTCGAGCCGCCTGAGATTATCGTTTG). The PCR product was digested with 
NdeI and XhoI and ligated into NdeI/XhoI-digested pET-21a (Novagen) using T4 DNA 
ligase (NEB), to generate a vector encoding CsgD with a 6xHis tag at the C-terminal end. 
E. coli BL21-DE3 + pET21a-csgDHis was grown at 37°C with agitation at 200 rpm in 
LB supplemented with 100 µg mL-1 ampicillin until an OD600 of 0.7 was reached; 
expression of CsgD-His was induced by adding IPTG to a final concentration of 1mM 
and growing for 2 h. Cells were harvested, lysed and CsgD-His was purified using a Ni-
NTA agarose column (Qiagen), following procedures outlined by the manufacturer 
(Qiagen; The QIAexpressionist, Protocol 9). Approximately 5 mg of purified CsgD-His 
was used for Rapid Prime - Custom Monoclonal Antibody Development (ImmunoPrecise 
Antibodies Ltd., Victoria, BC, Canada). Concentrated tissue culture supernatants 
containing a CsgD-specific monoclonal antibody were used for western blotting 
experiments. 
  105 
4.4.8 Measurement of c-di-GMP levels inside cells. 
 Planktonic cells and multicellular aggregates were harvested from 100 mL S. 
Typhimurium biofilm cultures grown for 8 h (TP1) or 13 h (TP2). Planktonic cell 
samples were prepared by centrifugation (10,000 x g, 10 min) and multicellular aggregate 
samples were homogenized as above in cell-free culture supernatant. Cyclic-di-GMP 
extractions were performed with 100 uL of 40% methanol-40% acetone in 0.1 N formic 
acid used for every 48 mg wet weight of cells (37). Cell samples were transferred into 
screw-capped tubes containing 0.2 g of 0.1 mm Zirconia beads and homogenization was 
performed in a high-speed mixer mill (Retsch; MM400) for 2 minutes at 30 Hz. After 
centrifugation (16,000 x g, 2 min), the supernatant was neutralized by the addition of 4 
ml of 15% ammonium bicarbonate per 100 ml of sample. 50 mL aliquots of each sample 
were dried down in a speed-vacuum concentrator and residues were dissolved in 300 uL 
of 30% methanol followed by solid-phase extraction with Agilent OPT 30mg/mL 
reversed-phase cartridges (Agilent# 5982-3013) to remove lipids and other lipophilic 
compounds.  The flow-through fractions were collected under a 3-5 psi vacuum and the 
cartridges were washed with 400 mL of 30% methanol. The flow-through fractions were 
collected and pooled for each sample and were dried down in a speed-vacuum 
concentrator. The residues were resuspended in 50 mL of 80% acetonitrile and 20 uL 
aliquots were injected into a Dionex UPLC 3000 system coupled to an AB Sciex 4000 
QTRAP mass spectrometer, which was operated in the electrospray ionization and 
negative ion multiple-reaction monitoring (MRM) mode.  The MRM transition for 
quantitation was 689.2/344.2.  UPLC separation was carried out on a 10-cm long UPLC 
column, which was run in a hydrophilic interaction (HILIC) mode. The mobile phase was 
ammonium acetate – acetonitrile for binary gradient elution.  The column temperature 
was 30oC and the flow rate was 0.40 mL/min.  A standard curve for cyclic-di-GMP 
(www.axxora.com; #BLG-C057) was prepared within a concentration range of 2 to 400 
fmol/mL. The concentration of cyclic-di-GMP in each sample was calculated with 
external calibration. Since multicellular aggregates consist of both cells and extracellular 
matrix, a conversion factor was applied to all c-di-GMP concentrations. 1 mg wet weight 
of planktonic cells was equivalent to 6.94 x 108 CFU, whereas 1 mg wet weight of 
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multicellular aggregates was equivalent to 1.73 x 108 CFU. This conversion was thought 
to represent a more accurate cell-to-cell comparison between samples.  
4.4.9 RNA purification procedure. 
 Total RNA was isolated using a modified procedure based on the SV Total RNA 
Isolation Kit (Promega). At TP1, cells were sedimented by centrifugation (10,000 x g, 2 
min, 4ºC) and resuspended in 1 mL of RNALater (Life Technologies). At later time 
points, cell subpopulations were first separated by slow-speed centrifugation, as 
described above. Planktonic cell fractions were sedimented as above and resuspended in 
1 mL of RNALater (Life Technologies). Multicellular aggregate samples were 
resuspended in 1 mL of RNALater and homogenized for approximately 30 s using a 
tissue grinder.  Cells in 1 mL of RNALater were sedimented by centrifugation (13,200 x 
g, 1 min) and resuspended in 700 µl of RNA Lysis Buffer (RLA). This cell suspension 
was transferred to a 1.5 mL screw-capped tube containing 0.2 g of 0.1 mm Zirconia 
beads, and homogenized in a high-speed mixer mill (Retsch; MM400) for 5 minutes at 30 
Hz. Approximately 300 – 400 uL RLA solution was recovered from the beads, 600 – 800 
mL of RNA Dilution Buffer was added, followed by 0.4 volumes of 95% ethanol. 
Samples were centrifuged (13,200 x g, 10 min) to remove extracellular debris that 
precipitated upon addition of ethanol, prior to loading onto the RNA purification column. 
This step was necessary to avoid plugging the column, especially with the multicellular 
aggregate samples. Column washing steps and on-column DNase I treatment were 
performed according to manufacturer’s instructions. Bound RNA was eluted from each 
column with 2 x 50 µL of RNase-free water for a final volume of 100 µL. After elution, 
samples were DNase treated a second time in solution using a Turbo DNA-free kit (Life 
Technologies #AM1907). The MICROBExpress™ Bacterial mRNA Enrichment Kit 
(Life Technologies #AM1905) was used for mRNA enrichment. To assess quantity, 
purity and integrity of RNA, samples were analyzed using a NanoDrop ND-1000 
spectrophotometer (Fisher Scientific) and Agilent 2100 Bioanalyzer with a Prokaryote 
Total RNA Nano chip. 
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4.4.10 Directional RNA-seq 
 For sequencing on the Illumina HiSeq 2000, first strand cDNA was synthesized 
from RNA using random hexamer priming and reverse transcriptase. Second strand 
cDNA synthesis was performed with DNA polymerase I in presence of dATP, dGTP, 
dCTP and dUTP. Double-stranded cDNA was fragmented by sonication and 70-200 bp 
fragments were purified with AMPure magnetic beads (Beckman-Coulter). After the 
standard addition of 18 mL of AMPure beads to every 10 mL of sample, 9.3 mL 
isopropanol was added. This step allows recovery of fragments below 100 bp, as 
described in the AxyPrep Mag PCR Clean-up kit protocol (Axygen Biosciences Inc.). 
cDNA fragments were ligated to Illumina adapters and primers containing bar-coded 
sequences; fragment sizes in the final library ranged from approximately 196 to 326 bp. 
The second cDNA strand containing UTP was selectively removed by uridine digestion 
(37°C, 15 min) in 5 mL of 1x TE buffer, pH 7.5 with 1 unit of Uracil-N-Glycosylase 
(UNG; Applied Biosystems), prior to library amplification and sequencing (38). In total, 
21 libraries were sequenced (75 bp paired-end PET sequencing), prepared from three 
biological replicates of planktonic cells (samples at TP1, TP2, TP3 and TP4) and 
multicellular aggregates (samples at TP2, TP3 and TP4).  
 For sequencing on the Illumina MiSeq, cDNA libraries prepared from S. 
Typhimurium 14028 ∆csgD at TP2 were constructed using the NEBNext Ultra 
Directional RNA Library Prep Kit for Illumina (New England Biolabs) as per the 
manufacturer’s protocol. This differs from the above protocol in that fragmentation 
occurs through autocatalysis of RNA before first strand cDNA synthesis.  Final library 
fragment sizes were 200-300 bp.  This approach also incorporates dUTP into the second 
cDNA strand synthesis followed by digestion of the second strand before PCR 
amplification. 75 bp paired-end PET sequencing was performed on three libraries using 
the MiSeq Reagent Kits v3 (Illumina). 
4.4.11 Mapping and Comparison of Sequencing Reads 
 Sequencing reads were mapped onto the S. Typhimurium ATCC 14028 
chromosome (NC_016856) and plasmid (NC_01685) sequence using Geneious v5.6.5 
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(www.biomatters.com). The mapping parameters were set as following: 1) gaps not 
allowed; 2) words repeated more than twice ignored; and 3) maximum mismatches per 
read set as 4%. Other parameters conform to the default settings of Geneious. The 
coordinates and strand of each putative protein-encoding gene were according to genome 
annotations (39), and in-house perl scripts were used for counting the number of mapping 
reads to each protein encoding gene and its antisense strand. The sRNA coverage was 
counted in a similar way. The full set of known Salmonella sRNAs (40), were retrieved 
and the orthologous counterparts in S. Typhimurium 14028 were found by direct 
sequence alignment.  
 Before comparing the gene expression levels between samples, the counts of 
mapped reads were normalized with edgeR, which, instead of using RPKM notation, 
assumes the total RNA amount could vary among different samples, and expression of 
more genes should be stable among libraries (41).  A negative binomial distribution was 
fit for the normalized read counts for each pair of genes. Differentially expressed genes 
were identified as those with p value < 0.05, determined by a Benjamini & Hochberg 
correction for the multiple testing results (42, 43) with the False Discovery Rate (FDR) 
set as < 0.05. The normalization effect was evaluated before data analysis by observing 
the variance among technical and biological repeats after normalization.  
4.4.12 Motility comparison between planktonic cells and multicellular aggregates. 
 Cell subpopulations were isolated from S. Typhimurium biofilm cultures at TP2 
and either tested for motility directly or after homogenization for 30s in a tissue grinder. 1 
mL aliquots (approximately 5 x 106 CFU) of each cell suspension were inoculated into 
the middle of swim agar (lysogeny broth (Luria) + 0.25% agar) and plates were allowed 
to dry for 20 min. Migration distances from the center of the plate were recorded after 
incubation at 37°C for 8 h. Five technical replicates of each sample were tested prepared 
from three biological replicate cultures. Statistical difference between samples was 
calculated using unpaired t tests (** p <0.01). 
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4.4.13 Invasion assay using polarized Caco-2 cells. 
 Caco-2 cells (obtained from Brett Finlay, University of British Columbia) were 
grown at 37°C in the presence of 5% CO2 in DMEM complete media (HyClone Dulbecco 
modified Eagle medium (Fisher Scientific) supplemented with 10% fetal bovine serum 
(Seracare Life Sciences) and 1% nonessential amino acids (Life Technologies)). To 
obtain polarized monolayers, Caco-2 cells were seeded onto Transwell inserts (24 mm in 
diameter, 0.4-mm pore size; product #3470, Corning Life Sciences) for approximately 21 
days. The cells were used for invasion assays once the transepithelial resistance (TER) 
was 700 - 900 Ω cm-2 (33). Planktonic cells and multicellular aggregates isolated from S. 
Typhimurium cultures were suspended in DMEM complete media and applied in 200 mL 
aliquots to the apical surface of the Caco-2 cells; invasion in three replicate wells was 
assessed for every sample. Wildtype and ∆SPI-1 mutant strains grown to late-exponential 
phase, at an OD600 of 0.7 in LB at 37°C, were used as positive and negative invasion 
controls, respectively. After 1 h exposure to S. Typhimurium, Caco-2 cells were washed 
three times with 200 µL of PBS and incubated for 2 h with DMEM complete containing 
1.2 mg mL-1 gentamicin to kill any remaining extracellular bacteria. Caco-2 cells were 
washed two times with 200 µl of PBS and lysed by exposure to 1% Triton. Serial 
dilutions of the Salmonella-containing lysate were plated in 4 mL drops on LB agar and 
incubated overnight at 37ºC. We aimed for a multiplicity of infection (MOI) of 10 based 
on an estimated 2.5 x 105 polarized Caco-2 cells per well. The true MOI was determined 
by serial dilution and plating on LB agar followed by incubation overnight at 37°C. 
4.4.14 Gentamicin susceptibility testing. 
 Samples containing approximately 5 x 107 CFU mL-1 of planktonic cells or 
multicellular aggregates isolated from S. Typhimurium 14028 cultures were prepared in 
cell-free, spent culture media. 1 mL aliquots were centrifuged (8000 x g, 2 min), and cells 
were resuspended in 1 mL of DMEM complete containing gentamycin at concentrations 
ranging from 0.2 to 1.2 mg mL-1. After 2 h exposure, cells were sedimented, washed and 
resuspended in PBS, and homogenized for 30s using a tissue grinder. Serial dilutions of 
each sample were plated on LB agar and grown overnight at 37°C to determine the 
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number of CFU. Four technical replicates of each sample were tested and the experiment 
was repeated three times. Statistical difference between samples was calculated using 
unpaired t tests (* p <0.05, ns p >0.05). 
4.4.15 Competitive index (CI) infections of mice.  
 Female C57BL/6 mice (6 to 8 weeks old) purchased from Jackson Laboratory 
(Bar Harbor, ME) were assigned to cage groups using a randomization table prepared in 
Microsoft Excel and individual mice were marked with ear notches. Challenge 
formulations A and B were prepared in 100 mM HEPES pH8 at a concentration of ~107 
CFU per 100 µL, consisting of an approximate 1:1 ratio of cells isolated from CmR or 
KnR S. Typhimurium cultures at TP2 (Fig. 4.11). Animal care technicians assigned 
challenge A and B to 2 cages each (i.e., 4 groups of 6 mice, n = 24) and performed all 
infections. Cage assignments were only revealed to members of the White lab after the 
final results were analyzed. Infected mice were weighed daily and monitored for clinical 
signs of infection; mice that had a >20% drop in weight were euthanized, typically 4 – 7 
days post-infection. The spleen, liver, cecum and mesenteric lymph nodes (MLN) were 
homogenized in Eppendorf Safe-Lock Tubes containing 1 mL of PBS and a 5 mm 
stainless steel bead (Qiagen # 69989) using a high-speed mixer mill (Retsch; MM400). 
To determine the number of CFU in the initial challenges or organ homogenates, serial 
dilutions were plated on LB agar supplemented with 10 µg mL-1 Cm or 50 µg mL-1 Kn. 
The competitive index (CI) was calculated as [CFU planktonic/CFU biofilm]output/[CFU 
planktonic/CFU biofilm]input. For statistical analysis, the normality of each set of CI data 
was assessed using the Shapiro-Wilk normality test followed by the Wilcoxon signed 
rank test to determine if the median CI was significantly different from 1 (** p<0.01, 
*** p <0.001, **** p <0.0001, ns p >0.05). 
4.4.16 Input and output ratios for CI infections.  
 For the initial CI trial, the input ratio for challenge A was 0.76 (7.9 × 106 CFU 
planktonic cells, and 1.0 × 107 CFU aggregates) and for challenge B was 0.60 (5.9 × 106 
CFU planktonic cells and 9.9 × 106 CFU aggregates). To analyze the effect of 
homogenization, challenge mixtures were homogenized in a tissue grinder for 
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approximately 30 s before oral gavage. The input ratio for challenge A was 1.19 (4.8 × 
106 CFU planktonic cells and 4.0 × 106 CFU aggregates) and for challenge B was 0.85 
(5.6 × 106 CFU planktonic cells and 6.6 × 106 CFU aggregates). Input ratios for the 
wildtype planktonic cells versus ∆csgD planktonic cells trial were 1.07 for challenge A 
(6.7 × 106 CFU wildtype, and 6.3 × 106 CFU ∆csgD) and 1.11 for challenge B (7.7 × 106 
CFU wildtype, and 6.9 × 106 CFU ∆csgD). For the trial using planktonic cells and 
multicellular aggregates prepared from ΔSPI-1 cultures, the input ratio for challenge A 
was 0.27 (4.8 × 106 CFU planktonic cells, and 1.8 × 107 CFU aggregates) and for 
challenge B was 3.7 (4.4 × 106 CFU planktonic cells and 1.2 × 106 CFU aggregates). For 
the trial using dehydrated planktonic cells and multicellular aggregates (see below), the 
input ratio for challenge A was 0.11 (7.2 × 105 CFU planktonic cells, and 6.5 × 106 CFU 
aggregates) and for challenge B was 0.07 (3.0 × 105 CFU planktonic cells, and 4.2 × 106 
CFU aggregates).  
4.4.17 Desiccation of S. Typhimurium challenge formulations. 
 Planktonic cells and multicellular aggregates from the initial CI trial were 
suspended in spent culture supernatant and 200 mL aliquots were pipetted into individual 
wells of 24-well tissue culture plates. The plates were placed in a biological safety 
cabinet, the liquid was allowed to evaporate, and then plates were covered and left to sit 
on the lab bench. At time 0, 4 weeks and 5.5 weeks, 500 mL of PBS was added to 
individual wells and the cells were allowed to rehydrate for 30 min prior to 
homogenization using a tissue grinder and plating to determine the number of surviving 
CFU from each cell type. Statistical difference between samples was calculated using 
unpaired t tests (** p <0.01, **** p <0.0001). For the CI trial performed at 4 weeks, cells 
were resuspended in a total volume of 3 mL of 100 mM HEPES pH 8 per 24-well plate. 
4.4.18 Ethics Statement 
 All animals were cared for and used in accordance with the Guidelines of the 
Canadian Council on Animal Care, the Regulations of the University of Saskatchewan 
Committee on Animal Care and Supply, and in accordance to the “3R principles”. All 
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mouse experiments were performed under Animal Use Protocol # 20110057 that was 
approved by the University of Saskatchewan’s Animal Research Ethics Board. 
4.5 Results 
 We grew S. Typhimurium 14028 in liquid culture under biofilm inducing 
conditions to examine differentiation within the population. After 13 h growth, 
multicellular aggregates were clearly visible within the culture (Fig. 4.1A), ranging in 
size between 100 – 500 mm (Fig. 4.1B). The aggregates had high levels of csgBAC 
(curli) transcription, as measured using a GFP reporter (Fig. 4.1C). To monitor the 
dynamics of the differentiation process, we measured the real-time expression of csgD in 
the total population while observing the appearance of multicellular aggregates (Fig. 
4.2A). Four time points were chosen for further analysis: Time point 1 (TP1) was 
considered a pre-aggregation condition, when overall csgD expression was low (Fig. 
4.2A) and the culture appeared homogeneous (data not shown); TP2 had peak csgD 
expression that coincided with the appearance of multicellular aggregates; TP3 had high 
csgD expression and the culture appeared fully differentiated; and TP4 was visually the 
same as TP3, but csgD expression had dropped to near baseline levels. Slow-speed 
centrifugation was used to sediment the multicellular aggregates while the planktonic 
cells remained suspended in the medium (Fig. 4.3). The formation of these two cell types 
was consistent, with a coefficient of variation of less than 10% between biological 
replicate cultures. The aggregates could be disrupted using a tissue grinder, which 
generated a primarily single cell population. Using this technique, we were able to 
establish a correlation between the wet weight of aggregated cells and the number of 
colony forming units (Fig. 4.3). In addition to the cells in the fluid phase, there were cells 
that formed an adherent biofilm at the air-liquid interface of the culture flask. These cells 
differ in terms of oxygen availability (30) and the amount of biofilm formed was highly 
variable (data not shown), therefore, they were excluded from further analysis. 
 Western blot analysis of the subpopulations isolated from the fluid phase 
confirmed the bistable production of CsgD; multicellular aggregates displayed high levels 
of CsgD at all time points, whereas the planktonic cells had either low (TP2), trace (TP1, 
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Figure 4.1. Differentiation of cells within a S. Typhimurium biofilm culture. 
(A) An aliquot of S. Typhimurium 14028 culture containing multicellular aggregates and 
planktonic cells is shown after 13h growth at 28ºC, prior to separation of the two 
subpopulations. (B) Isolated aggregates are shown resuspended in PBS to give an 
example of their relative size. (C) Aggregates were isolated from a S. Typhimurium 
culture containing a csgBAC promoter-GFP fusion plasmid (25) and visualized on a Leica 
TCS SP5 Confocal microscope. 
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Figure 4.2. Analysis of multicellular aggregates and planktonic cells isolated from S. 
Typhimurium biofilm cultures. 
(A) csgD expression was measured during growth using a promoter-luciferase 
(luxCDABE) fusion plasmid, designed to measure gene expression by light production 
(counts per second, CPS). The line represents the average CPS of two biological replicate 
cultures, measured at hourly intervals in triplicate; the error bars represent the range of 
expression. Time points (TP1-4) were chosen to reflect the dynamics of cellular 
differentiation. (B) Cell fractions were isolated at each time point and analyzed by 
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western blotting for synthesis of CsgD, the central regulator of Salmonella biofilm 
formation, and CsgA, the major subunit of curli fimbriae. GroEL was detected as a 
loading control to ensure that equal amounts of protein were loaded into each lane. (D) 
Cyclic-di-GMP concentration values were calculated as pmol per 107 CFU. Each point 
represents the measurement from one biological replicate culture; c-di-GMP could not be 
detected for two samples of planktonic cells at TP1. The horizontal bars represent the 
median values. Statistical significance is noted as: *, p <0.05, **, p <0.01. 
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Figure 4.3. Isolation and quantitation of multicellular aggregates and planktonic 
cells and homogenization of multicellular aggregates. 
(A) Culture aliquots were centrifuged at 210 x g for the times shown on the x-axis. The 
number of cells remaining in the supernatant was determined by performing serial 
dilutions followed by overnight growth on LB agar. The experiment was repeated three 
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times and the results of one representative experiment are shown. Statistical comparison 
between samples was performed using unpaired t tests. (B) Quantification of the two 
subpopulations present in replicate 100 mL cultures; for multicellular aggregates, the wet 
weight represents the total amount present in the culture flask, whereas for planktonic 
cells, the optical density is representative of the remaining culture media after removal of 
the aggregates. Horizontal bars represent the mean values. (C) Aggregates were 
resuspended in 1 mL of PBS and homogenized for 30 s using a tissue grinder, prior to 
performing serial dilutions. Each point represents the average from at least 3 technical 
replicates. The dotted lines represent the 95% confidence intervals (C.I.) of the data. (D) 
Colony forming units (CFU) present in aggregate or planktonic cell subpopulations from 
(B), as determined by the slope equation generated in (C) (aggregates) or by serial 
dilution plating (planktonic cells). The conversion factors were determined to be 1.73 x 
108 CFU/mg of aggregates and 1.92 x 109 CFU/OD for planktonic cells. The bar graph 
represents the total CFU estimated within a biofilm flask culture and the relative 
proportion of cells within the aggregates (blue) and planktonic cell (red) subpopulations. 
The total number of planktonic cells within the culture is based on an approximated 
culture volume of 90 mL. (E) Aggregates from a S. Typhimurium culture containing a 
csgBAC promoter-GFP fusion plasmid were homogenized and visualized on a Leica TCS 
SP5 Confocal microscope. This image is representative of 60 slides that were prepared 
from three biological replicate cultures, showing that the homogenized suspension 
existed primarily of single cells. Small clusters of aggregated cells (i.e., <10 mm) were 
observed in ~3% of the fields of view analyzed (data not shown). 
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TP3) or undetectable levels (TP4) (Fig. 4.2B). We also analyzed both subpopulations for 
production of curli fimbriae, an important biofilm extracellular matrix component and 
functional bacterial amyloid (29). The major subunit protein of curli, CsgA, was detected 
in abundance in all aggregate fractions, whereas the planktonic cell fractions at TP2, TP3 
and TP4 were negative (Fig. 4.2B). These results confirmed that the subpopulations had 
been cleanly separated by slow speed centrifugation. Trace amounts of CsgA were 
detected at TP1 (Fig. 4.2B), indicating that some cells had already begun to differentiate 
at this early time point. 
 The bacterial secondary messenger cyclic diguanylate monophosphate (c-di-
GMP) is known to play a role in regulating csgD transcription and CsgD activity (30, 31). 
High levels of c-di-GMP are associated with biofilm formation whereas low levels are 
associated with a single cell lifestyle (44). To test if these same principles were at work in 
our system, we measured the intracellular concentration of c-di-GMP in planktonic cells 
at TP1 and in multicellular aggregates and planktonic cells at TP2. While planktonic cells 
at TP1 had nearly undetectable levels of c-di-GMP, there was an order of magnitude 
increase for planktonic cells at TP2 and another order of magnitude increase for 
aggregates, which had the highest levels (Fig. 4.2C). The levels of c-di-GMP correlated 
with the levels of CsgD in these cell types. 
4.5.1 Transcriptome divergence between planktonic and aggregate cell types. 
 To get a comprehensive view of the transcriptional differences, RNA was purified 
from each cell subpopulation at each time point and directional RNA-seq was performed 
(Table 4.1). In total, 1856 genes or ~34% of genes in the genome were differentially 
expressed when comparing  planktonic cells to multicellular aggregates at each time point 
(Tables A1 and A2; p <0.05). The largest differences were identified at TP2, with 1240 
genes being differentially expressed (Fig. 4.4A). At TP3 and TP4, the number of 
differentially expressed genes was reduced to 778 and 668, respectively. 642 of the 
differentially expressed genes were shared by at least two time points and 188 were 
shared for all three time points. From the 1856 genes that were differentially expressed, 
784 were expressed at higher levels in multicellular aggregates (Fig. 4.4B) and 1072 were 
higher expressed in planktonic cells (Fig. 4.4C). We also performed a comparison 
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between the non-aggregative ∆csgD strain, which represents an entirely single cell 
population (13, 21), and the wildtype planktonic cells at TP2.  Gene expression in 
planktonic cells from these two strains was more similar, with only 220 genes being 
differentially expressed (Tables A3 and A4).  
 Closer analysis of the activated genes revealed that the planktonic cells had higher 
expression of numerous pathways involved in virulence, including both Salmonella 
pathogenicity island (SPI) 1 and 2 T3SSs, part of the phoPQ regulon, motility and 
chemotaxis, and a high proportion (>40%) of function unknown (FUN) genes (Fig. 
4.4D). In contrast, multicellular aggregates had higher expression of genes associated 
with extracellular matrix production in biofilms (i.e., csgDEFG, csgBAC and yaiC 
(adrA)), changes in metabolism (i.e., amino acid, carbohydrates, lipids and nucleotides), 
and pathways associated with stress response (i.e., osmoprotection) (Fig. 4.4D). The 
nature of the transcriptional differences between planktonic cells and multicellular 
aggregates suggested that they represented specialized cell types.  Many of the genes 
listed in Datasets 4.1 and 4.2 were distributed into operons predicted from RNA-seq 
through a combination of transcriptional start and termination sites, intergenic distance 
and co-expression information (Y. Wang, K.D. MacKenzie and A.P. White, submitted for 
publication).  
4.5.2 Expression of c-di-GMP enzymes and other genetic factors contributing to CsgD 
bistability. 
 We identified several differentially expressed genes associated with the complex 
c-di-GMP signaling system that contributes to CsgD regulation (Table 4.2). Two 
diguanylate cyclases (i.e., c-di-GMP-generating enzymes) STM1987 (45) and adrA (46), 
were more highly expressed in aggregates at TP2, which correlated with higher levels of 
c-di-GMP in these cells. yhjH, which encodes a phosphodiesterase (i.e., c-di-GMP-
degrading enzyme) with a critical role in controlling motility (46, 47), was more highly 
expressed in planktonic cells, and this correlated with lower amounts of c-di-GMP. Three 
diguanylate cyclases characterized as having positive effects on invasion (yeaJ; (48)), 
motility (STM2503; (49)) or motility and virulence (STM4551; (49)), were more highly
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Table 4.1. RNAseq-based transcriptome analysis of planktonic cells and multicellular aggregates isolated from S. 
Typhimurium culture.  
 
 
Characteristic 
Wildtype planktonic Wildtype aggregates ∆csgD 
planktonic 
TP1 TP2 TP3 TP4 TP2 TP3 TP4 TP2 
Total no. of readsa 50,889,232 64,194,848 60,641,580 66,424,412 64,372,950 51,211,612 59,213,696 32,648,668 
mRNA & sRNA 5,142,914 9,183,473 6,970,035 4,208,777 7,112,841 4,395,392 4,089,516 3,971,434 
Genome Coverageb 77.7 138.7 105.3 63.6 107.5 66.4 61.8 61.2 
Protein-coding genesc          
   Sense (%) 75.3 74.0 68.9 66.0 74.8 71.6 70.3 73.9 
  Antisense (%) 5.9 5.4 6.7 8.9 2.8 4.1 4.4 10.4 
sRNAs (%)d 8.0 10.6 14.2 9.5 14.4 13.9 8.9 6.5 
Intergenic regions (%) 10.8 10.0 10.2 15.6 8.0 10.4 16.4 9.1 
Plasmid (%) 0.8 0.8 0.7 0.6 0.4 0.4 0.4 0.8 
a Reads of three technical replicates were merged for each time point of each sample. In total, 416 million strand-specific reads 
of 75 nt length were obtained.  
b The reads mapped to rRNAs and tRNAs were removed prior to statistical and comparative analysis. This yielded an average 
genome coverage of 89.9 × (±23.2) for each time point of each sample excluded. 
c There are 5,414 putative ORFs in the S. Typhimurium ATCC 14028 genome, including 5,313 chromosome-encoding and 101 
plasmid-encoding ORFs.  
d The full set of known sRNAs in Salmonella was annotated from (40). Approximately 11.5 ± 2.8% of the mapped reads 
encoded known sRNAs and 11.8 ± 3.4% of the reads mapped to additional intergenic regions. 
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Figure 4.4. RNAseq-based transcriptome comparison between multicellular 
aggregate and planktonic cell subpopulations.  
(A) The Venn diagram shows the total number of differentially expressed genes (p <0.05) 
between planktonic cells and multicellular aggregates at each time point. This total was 
subdivided into genes that were higher expressed in aggregates (B), and genes that were 
higher expressed in planktonic cells (C). (D) Differentially expressed genes in aggregates 
versus planktonic cells were categorized using the KEGG pathway database (Kyoto 
Encyclopedia of Genes and Genomes; http://www.genome.jp/kegg/) and are listed in 
Dataset S1.  
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expressed in planktonic cells at TP2, which correlated with the predicted phenotype of 
these cells. nlpI, encoding a putative membrane protein with a repressive effect on CsgD 
synthesis (50) was also more highly expressed in planktonic cells, which matched the 
lower levels of CsgD in these cells. In contrast, high expression of ycgR and ydiV in 
planktonic cells at TP2 did not match the predicted phenotypes. YcgR contains a PilZ 
domain for binding c-di-GMP and represses motility by acting as a type of flagellar brake 
(51, 52). Based on the published function, we would have expected ycgR to be more 
highly expressed in multicellular aggregates and to function at higher c-di-GMP levels 
inside the cell. YdiV represses expression of yhjH and also negatively regulates motility 
(53). It is possible that the synthesis of YcgR and YdiV result in localized effects within 
the cell, but the overall c-di-GMP pool is predominantly influenced by the increased 
expression of yhjH (46, 47). In general, the RNA-seq findings were consistent with the 
levels of c-di-GMP detected and the predicted phenotypes of planktonic cells and 
multicellular aggregates.  
 Bistable gene expression in bacteria is usually the result of positive autoregulation 
of a master regulatory gene (54, 55). There has been a feed-forward loop proposed for 
csgD in E. coli, but it has not been proven in S. Typhimurium (30). CsgD is proposed to 
activate expression and synthesis of IraP, which inhibits the degradation of RpoS, thus 
leading to greater csgD transcription (56). RNAseq analysis revealed that multicellular 
aggregates had elevated transcription of rpoS at TP2 and csgD and iraP (yaiB) at TP3 
and TP4, potentially confirming this regulatory loop (Fig. 4.5). 
4.5.3 SPI-1 T3SS expression and synthesis and motility are increased in planktonic cells 
 The SPI-1 T3SS is a 3.5 megadalton translocation apparatus that is required for 
injection of Salmonella effector proteins into the cytoplasm of host cells. These effector 
proteins stimulate Salmonella invasion and dissemination, as well as host inflammation 
(6). The current dogma is that SPI-1 T3SS synthesis is activated by the body 
temperatures of warm-blooded hosts (57). This is primarily based on the finding that the 
nucleoid-associated protein H-NS represses transcription of key SPI-1 regulators at lower 
growth temperatures, such as 25°C (58). Biofilm growth conditions (i.e., low osmolarity, 
28°C, stationary phase) were traditionally thought to be non-SPI-1 inducing because they 
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Table 4.2. Differentially expressed genes in the c-di-GMP signaling network.  
Gene Namea Enzyme typeb Functionc Fold changed Time pointse 
STM14_5467 
(STM4551) 
DGC Positive regulator of motility and virulence by both c-di-GMP 
dependent and independent mechanisms (49); an additional 
report states that function is the exact opposite (48) 
4.05 TP2|TP3|TP4 
yeaJ (STM1283) DGC Stimulates invasion (48) 3.18 TP2|TP3 
yhjH (STM3611) PDE Negative regulator of rdar morphotype; positive regulator of 
motility (46) 
4.47 TP2 
STM14_3068 
(STM2503) 
DGC Positive effect on motility (49) 3.13 TP2 
ycgR c-di-GMP 
biosensor 
Binds c-di-GMP through a high affinity PilZ domain; represses 
motility by binding directly to FliG (51, 52) 
4.07 TP2 
ydiV 
(STM1344) 
EAL-like 
protein 
Positive regulator of csgD transcription and negative regulator 
of motility, but does not have a direct role in c-di-GMP 
turnover; represses expression of yhjH (53) 
3.58 TP2 
nlpI  Outer 
membrane 
protein 
NlpI can negatively influence the expression of yjcC, which 
codes for a DGC affecting CsgD expression (50) 
3.89 TP2|TP3|TP4 
adrA (yaiC) DGC Positive regulator of cellulose production (46) 0.34 TP2|TP3|TP4 
STM14_2408 
(STM1987) 
DGC Positive effect on rdar morphotype, CsgD expression, cellulose 
(45) 
0.54 TP2 
a Gene names are listed as they appear in the S. Typhimurium 14028 genome (39); the S. Typhimurium LT2 gene names are listed in parenthesis. 
b An enzyme that generates c-di-GMP is called a diguanylate cyclase (DGC), an enzyme that breaks down c-di-GMP is called a phosphodiesterase 
(PDE). PDE enzymes contain EAL domains.  
c Functions are listed in the context of c-di-GMP regulation and turnover, CsgD expression, motility, and virulence. 
d Fold-change represents the expression ratios of planktonic / aggregates at TP2; genes with values >1 have higher expression in planktonic cells, 
whereas genes with values <1 have higher expression in multicellular aggregates.  
e Time points are listed where the expression difference between planktonic cells and multicellular aggregates was statistically significantly (p 
<0.05).aggregates had elevated transcription of rpoS at TP2 and csgD and iraP (yaiB) at TP3 and TP4, potentially confirming this regulatory loop 
(Fig. 4.5). 
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Figure 4.5. The feed forward regulatory loop for CsgD activation.  
(A) The regulatory network representing a potential feed-forward loop for CsgD 
activation (Gualdi, L., L. Tagliabue, and P. Landini. 2007. J. Bacteriol. 189: 8034-8043). 
σS represents the RpoS sigma factor, which is required for activation of csgD 
transcription. Thick black lines represent regulation of transcription, with the exception 
that IraP stabilizes RpoS protein; thin black lines represent protein synthesis. We added a 
thick line representing auto-regulation of CsgD (Ogasawara, H., K. Yamamoto, and A. 
Ishihama. 2011. J Bacteriol. 193: 2587-97). (B) Relative mRNA expression for each of 
the genes shown at TP2, TP3 and TP4. The dotted line represents no difference in gene 
expression between multicellular aggregates and planktonic cells. 
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are so different from classical SPI-1 inducing conditions (i.e., high osmolarity, 37°C, 
late-exponential phase) (57, 59, 60).  
 RNA-seq analysis revealed that 41 of 44 SPI-1 T3SS related genes were more 
highly expressed in planktonic cells grown under biofilm-inducing conditions (Dataset 
4.1). These genes included pivotal transcriptional regulators (Fig. 4.6A), as well as 
apparatus, chaperone and effector genes (Fig. 4.6B). HilA activates transcription of SPI-1 
apparatus genes distributed in the inv/spa and prg/org operons (57). InvF is encoded as 
part of the inv/spa operon, and together with SicA promotes transcription of the sic/sip 
operon encoding the translocon, as well as numerous effector genes. Temporal expression 
analysis of the SPI-1 genes followed a pattern consistent with the establishment of 
secretion-competent organelles in planktonic cells; apparatus genes had highest 
expression at TP1, while translocon and numerous effector genes had peak expression at 
TP2 (Fig. 4.7). In contrast, expression levels of all SPI-1 genes were reduced in 
multicellular aggregates (Fig. 4.7). Comparison between wildtype planktonic cells and 
ΔcsgD planktonic cells at TP2 revealed that sipD and sopE2 were higher expressed in the 
wildtype cells (Dataset 4.2). In addition, several other SPI-1 genes were higher expressed 
in wildtype cells but had p values just above the cut off for significance (data not shown). 
These findings suggested that there could be a potential regulatory link between CsgD 
and the SPI-1 T3SS.  
 To determine if SPI-1 transcriptional differences were reflected at the protein 
level, whole cell lysates of either cell type were analyzed by western blotting. InvG, the 
OM secretin (61), was detected at high levels in planktonic cells at all time points and 
was nearly undetectable in the multicellular aggregate samples (Fig. 4.6C). The on/off 
pattern of synthesis for this critical structural component indicated that planktonic cells 
had the capacity to form a greater number of SPI-1 T3SS organelles than aggregated 
cells. SipD, the translocon tip protein that interacts with host cell membranes (62), was 
also present at high levels in planktonic cells at all time points (Fig. 4.6C). SopB and 
SopE2, two of the earliest expressed effectors that stimulate host cell cytoskeleton 
rearrangements (63), were also synthesized at higher levels in planktonic cells at TP2 and 
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Figure 4.6. Expression and synthesis of the SPI-1 T3SS in S. Typhimurium 
planktonic cells.  
(A) A schematic of a bacterial cell showing the regulatory map and main transcriptional 
activators (green) or repressors (red) for SPI-1 T3SS expression, adapted from (6). The 
fold-change values for the regulators shown are displayed as red bars on the 
accompanying graph, calculated from RNA-seq data at TP2. (B) The SPI-1 T3SS 
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translocation apparatus (left), adapted from (90), was divided into five component 
groups, including proteins embedded in the bacterial inner or outer membrane or host cell 
membrane (IM, OM, HCM). Each point on the accompanying graph represents the fold 
change value for the following genes at TP2 for Effectors: sopE2, sopB, sipA, sopD, 
gtgE, sopA, avrA, sptP, gogB; Chaperones: sicA, sicP, invB, sigE (pipC); ATPase 
platform: invC, spaO, orgA, orgB; Export apparatus: invG, spaR, prgH, invI, invA, invE, 
prgK, spaP, spaQ, invJ, spaS, invH; Needle, prgI, prgJ; and Translocon: sipB, sipC, sipD 
(6). The dotted line at 1 represents no difference in gene expression; the vertical lines 
represent the mean fold-change for the group. (C) Whole cell lysates of planktonic cells 
and multicellular aggregates were analyzed by western blotting to detect the SPI-1 T3SS 
proteins as shown; Plank = planktonic cells, Agg = multicellular aggregates. (D) InvG 
and SipD were detected in ΔcsgD planktonic cells at TP2 and the relative levels were 
compared to aggregates and planktonic cells isolated from wildtype cultures. 
  128 
 
 
Figure 4.7. Transcriptional dynamics of genes associated with the SPI-1 type three 
secretion system.  
The relative mRNA expression of SPI-1 T3SS apparatus (A), translocon (B), chaperone 
(C), and effector (D) genes in each subpopulation of cells was compared across time 
points. Genes were assigned to the same functional classes as listed in Figure 4B. 
Relative expression was obtained by dividing the absolute expression level (i.e., number 
of mapped cDNA reads obtained by RNA-seq) for each gene at each time point by the 
absolute expression level of that gene at TP1. The starting value for each gene is at 1.0. 
The expression profile of avrA did not match the other effector genes; therefore it was not 
included in (D). 
  129 
TP3, with the difference decreasing by TP4 (Fig. 4.6C). SPI-1 protein levels were also 
analyzed in ∆csgD cells at TP2. InvG and SipD levels were noticeably lower in ∆csgD 
cells as compared to wildtype planktonic cells (Fig. 4.6D), whereas SopB and SopE2 had 
no detectable difference between the two strains (data not shown).   
 Recent evidence suggests that the SPI-1 T3SS and flagellar-mediated motility are 
required for targeting of permissive invasion sites on host cells (64) and these systems are 
often co-regulated (65). In our RNA-seq experiment, 28 genes coding for flagella 
assembly and chemotaxis proteins were identified as being more highly expressed in 
planktonic cells (Dataset 4.1). We performed a swim assay, which confirmed that 
planktonic cells had enhanced motility compared to multicellular aggregates, but were 
not significantly different from ∆csgD planktonic cells (Fig 4.8).  
4.5.4 Transcriptional priming of the SPI-2 T3SS in planktonic cells 
 Salmonella pathogenicity island 2 (SPI-2) encodes a second T3SS that has an 
important role once Salmonella has invaded host cells. The SPI-2 T3SS is required for 
modification of the phagolysosome to make it conducive for Salmonella replication, 
particularly inside of macrophages (6). 37 of 42 genes encoding for the SPI-2 T3SS were 
more highly expressed in planktonic cells as compared to the multicellular aggregates 
(Dataset 4.1). However, unlike SPI-1, we were unable to detect SPI-2 protein synthesis, 
such as SsaC, the equivalent of InvG, in any cell fractions (data not shown). This 
suggested that functional SPI-2 needles were not present on the surface of planktonic 
cells and supported the possibility that transcriptional priming was occurring, as has been 
observed prior to host cell invasion (66, 67).  
4.5.5 Planktonic cells display enhanced invasion of a human intestinal cell line 
 To our knowledge, SPI-1 T3SS synthesis has never been observed before under 
biofilm-inducing conditions, but it is usually correlated with increased invasion and 
virulence (68). Therefore, we tested the invasion of different S. Typhimurium cell types 
into polarized Caco-2 cells, a human intestinal cell line. Planktonic cells isolated at TP2 
displayed the same invasiveness as planktonic cells grown under classical SPI-1 inducing 
conditions (Fig. 4.9), confirming that the SPI-1 organelles synthesized under biofilm-
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Figure 4.8. Swim assay of multicellular aggregates and planktonic cells.  
Cell subpopulations were isolated from S. Typhimurium biofilm cultures at TP2, and 
either tested for motility directly or after homogenization for 30s in a tissue grinder. 
Swim plates (lysogeny broth (Luria) + 0.25% agar) were inoculated with 5 x 106 CFU 
and incubated at 37°C for 8 h prior to measuring the swim radius. Statistical comparison 
between samples was performed using an unpaired t test (**, p <0.01).  
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inducing conditions were functional. Planktonic cells isolated at later time points (i.e., 
TP4) still retained efficient invasion, suggesting that this phenotype was stable. In 
contrast, the multicellular aggregates were significantly less invasive, presumably 
because of reduced type three secretion synthesis. Surprisingly, ∆csgD cells, which had 
reduced InvG and SipD levels, only showed a slight drop in invasion that was not 
statistically different than wildtype planktonic cells. For the aggregates, we reasoned that 
reduced invasion could be influenced by the presence of extracellular matrix polymers 
blocking access to the Caco-2 cell surface. To disrupt the matrix, we homogenized the 
aggregates prior to repeating the assay, but it did not lead to increased invasion (Fig. 4.9, 
homogenized aggregates). It was noted, however, that the aggregated cells invaded 
significantly better than a ΔSPI-1 deletion strain, suggesting that they would retain a 
capacity for virulence.  
 As part of the Caco-2 cell invasion assays, the aminoglycoside antibiotic 
gentamicin was added to kill any extracellular bacteria that had not invaded. Prior to 
performing the assays, we tested the susceptibility of multicellular aggregates and 
planktonic cells to gentamicin. While the planktonic cells were completely killed (below 
the limit of detection) at standard concentrations of 200 – 400 µg mL-1 (33) the 
multicellular aggregates displayed enhanced resistance and were only depleted once the 
concentration reached 1200 µg mL-1 (Fig. 4.10). This confirmed that the multicellular 
aggregates represented a more resistant subpopulation of cells.  
4.5.6 Planktonic cells display a significant virulence advantage in murine infection. 
 Based on the expression data and Caco-2 invasion results, we hypothesized that 
the planktonic cells were more virulent, whereas the multicellular aggregates were likely 
to have enhanced persistence. To test the colonization efficiency and virulence of each 
cell type, we performed formally randomized, blinded co-infections of mice with 1:1 
ratios of multicellular aggregates and planktonic cells isolated from kanamycin- or 
chloramphenicol-resistant strains of S. Typhimurium (Fig. 4.11). For the initial 
competitive index (CI) trial, we wanted to keep the cell subpopulations in their native 
physical state; therefore, we minimized the handling of cells and used a wide bore gavage 
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Figure 4.9. Invasion of polarized Caco-2 cells by different S. Typhimurium 
subpopulations.  
Planktonic cells and multicellular aggregates isolated from S. Typhimurium 14028 
biofilm cultures at TP2 and TP4 were used to infect polarized Caco-2 cells. Aggregates 
that were homogenized using a tissue grinder were also tested, along with planktonic 
cells prepared from ΔcsgD cultures. Wildtype and ∆SPI-1 cells grown in LB at 37°C 
were used as positive and negative invasion controls, respectively. Each point represents 
the average value from invasion of three replicate wells of Caco-2 cells; the horizontal 
bars represent the mean values. The average MOI was 17, based on an estimate of 2.5 x 
105 polarized Caco-2 cells per well. Statistical significance is noted as: ***, p <0.001, *, 
p <0.05, ns, p >0.05. 
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Figure 4.10. Antimicrobial killing assay of multicellular aggregates and planktonic 
cells exposed to gentamycin.  
Multicellular aggregates and planktonic cells were exposed to gentamycin for 2 h at the 
concentrations shown on the x-axis. The number of surviving cells is plotted on the y-
axis; the dotted line represents the limit of detection of 250 CFU. Points and error bars 
represent the means and standard deviations from three biological replicate experiments. 
Statistical differences in viable cell counts between the cell types was performed using an 
unpaired t test; *, P < 0.05, ****, P < 0.0001. 
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needle to prevent shearing of aggregates during oral delivery. Under these conditions, the 
planktonic cells exhibited a significant virulence advantage, as demonstrated by their 
proportionally increased recovery from spleen, liver, cecum and mesenteric lymph nodes 
in the majority of infected mice (Fig. 4.12A, red triangles). As predicted, the multicellular 
aggregates did retain a capacity for virulence and were recovered at higher proportions in 
several mice (Fig. 4.12A, blue triangles). We reasoned that despite being comprised of 
hundreds to thousands of cells, each aggregate might only function as a single infectious 
unit. Therefore, we homogenized the aggregates to generate a single cell suspension prior 
to repeating the CI trial. The CI values were slightly reduced, but the overall trend 
remained the same (Fig. 4.12B), indicating that the increased virulence of planktonic 
cells was not due to a difference in multiplicity of infection. We also competed wildtype 
planktonic cells and ∆csgD planktonic cells, and again the wildtype planktonic cells 
displayed a strong virulence advantage (Fig. 4.12C). This was surprising because the 
invasion phenotypes of these two strains were similar; however, there could be other 
impairments related to the ∆csgD mutation (69). To assess the importance of SPI-1 in the 
colonization advantage displayed by planktonic cells, we repeated a CI trial with 
planktonic cells and multicellular aggregates prepared from a ∆SPI-1 mutant strain. For 
each organ, the median CI values dropped approximately 10-fold and were near 1 (Fig. 
12D), which indicated that the SPI-1 T3SS was the primary factor responsible for 
increased colonization of planktonic cells. However, small differences were still detected 
for the spleen, liver and cecum (Fig. 4.12D), indicating that the planktonic cells had other 
adaptations (e.g., increased motility) that provide them with a colonization advantage.  
4.5.7 Persistence of multicellular aggregates reduces the competitive advantage of 
planktonic cells 
 To assess how the multicellular aggregates and planktonic cells responded to a 
potential environmental stress, aliquots of the challenge inocula from the first CI 
experiment were desiccated and stored in 24-well plates at room temperature. Viability 
assays performed on the desiccated challenge inocula revealed that the multicellular 
aggregates survived significantly better than the planktonic cells (Fig. 4.13A). At the 
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Figure 4.11. Preparation of mixed bacterial challenges of multicellular aggregates 
and planktonic cells for competitive infection assays.  
Cell subpopulations were isolated from CmR or KnR S. Typhimurium cultures and used 
for reciprocal co-infections of C57BL/6 mice. We aimed for a challenge dose of 107 CFU 
consisting of an approximate 1:1 ratio of planktonic cells and multicellular aggregates. 
Mice were randomly assigned into four groups of six mice; challenge A and challenge B 
was given to two groups each. At 4-7 days post infection, mice were euthanized and their 
organs were homogenized to determine the number of CFU of CmR or KnR S. 
Typhimurium that were present; MLN, mesenteric lymph nodes. 
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Figure 4.12. Competitive infections between multicellular aggregate and planktonic 
cells prepared from wildtype, ΔSPI-1 and ΔcsgD cultures. 
The competitive index (CI) was determined by oral co-infection of C57BL/6 mice with a 
1:1 ratio of different cell types. (A) Trial between planktonic cells and multicellular 
aggregates, using a wide-bore gavage needle to prevent shearing of aggregates. (B) Trial 
between planktonic cells and multicellular aggregates after homogenization of the 
aggregates to generate a single cell population. (C) Trial between wildtype planktonic 
cells and ΔcsgD planktonic cells. (D) Trial between planktonic cells and multicellular 
aggregates isolated from a ∆SPI-1 biofilm culture. Each point in A-D represents the CI 
value calculated from one organ from a single mouse, with either cell type winning the 
competition (red or blue triangles). The solid lines represent the median of all CI values 
from a particular organ. The dotted line represents a CI value of 1, which indicates no 
difference in virulence. MLN = mesenteric lymph nodes. Statistical significance is noted 
as: * p <0.05, ** p <0.01, *** p<0.001, **** p <0.0001, ns p >0.05.  
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four-week time point, there were approximately 10 times more aggregated cells alive 
(Fig. 4.13A, dotted line). We performed another CI trial at this time point, after 
rehydration and resuspension of the cells. The values for each organ indicated no 
significant advantage for either subpopulation, with aggregates or planktonic cells 
winning the competition in an approximately equal number of mice (Fig. 4.13B). This 
indicated that upon exposure to environmental stress, the multicellular aggregates had a 
fitness advantage. If these results were extrapolated into the natural world, one could 
envision a scenario where after extended periods of environmental exposure only 
multicellular aggregates would be alive and be able to infect new hosts.  
4.6 Discussion 
 In this study, we isolated and analyzed two distinct subpopulations of cells within 
a clonal population of S. Typhimurium. Based on genetic, biochemical and functional 
characterization, we hypothesize that the planktonic cells and multicellular aggregates 
formed under biofilm-inducing conditions represent specialized cell types that are 
adapted for virulence and persistence, respectively. Due to the presence of functional 
SPI-1 T3SS organelles, we predict that the planktonic cells are proficient at direct host-
to-host transmission, whereas the resistant, multicellular aggregates can survive in the 
environment and cause infections at later times. The connection of virulence and 
persistence within an individual population represents an elegantly simple strategy that 
would prepare S. Typhimurium for unpredictability and improve the chances for 
transmission each time they leave an infected host. This scenario also implies that the 
host immune system may respond differently to these specialized cell types. If hosts 
routinely encounter multicellular aggregates, it could explain why curli fimbriae are such 
potent stimulators of the innate immune system (29, 70, 71) even though these organelles 
do not appear to play a role in Salmonella infections (25).  
 The concept of bistability was described by Novick and Weiner over 50 years ago 
as the existence of different subpopulations of enzyme-producing cells within a 
genetically identical population of E. coli, controlled by a feed forward loop (72). CsgD 
lies at the heart of a feed-forward loop in S. Typhimurium when cells are grown under 
biofilm-inducing conditions. CsgD is synthesized at high levels in specific cells, leading 
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Figure 4.13. Enhanced persistence of S. Typhimurium multicellular aggregates. 
(A) Multicellular aggregates and planktonic cells used for the trial in Fig. 6A were 
desiccated and stored in 24 well plates. Survival of each cell type was determined after 
storage for the times displayed on the x-axis. Statistical significance is noted as: * p 
<0.05, ** p <0.01, **** p <0.0001. The dotted line represents the time at which cells 
were resuspended and a CI trial was performed (B). Each point represents the CI value 
calculated from one organ from a single mouse and the solid lines represent the median 
of all CI values from a particular organ. The dotted line represents a CI value of 1, or no 
difference in virulence; none of the organs displayed CI values that were significantly 
different from 1 (ns = p > 0.05).  
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to production of extracellular matrix polymers and the formation of multicellular 
aggregates (25, 30). The regulation of csgD transcription and CsgD synthesis is 
extremely complex (reviewed in (31)). Numerous transcription factors are involved, 
including OmpR, MlrA, and CpxR, non-specific DNA-binding proteins H-NS and IHF, 
in addition to the feed-forward loop involving rpoS and the factors that regulate RpoS 
activity, including IraP and Crl. In addition, at least five sRNAs can bind to the 5’ 
untranslated region of the csgD mRNA and regulate CsgD synthesis (73). Robust control 
of CsgD production is clearly important, given that > 30% of genes in the genome were 
differentially expressed between the S. Typhimurium multicellular aggregates and 
planktonic cells. The large number of differentially expressed genes represents a 
tremendous amount of non-heritable genetic change, on the order of a developmental 
program in bacteria (74). Since only 20 CsgD-specific targets were identified in a recent 
E. coli ChIP-seq study (75), we hypothesize that CsgD initiates the aggregation process, 
and a cascade of gene expression changes follows as cells produce an extracellular matrix 
(35). Ultimately, this cascade would be the cumulative result of numerous connected 
signaling pathways, including c-di-GMP (44). 
 Recent reports have shown that bistable gene expression can occur within 
bacterial virulence gene networks. In Vibrio cholerae, bimodal expression of ToxT 
results in virulent and non-virulent cell subpopulations (76). Bistable production of the 
SPI-1 T3SS in S. Typhimurium has also recently been described (77-79). These authors 
observed that nearly 100% of S. Typhimurium cells interacting with intestinal tissues 
were positive for SPI-1 expression while only 15% of cells in the intestinal lumen were 
positive (77). The presence of both SPI-1+ and SPI-1- cells seems important for 
stabilizing the virulence traits of S. Typhimurium (78). At the moment, it is unclear how 
these findings are connected to what we have observed. Our finding that SPI-1 T3SS 
synthesis occurs in planktonic cells under biofilm-inducing conditions may indicate that 
an alternative regulatory pathway exists for SPI-1 activation. It is also possible that the 
planktonic population consists of both SPI-1+ and SPI-1- cells. Alternatively, the 
subpopulation of cells that form multicellular aggregates under biofilm-inducing 
conditions could be related to the SPI-1- cells described by WD Hardt and colleagues 
(e.g., similar genetic pathways activated or repressed). One of our initial goals was to 
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determine if the differentiation of cells was more than an in vitro phenomenon. Since the 
planktonic cells were more virulent than multicellular aggregates, even after the 
aggregates were homogenized into a single cell suspension, it suggested that 
differentiation was retained until cells reached the murine intestine. The importance of 
SPI-1 in this process was confirmed since planktonic cells and multicellular aggregates 
from a ∆SPI-1 mutant strain had nearly equal colonization efficiencies. Furthermore, the 
reduction in virulence that we observed for the ∆csgD strain, together with recent 
connections between c-di-GMP, virulence (28) and motility (52) suggest that the master 
biofilm regulator, CsgD, can modulate the virulence capacity of S. Typhimurium.  
 Bet hedging is characterized as a risk-spreading strategy displayed by clonal 
populations, where each phenotype performs more or less well at any time, depending on 
the selection pressures present (80). Although we can’t be certain of the evolutionary 
selections that led to bistable CsgD expression, the passage of Salmonella isolates 
between host and non-host environments represents a model of unpredictability (7). 
Aggregation is known to have many evolutionary benefits to ensure the survival of 
populations, but instead of it being interpreted as altruistic behavior, it may be driven by 
harsh penalties associated with an individual not being part of the group (81). For 
pathogens like S. Typhimurium, the maintenance of a subset of cells primed for invasion 
but not ideally suited for environmental survival would be a penalty unless a host is 
encountered. The energy commitment required to make SPI-1 T3SS organelles (82) or 
extracellular matrix polymers (83, 84) in different subpopulations indicates that it might 
be a strategy for S. Typhimurium to prepare for unpredictability. A proportion of cells 
could survive exposure to either the host or non-host environments, with the ultimate goal 
being preservation of the shared genome for the next generation (54, 80). We speculate 
that signaling can occur between the host immune system, the microbiota and the 
invading pathogen, with the distinct possibility that S. Typhimurium, and presumably 
other NTS isolates, can modulate their virulence (85) or persistence (7) as a result of 
these interactions.  
 As pathogens evolve, there is thought to be continual selection pressure for them 
to adapt to their hosts (86). Host-adaptation has the benefit of reducing the variation and 
unpredictability that a bacterial pathogen is exposed to, but makes strains more dependent 
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on a direct means of transmission (4). Differences in transmission could potentially 
explain the correlation between an invasive, host-adapted way of life and loss of the rdar 
morphotype in Salmonella and E. coli (17, 26). In E. coli, bistable expression of CsgD 
does occur in specific pathogenic strains (87); however, human-adapted enteroinvasive E. 
coli and Shigella isolates have lost their ability to aggregate (27). Similarly, the evolution 
of S. Typhi has been strongly influenced by the human carrier state (5) and nearly all 
isolates are negative for the rdar morphotype (25, 26). We hypothesize that host-adapted 
or host-restricted isolates favor a single cell mode of growth because shedding from 
chronic carriers makes them less dependent on long-term survival to complete the 
transmission cycle. S. Typhi is capable of other forms of biofilm growth that are required 
for persistence inside human carriers, such as the attachment to the surfaces of gallstones 
(88) and recent evidence indicates that S. Typhi can be transmitted indirectly via 
contaminated water (89). This suggests that there are other factors to consider when 
correlating a loss of persistence with host-adaptation. Nevertheless, identifying the 
molecular mechanisms that connect virulence and persistence may hold the key for 
understanding transmission and ultimately reducing the spread of these human pathogens. 
We predict that the bet-hedging program described here for S. Typhimurium is a common 
strategy for survival, especially for other enteric pathogens that spend a significant 
portion of their lifecycle in the environment. 
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5.1 Interface 
 In sub-Saharan Africa, nontyphoidal Salmonella have surpassed Salmonella 
Typhi as the predominant cause of bacterial bloodstream infections. Little is known about 
the reservoirs and routes of transmission for nontyphoidal Salmonella strains associated 
with an invasive disease. In chapter 4, our characterization of multicellular aggregates 
and planktonic cells suggested that the subpopulations that result from CsgD bistability 
are part of a conserved transmission strategy used by Salmonella. In this chapter, we 
applied the principles we had learned about Salmonella biofilm formation to better 
understand the lifecycle of invasive nontyphoidal Salmonella strains. We evaluated select 
strains of invasive nontyphoidal Salmonella for CsgD bistability and the ability to form 
multicellular aggregates and planktonic cells. We provide evidence that invasive 
nontyphoidal Salmonella are impaired for biofilm formation and link this observation to 
strain-specific genetic polymorphisms. 
5.2 Abstract 
 Nontyphoidal Salmonella strains are predominantly associated with gastroenteritis 
and diarrheal disease in humans, but recent reports have linked some clades to 
bloodstream infections in sub-Saharan Africa. It is hypothesized that this modern 
epidemic of invasive nontyphoidal Salmonella infections has stemmed from the 
geographical availability of an immune-compromised human population. Salmonella 
strains associated with extraintestinal diseases in humans are often host-adapted, 
infecting a narrowed range of susceptible host species. At the genetic level, these strains 
consistently exhibit features of genome degradation, where loss of gene function is 
associated with pathogen replication in the intestine and transmission via the fecal-oral 
route. Biofilm formation is suspected to have a role in Salmonella transmission, allowing 
cells to persist within the environment between host infections. Following the established 
correlation between host adaptation and loss of biofilm phenotype, we investigated the 
biofilm-forming ability of two invasive nontyphoidal Salmonella strains isolated from 
Malawi, S. Typhimurium D23580 and S. Enteritidis D7795. We assessed the phenotypic 
and genotypic conservation of the CsgD-regulated biofilm phenotype in these strains 
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compared to a panel of typical nontyphoidal Salmonella strains associated with 
gastroenteritis and host-restricted S. Typhi strains belonging to the H1 and H58 
haplotypes. Both S. Typhimurium D23580 and S. Enteritidis D7795 demonstrated 
impairments in biofilm formation, which we attributed to specific genetic polymorphisms 
that are unique to each invasive nontyphoidal strain. We predict that biofilm impairment 
may reflect changes in these strains as they become more host-adapted and have a greater 
reliance on person-to-person transmission. 
5.3 Introduction 
 Salmonella enterica are responsible for two contrasting diseases that inflict a 
significant burden on global health. More than half of the approximately 2600 Salmonella 
serovars identified to date belong to the subspecies enterica, which is associated with 
infections in warm-blooded hosts and is accountable for over 95% of human cases of 
salmonellosis (1, 2). Most of the serovars in subspecies enterica contribute to over 150 
million annual cases of gastroenteritis, with serovars Typhimurium and Enteritidis 
responsible for the majority of these infections (3, 4). In immunocompetent individuals, 
nontyphoidal Salmonella infections involve the short-term colonization of the pathogen 
within the gastrointestinal tract, resulting in a localized inflammatory immune response 
accompanied by profuse diarrheal production. Salmonella serovars responsible for such 
cases of gastroenteritis are collectively referred to as nontyphoidal Salmonella. In 
contrast, a small number of serovars in subspecies enterica are known as typhoidal 
Salmonella, and are associated with an estimated 26.9 million annual cases of enteric 
fever (5). This distinct disease involves invasion of the extraintestinal compartment, often 
without the induction of inflammation or diarrhea (6). While such infections can occur 
asymptomatically, clinical manifestations of typhoidal Salmonella infections may include 
a persistent and gradual fever that elevates in a stepwise manner, as well as other 
symptoms such as headache, chills, nausea, coughing, malaise, or a rapid pulse (6, 7). 
Typhoidal Salmonella have the potential to persist asymptomatically within their human 
host over periods of several weeks to years as a result of the pathogen’s intracellular 
association with monocytes and macrophages of the reticuloendothelial system and 
potential long-term colonization of the gall bladder (8).  
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 In contradiction to this dichotomy, nontyphoidal Salmonella serovars have 
become increasingly responsible for bacterial bloodstream infections in sub-Saharan 
Africa (9). Like typhoidal Salmonella infections, invasive nontyphoidal Salmonella 
(iNTS) disease frequently lacks diarrheal symptoms, with febrile illness being the 
dominant clinical presentation in 95% of cases (10). This disease is responsible for an 
estimated 681,000 deaths per year, with nonspecific symptomology, multidrug resistance, 
and poor clinical outcomes despite correct diagnosis increasing the urgency to better 
understand this disease (9). A review of several clinical studies has revealed a significant 
association between invasive infections with nontyphoidal Salmonella and the presence 
of an immunocompromised population in the sub-Saharan region, particularly children 
with malnutrition or severe malaria and adults with advanced infections of human 
immunodeficiency virus (HIV) (9-11). Failure of the immune system to maintain the 
intestinal epithelial barrier or control intracellular Salmonella infections in these 
individuals provides a unique opportunity for nontyphoidal Salmonella serovars to 
exploit the availability of the systemic niche (10). 
 Nontyphoidal and typhoidal Salmonella serovars associated with extra-intestinal 
diseases are representative of the process of host adaptation, where events that affect a 
pathogen’s evolution subsequently shift the dynamics of host-pathogen interactions (12). 
Most nontyphoidal Salmonella infect a broad range of host species and as such are 
considered host-generalist pathogens (13). While the exact chronology of events that 
resulted in host specialization for invasive nontyphoidal and typhoidal Salmonella 
infections remains elusive, the switch to a systemic niche and increased virulence during 
human infections has been correlated with significant genomic changes in these 
pathogens (12). Salmonella that survive and replicate in the systemic niche are faced with 
novel selection pressures that drive these genomic changes, including gene acquisition, 
genome degradation, and genetic rearrangements. These genetic changes are apparent in 
genome comparisons between strains associated with gastroenteritis versus invasive, 
systemic infections. Genome degradation, or the loss of gene function due to deleterious 
mutations or pseudogene formation, is a consistent genetic signature demonstrated in 
both typhoidal serovars S. Typhi and S. Paratyphi A and in clades of S. Typhimurium and 
S. Enteritidis associated with iNTS disease (14-19).  Many of these gene mutations affect 
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metabolic processes involved in anaerobic respiration on unique carbon sources, a 
mechanism that is pivotal to the replication and outgrowth of Salmonella in the inflamed 
intestinal tract (20-22). Additional gene mutations affect adhesins and type three 
secretion systems, which are essential to successful intestinal colonization and 
replication. For nontyphoidal Salmonella associated with gastroenteritis, these factors are 
naturally selected due to their important role in enhancing pathogen transmission to the 
next host via the fecal-oral route (23).  
 In addition to colonization and replication, Salmonella must be able to 
successfully transmit to the next host to ensure its continued survival. For host-generalist 
strains of nontyphoidal Salmonella, maximal transmission potential is achieved through 
unique resource utilization in the inflamed intestinal niche and adoption of a broad range 
of susceptible host species. As a consequence of the fecal-oral route of transmission, 
nontyphoidal Salmonella are exposed to the environment between host colonization 
events (23, 24). Biofilm formation is proposed to aid in the survival and persistence of 
nontyphoidal Salmonella cells during this environmental phase of the transmission cycle 
(25, 26). Salmonella biofilm physiology has been termed the rdar (red, dry, and rough) 
morphotype, where a self-produced extracellular matrix of curli fimbriae, cellulose, and 
O-antigen capsule polymers interconnects cells and facilitates their adherence to abiotic 
and biotic surfaces (27-30). Conditions of low temperatures, low osmolarity, and nutrient 
limitation promote the expression of the rdar morphotype by activating RpoS, the sigma 
factor for the general stress response, and CsgD, a member of the RpoS regulon and the 
primary transcriptional activator of the rdar morphotype (28, 29). The genes for both curli 
fimbriae and cellulose are highly conserved in Salmonella and Escherichia coli; however, 
almost all typhoidal Salmonella serovars are phenotypically negative for the rdar 
morphotype (31-36). As host-adapted pathogens, typhoidal serovars have potentially lost 
this mechanism of environmental survival, instead relying on chronic persistence in the 
human host and intermittent shedding via the biliary tract and gall bladder to improve 
their odds of transmission (37). Therefore, loss of the rdar morphotype may represent an 
additional signature of host adaptation. 
 Humans are also speculated to be the primary reservoir for invasive nontyphoidal 
Salmonellae (17, 19, 38). Preliminary field studies into the transmission of iNTS serovars 
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have emphasized the importance of person-to-person spread. In these studies, iNTS 
isolates retrieved from index patients were matched to isolates from persons in close 
contact, but not to isolates obtained from nearby environmental reservoirs such as 
animals, soil, sewer, water, or food products (38, 39). However, the level of host 
restriction for iNTS serovars is currently under debate. S. Typhimurium D23580, a strain 
of invasive Salmonella belonging to the predominant sequence type ST313, has been 
demonstrated to cause infection in different animal challenge models, including mice, 
cattle, chicks, and rhesus macaques (18, 40-43). In contrast, S. Enteritidis D7795, a 
representative of the recently described epidemic Central/Eastern African clade for this 
serovar, demonstrated a reduced ability to cause systemic infection in chicks (19). To 
date, there have been few investigations in the biofilm phenotype of these invasive 
nontyphoidal Salmonella strains. 
 In this study, we present a detailed evaluation of the biofilm-forming capacity of 
the type-strains of iNTS, S. Typhimurium D23580 and S. Enteritidis D7795, in 
comparison with typical NTS strains as well as host-restricted S. Typhi strains of the H1 
and H58 haplotypes. We analyzed the rdar morphotype via growth on agar plates and 
multicellular aggregation in liquid cultures, both of which have been demonstrated to 
correlate with the ability of a strain to form biofilm. We monitored expression of RpoS, 
CsgD, and other biofilm transcriptional regulators in each strain, and searched for 
sequence polymorphisms in the genome sequences. S. Typhimurium D23580 
demonstrated an impaired ability to aggregate both by the rdar morphotype and in liquid 
cultures, and S. Enteritidis D7795 was negative in both growth formats. In agreement 
with this, S. Typhimurium D23580 did produce curli fimbriae and cellulose at a reduced 
capacity, while D7795 was negative for both polymers. We identified a pivotal mutation 
in the promoter region of csgD in S. Enteritidis D7795, which resulted in this being a null 
promoter when compared to other nontyphoidal Salmonella isolates. For S. Typhimurium 
D23580, the changes were subtler, with a potential polymorphism detected in the 
STM1987 gene that produces the key biofilm signaling molecule, cyclic-di-GMP. 
Overall, our results correspond with the hypothesis of reduced host ranges for these two 
iNTS isolates, and suggests that mutations affecting the rdar morphotype may serve as a 
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sensitive indicator of the position of Salmonella strains on the continuum of host 
adaptation.  
5.4 Materials and Methods 
5.4.1 Bacterial strains, media, and growth conditions 
 The bacterial strains used in this study are listed in Table 5.1. For standard 
growth, strains were inoculated from frozen stocks onto LB agar (lysogeny broth-Miller 
plus 1.5% agar) and grown overnight at 37˚C. One isolated colony was used to inoculate 
5 mL LB broth (containing 1% NaCl) and the culture was incubated for 18 hours at 37˚C 
with agitation at 200 RPM. For colony morphology assays, overnight cultures of each 
strain were normalized to an optical density of 1.0 at 600 nm and 2 µL were spotted onto  
1% tryptone medium containing 1.5% Difco agar (T agar) (27). To visualize cellulose 
production, T agar was supplemented with calcofluor white (fluorescent brightener 28; 
Sigma-Aldrich Canada) at a final concentration of 200 µg/mL (34). To analyze liquid 
culture growth under biofilm-inducing conditions, approximately 1 x 109 CFU were 
inoculated into 100 mL of 1% tryptone, pH 7.4, and incubated at 28˚C for 24 or 48 hours 
with agitation at 200 rpm. 
 For bioluminescence assays, overnight cultures of the Salmonella strains were 
diluted 1 in 600 in 1% tryptone broth supplemented with 50 µg mL-1 Kn in a final volume 
of 150 µL in 96-well clear-bottom black plates (9520 Costar; Corning Inc.). To minimize 
evaporation of the medium during the assay, cultures were overlaid with 50 µL of 
mineral oil. Cultures were assayed for absorbance (590 to 600 nm, 0.1 s) and 
luminescence (1s; in counts per second [CPS]) every 30 min during growth at 28˚C with 
agitation in a Victor X3 multilabel plate reader (Perkin-Elmer). 
5.4.2 Generation of bacterial luciferase reporters and pBR322-STM1987 plasmid vectors 
 The pCS26 bacterial luciferase (lux) operon fusion plasmids containing 
csgDEFG, csgBAC, adrA, and rpoS promoter sequences from S. Typhimurium 14028 
have been described previously (26, 32). The RpoS-dependent reporter plasmid sig38H4 
contains the luxCDABE operon preceded by a promoter designed based on the alignment 
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Table 5.1. Strains used in this study. 
Strain or Plasmid Genotype Source or Reference 
Strains   
S. Typhimurium 14028 Wild-type strain ATCC 
S. Typhimurium SL1344 Wild-type strain ATCC (Wolfgang Köster, 
University of 
Saskatchewan) 
S. Enteritidis ATCC 4931 Wild-type strain ATCC (Darren Korber, 
University of 
Saskatchewan) 
S. Enteritidis 301 (Sal18) Wild-type strain Wolfgang Köster, 
University of 
Saskatchewan (88) 
S. Typhimurium D23580 Wild-type strain Gordon Dougan (17) 
S. Enteritidis D7795 Wild-type strain Gordon Dougan (19) 
S. Typhi E02-2759 Wild-type strain Gordon Dougan (16) 
S. Typhi E03-9804 Wild-type strain Gordon Dougan (16) 
S. Typhi ISP03-07467 Wild-type strain Gordon Dougan (16) 
S. Typhi ISP04-06979 Wild-type strain Gordon Dougan (16) 
S. Typhi 8(04)N Wild-type strain Gordon Dougan (16) 
S. Typhi CT18 Wild-type strain Gordon Dougan 
S. Typhimurium 14028 ∆STM1987 This study 
   
Plasmids   
pCS26  (44) 
pCS26-adrA  (26) 
pCS26-csgB  (26) 
pCS26-sig38H4  (26) 
pU220  (44) 
pU220-csgD  (26) 
pCS26-cpxR  This study 
pKD3  (47) 
pKD46  (47) 
pBR322   
pBR322-STM1987 (14028)  This study 
pBR322-STM1987 (D23580)  This study 
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of several RpoS-controlled promoters (26) To generate the pCS26-cpxR promoter-
luxCDABE construct, the cpx intergenic region  was PCR amplified from S. 
Typhimurium 14028 genomic DNA using primers cpxR1 and cpxR2 (Table 5.2) and 
Phusion high-fidelity DNA polymerase (New England BioLabs), with reaction conditions 
outlined by the manufacturer. The desired PCR product was purified (FroggaBio Inc.), 
sequentially digested with XhoI and BamHI (New England BioLabs), and ligated using 
T4 DNA ligase (New England BioLabs) into the pCS26 vector (XhoI-BamHI) containing 
the luxCDABE operon from Photorhabdus luminescens (44). To generate csgDEFG and 
csgBAC promoter-lux reporters, the csg intergenic region was PCR amplified from 
genomic DNA using primers agfD1 and agfD2 (Table 5.2). The PCR products were then 
ligated into either pCS26-Pac (XhoI-BamHI) or pU220 (BamHI-XhoI) to generate the 
csgBAC and csgDEFG promoter-reporter constructs, respectively. To generate pBR322- 
STM1987 plasmid vectors, DNA fragments containing STM1987 with native promoters 
were first PCR amplified from S. Typhimurium 14028 or S. Typhimurium D23580 from 
genomic DNA using primers STM1987forEco and STM1987revAatII (Table 5.2). These 
PCR products were purified, sequentially digested with EcoRI and AatII, and ligated 
using T4 DNA ligase into digested pBR322. Plasmids were transformed into Salmonella 
strains by electroporation and selected by growth at 37˚C on LB agar supplemented with 
either 50 µg mL-1 kanamycin (pCS26, pU220) or 10 µg mL-1 tetracycline (pBR322). 
5.4.3 SDS-PAGE and Western blotting 
 Approximately 5 x 1010 CFU of planktonic cells were sedimented by 
centrifugation (11,000 x g; 10 min; 4˚C) and resuspended in 1 mL of SDS-PAGE sample 
buffer (without 2-mercaptoethanol and bromophenol blue). Approximately 30 mg 
samples of multicellular aggregates were resuspended in 1 mL of water and homogenized 
with a glass tissue grinder for 25 dounces. The cell material was sedimented (10,000 x g; 
1 min) before resuspension in 1 mL of SDS-PAGE sample buffer. All samples were 
boiled for 5 min. Using the DC protein assay (Bio-Rad Laboratories), cell lysates were 
normalized to a final protein concentration of 3 mg/mL. Bromophenol blue (0.0002% 
final concentration) and 2-mercaptoethanol (0.2% final concentration) were added to 
each lysate before loading 15 µg of total protein per lane. SDS-PAGE was performed 
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Table 5.2. Oligonucleotides used in this study. 
Primer Sequence (5ʹ - 3ʹ)a Purpose 
agfD1 GTGCTCGAGGGACTTCATTAA
ACATGATG 
To amplify the csg intergenic 
and untranslated regions from 
chromosomal DNA 
agfD2 GCCGGATCCTGTTTTTCATGCT
GTCAC  
To amplify the csg intergenic 
and untranslated regions from 
chromosomal DNA 
cpxR1 GCCCTCGAGGTAACTTTGCGC
ATCGCTTG 
To amplify cpxRA promoter 
region from chromosomal 
DNA 
cpxR2 GCCGGATCCTTCATTGTTTACG
TACCTCCG 
To amplify cpxRA promoter 
region from chromosomal 
DNA 
STM14_2408-
ko_sense 
GTGCCGCACGAAACACTGTTA
GACAATCAAGGCTGGTTTAAA
AAGCTGGCGTGTAGGCTGTAG
CTGCTTC 
To amplify cat gene product 
for lambda-red recombination 
STM14_2408-
ko_antisense 
GAATGGACTATTTCTTTTCCCG
CTCCTGAGTCGCGTCGCTGGC
GCAAATACCTCCTTAGTTCCT
ATTCCG 
To amplify cat gene product 
for lambda-red recombination 
STM1987forEco GATCGAATTCAAACGGTGTTT
CGCAC 
To generate STM1987 
promoter and gene insert from 
chromosomal DNA for 
pBR322 cloning 
STM1987revAatII GATCGACGTCGGACTATTTCT
TTTCCCGCT 
To generate STM1987 
promoter and gene insert from 
chromosomal DNA for 
pBR322 cloning 
 
a Nucleotide sequences corresponding to restriction enzyme sites are underlined. 
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with a 5% stacking gel and a 12 or 15% resolving gel. Proteins were transferred to 
nitrocellulose for 40 min at 25 V using a Trans-Blot SD semidry transfer cell (Bio-Rad 
Laboratories) in tris-glycine buffer supplemented with methanol. To detect curli fimbriae, 
cell debris was sedimented following boiling in SDS-PAGE sample buffer, then washed 
twice with 500 µL of distilled water, suspended in 250 µL of 90% formic acid, frozen at -
80˚C, and lyophilized (27). The dried samples were resuspended in SDS-PAGE sample 
buffer and loaded directly without boiling into each SDS-PAGE gel lane (27). CsgD was 
detected using a CsgD-specific monoclonal antibody at a 1-in-6 dilution of tissue culture 
supernatant (ImmunoPrecise Antibodies Ltd., Victoria, BC) (45). To detect RpoS protein, 
a commercially available mouse polyclonal immune serum recognizing epitope 33 to 256 
of E. coli sigma factor S protein was used at a 1-in-2000 dilution (BioLegend; 1RS1). 
CsgA, the major subunit of curli fimbriae, was detected by using a rabbit polyclonal 
serum raised against whole purified curli (27). GroEL was used as a protein-loading 
control and was detected with rabbit polyclonal immune serum at a 1-in-60,000 dilution 
(Sigma-Aldrich; G6532). Secondary antibodies IRDye® 800CW Goat anti-Mouse 
immunoglobulin G (IgG) or 680RD Goat anti-rabbit IgG were used at a 1-in-10,000 
dilution and detected using the the Odyssey CLx imaging system and Image Studio 4.0 
software package (Li-Cor Biosciences). 
5.4.4 Cis versus trans reporter assays and statistical analysis 
 We evaluated strain-specific genetic changes to biofilm regulation using vector-
based promoter-reporter fusion constructs. Cis assays allowed us to quantify the effect of 
strain-specific sequence changes within the promoter of a biofilm-related gene. In these 
assays, the reporter genes from Photorhabdus luminescens (luxCDABE) were fused to 
promoter sequences originating from each of the 12 strains included in this study. 
Expression of each promoter-reporter construct was monitored in the S. Typhimurium 
14028 background. This experimental format ensures that promoter expression is 
measured in a consistent cellular environment, where the same collection of transcription 
factors is available, and their timing and expression are consistent. Trans assays measure 
the expression of a constant/specific promoter sequence within each strain to allow for 
detection of strain-specific variation in upstream regulatory components. In our 
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experiments, we transformed a collection of vectors with S. Typhimurium 14028 
promoter sequences fused to luxCDABE into each strain included in this study. The 
expression of a given S. Typhimurium 14028 promoter sequence was then monitored in 
each strain background, thereby allowing for detection of strain-specific differences in 
the upstream regulatory environment affecting the expression of the given promoter.  
 Statistical analysis of the data was performed using GraphPad Prism version 7.0a. 
Data collected from cis and trans assays was reported as the maximum luciferase 
expression measured during the course of the experiment, and was expressed as the mean 
± the standard deviation. This data was logarithmically transformed and evaluated for 
normal distribution using the Shapiro-Wilk normality test. If the data was normally 
distributed, comparisons of the mean maximum luciferase expression levels obtained 
from multiple experiments were performed using an ordinary one-way ANOVA with 
post-hoc analysis via Holm-Sidak’s multiple comparisons test with statistical significance 
set at p < 0.05. If the data was not normally distributed, comparisons were performed 
using the Kruskal-Wallis test with post-hoc analysis via Dunn’s multiple comparison test 
with statistical significant set at p < 0.05. For cis assays, the mean of maximal luciferase 
expression observed for a given strain was compared to the mean of every other strain in 
the experiment. For trans assays, the mean of maximal luciferase expression from a 
14028 promoter-reporter construct in each strain was compared to expression of the 
construct in every other strain in the experiment. 
5.4.5 Reference genome sequences 
 Whole genome sequences were obtained from the National Centre for 
Biotechnology Information (NCBI) via the following accession numbers: NC_016810 (S. 
Typhimurium SL1344); NC_016854 (S. Typhimurium D23580); NC_003198 (S. Typhi 
CT18). Mapped assemblies for S. Typhi H58 haplotype strains E02-2759, E03-9804, 
ISP03-07467, ISP04-06979 were available from 
http://www.sanger.ac.uk/Projects/S_typhi (16). Assembly of the S. Typhi 8(04)N was 
available from the European Nucleotide Archive under the name SGB112 and associated 
with the assembly number GCA_001362315.1. The sequence for S. Enteritidis D7795 
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was available from the Public Health England Pathogens BioProject on NCBI (accession 
number PRJNA248792). 
5.4.6 Chromosomal DNA isolation 
 Overnight liquid cultures of Salmonella were sub-cultured 1:100 in 200 mL LB 
broth and grown at 37˚C for 2.5 hours. Approximately 7 x 108 cells were centrifuged 
(5465 x g, 10 minutes, 4˚C), resuspended in Tris-EDTA solution (25:1M, pH 8.0) to a 
total volume of 3.5 mL, and then treated with 10 mg lysozyme (Sigma-Aldrich; L6876) 
and 200 units of mutanolysin (Sigma-Aldrich; M9901) for 1 hour at 37˚C. For cell lysis, 
each sample was treated with 50 µL of 25% SDS, 1 mg proteinase K (Applied 
Biosystems; AM23548), and 125 µL of a 5M sodium chloride solution and incubated at 
65˚C for 30 minutes. Nucleic acid was isolated from cell lysates using a series of 
phenol:chloroform:isoamyl and phenol:chloroform extractions, precipitated by the 
addition of ammonium acetate (at a final concentration of 2M), washed with ethanol, and 
resuspended in Tris-EDTA solution (10:1 M, pH 8.0). To remove RNA, RNase A was 
added to each sample at a final concentration of 0.2 mg/mL and incubated for 1 hour at 
37˚C. Samples were purified once more by phenol:chloroform:isoamyl extraction, 
precipitated with ammonium acetate, washed with ethanol, and resuspended in a final 
volume of 200 µL of Tris-EDTA (10:1 M, pH 8.0). 
5.4.7 Genome sequencing and sequence alignments 
 Purified chromosomal DNA samples from S. Enteritidis strains 4931 and 301 
were fragmented by cup horn sonication with a high-intensity ultrasonic processor 
(Vibra-Cell, Danbury, CT) for 10 cycles of a 30-second pulses and 2 minute rest. DNA 
libraries were prepared from 1 µg of fragmented DNA using the NEBNext Ultra DNA 
Library Prep Kit for Illumina (New England BioLabs; E7645S) and NEBNext Multiplex 
Oligos for Illumina (Index Primer Set 2) (New England BioLabs; E7500S) according to 
the manufacturer’s protocols. Adaptor-ligated DNA was size-selected between 400 and 
500 bp total library size (length of insert sequence and adaptor sequence) following kit 
instructions. DNA samples were assessed for quality, purity, and integrity by using a 
NanoDrop ND-1000 spectrophotometer (Fisher Scientific) and an Agilent 2100 
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Bioanalyzer with a High Sensitivity DNA chip (Agilent Technologies; 5067-4626). To 
ensure correct adaptor ligation, samples were analyzed quantitative PCR using the KAPA 
Library Quantification Kit for the Illumina platform (KAPA Biosystems; KK4824). 
Samples were sequenced using the MiSeq Reagent Kit version 3, 600 cycles (2 x 300 bp 
read length) (Illumina; MS-102-3003). Sequencing reads were aligned to the S. 
Enteritidis reference genome P125109 using Geneious version 8.1.5. 
 Sequence alignments were performed in Geneious Pro version 8.1.5, using the 
ClustalW alignment and an IUB cost matrix (gap open cost of 15, gap extend cost of 
6.66). A phylogenetic tree for strains included in this study was constructed based on the 
csg operon region by using the Geneious Tree Builder program included with the 
Geneious software package (46), with the Tamura-Nei model of genetic substitution and 
the neighbour-joining tree building method with bootstrapping (1000 replicates and 
support threshold of 70%). 
5.4.8 Generation of S. Typhimurium 14028 ∆STM1987 mutant strain 
 The S. Typhimurium 14028 ∆STM1987 strain was generated using the lambda red 
recombinase knockout procedure (47). Primers containing a 50-nucleotide sequence on 
either side of the STM1987 are listed in Table 5.2 and were used to amplify the cat gene 
from pKD3 using Phusion High-Fidelity DNA polymerase (New England BioLabs). The 
PCR products were purified (AxyPrep Mag PCR Cleanup kit; Axygen) and 
electroporated into S. Typhimurium 14028 cells containing pKD46. Mutant strains were 
first selected by growth at 37˚C on LB agar supplemented with 7 µg mL-1 
chloramphenicol (Cm) before restreaking onto LB agar containing 30 µg mL-1 Cm. The 
mutations were moved into clean wild-type backgrounds by transduction with P22 phage 
(48). The cat gene was resolved from the chromosome using pCP20 (47). DNA 
sequencing of PCR products amplified from the chromosome of the ∆STM1987 strain 
confirmed the loss of the majority of STM1987. 
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5.5 Results 
5.5.1 Evaluation of the biofilm phenotype for invasive nontyphoidal and typhoidal 
Salmonella strains 
 The appearance of Salmonella macrocolonies grown on T agar has routinely been 
used as a diagnostic tool for the biofilm behaviour of a strain, where the solid, dry, and 
rough appearance of a biofilm-positive strain contrasts from the smooth, mucoidal texture 
of one with a biofilm-negative phenotype (27, 35). After 5 days of growth at 28˚C on T 
agar, nontyphoidal and typhoidal Salmonella strains were easily distinguishable based on 
the different appearances of their macrocolonies (Fig. 5.1). Control strains of 
nontyphoidal Salmonella associated with gastroenteritis in humans were positive for the 
rdar morphotype, as demonstrated by the formation of concentric rings and colony 
wrinkling on the macrocolony surface. Typhoidal Salmonella strains were rdar-negative 
in appearance, forming smooth, mucoid, and non-aggregative macrocolonies.  S. 
Typhimurium D23580, an invasive nontyphoidal Salmonella strain, demonstrated a 
partial, incomplete biofilm pattern on its surface. Although macrocolonies of this strain 
appeared smooth and lacked the characteristic wrinkled appearance, there was evidence 
of textural differences between the outer edge of the colony, corresponding to the zone of 
active cell growth, and the inner region containing an older cell population (26, 49). 
These zones were visibly divided by a concentric ring pattern on the surface of the 
macrocolony. In contrast, S. Enteritidis D7795, the other representative invasive 
nontyphoidal strain included for study, was negative for the rdar morphotype. 
 Cellulose is an exopolysaccharide of the extracellular matrix that is essential for 
long-range interactions between cells in a rdar macrocolony (50). To detect the 
production of this polymer, macrocolonies of each strain were grown on T agar 
containing calcofluor white, a polysaccharide-binding fluorescent dye (34). Nontyphoidal 
Salmonella macrocolonies strongly produced cellulose, as demonstrated by their intense 
fluorescent signal under long-wave UV light. Similar fluorescence intensity was observed 
for S. Typhimurium D23580 macrocolonies, indicating the presence of cellulose 
production despite the partial rdar morphotype. In contrast, low fluorescent signaling 
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Figure 5.1. The biofilm phenotypes of nontyphoidal and typhoidal Salmonella strains. 
Top panel: 2 µL of cells from overnight cultures were grown at 28˚C for 48 hours on T agar; the red, dry, and rough morphotype is 
indicative of biofilm formation, and presents as the formation of concentric rings and a wrinkled appearance on the surface of 
macrocolonies. Middle panel: Cells were grown for 48 hours at 28˚C on T agar supplemented with 200 µg mL-1 of calcofluor white 
dye. The white and fluorescent appearance of macrocolonies visualized under UV light is indicative of calcofluor binding to cellulose. 
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Bottom panel: Strains were grown in 1% tryptone broth for 48 hours at 28˚C; at the population level, bistable expression of csgD 
limits biofilm expression to a subpopulation of cells, resulting in phenotypic switching. This phenomenon is visualized by the 
presence of both multicellular aggregates and planktonic cells in aliquots from liquid cultures. 
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from both S. Enteritidis D7795 and typhoidal Salmonella macrocolonies indicated that 
cellulose production was comparably minimal or absent from these strains. 
 Macrocolony appearance and the rdar morphotype provide a population-level 
analysis of the biofilm phenotype. While strong biofilm-producing strains of Salmonella 
have an obvious biofilm phenotype, other strains that are moderate or partially impaired 
in biofilm production may be incorrectly categorized as biofilm-negative. It was recently 
demonstrated that biofilm-producing Salmonella strains grown in flask cultures will 
produce two unique subpopulations of multicellular aggregates and planktonic cells (45, 
51). This heterogeneous expression of the biofilm phenotype is due to bistable expression 
of csgD within a clonal population. (52). We reasoned that multicellular aggregation in 
liquid cultures might provide a clearer diagnostic for the presence of a functioning 
biofilm phenotype in both strong and moderate biofilm-producing strains. Similar to the 
biofilm-positive nontyphoidal Salmonella strains included in our panel, cultures of S. 
Typhimurium D23580 contained visible multicellular aggregates and planktonic cell 
subpopulations. However, these aggregates were more slime-like in texture and made up 
a lower proportion of the population biomass compared to aggregates from nontyphoidal 
strains associated with gastroenteritis (data not shown). In contrast, cultures of S. 
Enteritidis D7795 and all typhoidal Salmonella strains were homogeneous and consisted 
solely of planktonic cells. Overall, our results suggested a strain-specific nature for the 
biofilm phenotype for invasive nontyphoidal Salmonella strains, where S. Typhimurium 
D23580 has retained a moderate but impaired biofilm phenotype, and S. Enteritidis has 
lost this phenotype altogether. 
5.5.2 Expression of the S. Typhimurium 14028 biofilm gene promoter library in invasive 
nontyphoidal and typhoidal strains 
 Impairment or loss of the biofilm phenotype for invasive nontyphoidal Salmonella 
may reflect mutations in the transcriptional regulatory network that controls the 
expression of curli fimbriae and cellulose. To compare the functionality of the biofilm 
regulatory network in our panel of Salmonellae, we transformed each strain with a 
reporter library of biofilm-related gene promoters from S. Typhimurium 14028 fused to 
bacterial luciferase genes from Photorhabdus luminescens, luxCDABE (26, 32). For our 
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analysis of promoter activity, we compared the maximum expression of a given promoter 
in each strain relative to its expression in the native S. Typhimurium 14028 strain (Fig. 
5.2). While our microplate culture conditions facilitated the growth of both nontyphoidal 
and typhoidal Salmonella, we noted a consistent delay in the exponential growth of S. 
Typhi strain E02-2759 (Fig. 5.2A). 
 We used transcription from the cpxRA promoter as an indicator of curli and 
cellulose biosynthesis (Figure 5.2B). Activation of the Cpx envelope stress response is 
proposed to represent a transition from the initial synthesis and establishment of biofilm 
polymers to a more mature biofilm state (53, 54). Envelope stress signals activate the 
two-component signaling system CpxAR, resulting in CpxR phosphorylation. In this 
activated state, CpxR potently inhibits further biosynthesis of curli fimbriae and cellulose 
by auto-activating its own transcription and repressing the transcription of both csg 
operons (53, 55-57). In our biofilm-positive nontyphoidal Salmonella strains, maximal 
expression of the cpxRA promoter ranged between 1 500 and 47,000 CPS. Expression of 
the cpxRA promoter in S. Typhimurium D23580 was consistent with its ability to form 
multicellular aggregates and further suggested the production of biofilm extracellular 
matrix components. In contrast, we observed a 2-log reduction in promoter activity for 
strains with a biofilm-negative phenotype.  
 CsgD promotes synthesis of the extracellular matrix through transcriptional 
activation of csgBAC, encoding the curli biosynthesis genes, and adrA, a diguanylate 
cyclase that indirectly activates cellulose biosynthesis through production of cyclic-di-
GMP (29, 35, 58, 59). We observed a notable difference in the expression of either 
promoter between biofilm-positive and biofilm-negative Salmonella strains included in 
our study. White et al. previously reported trans variability in the expression of the 
csgBAC promoter between biofilm-positive strains of Salmonella (32). Consistent with 
this finding, the maximal expression of this promoter ranged between approximately 
4,600 and 280,000 luminescence counts per second (CPS) in our biofilm-positive 
nontyphoidal Salmonella strains, with maximal expression of the promoter observed in its 
native strain, S. Typhimurium 14028 (Fig. 5.2C). Expression of the csgBAC promoter in 
invasive strain S. Typhimurium D23580 fell within this dynamic range. A similar pattern 
was observed for the adrA promoter; maximal expression ranged between 800 and 
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Figure 5.2. Analysis of the biofilm regulatory network in nontyphoidal and 
typhoidal Salmonella strains. 
(A) Absorbance measurements representing strain growth over 48 hours at 28˚C in 
microaerophilic cultures grown in 96-well microtiter plates. (A-F) Green - nontyphoidal 
Salmonella strains associated with gastroenteritis disease; blue - nontyphoidal Salmonella 
strains associated with invasive bloodstream infections; and pink - typhoidal Salmonella 
strains. (B-E) Maximal luminescence (counts per second, CPS) is reported for Salmonella 
strains harbouring vectors containing S. Typhimurium 14028 promoters fused to bacterial 
luciferase genes (luxCDABE). (F) Maximal luminescence from strains containing a 
vector-based synthetic RpoS-responsive promoter-luciferase fusion construct indicating 
the functional activity of the RpoS sigma factor in each strain. The maximal 
luminescence value reported represents the mean and standard deviation of values 
recorded from a minimum of 3 independent biological replicates. We used an ordinary 
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one-way ANOVA with Holm-Sidak’s multiple comparison test or a Kruskal-Wallis test 
with Dunn’s multiple comparisons test to detect strain-dependent variations in the 
maximal luciferase expression of a given promoter-reporter construct. Mean values that 
are not statistically different from other mean values are indicated with a common letter 
in black font. In contrast, mean values that are statistically different from all other mean 
values are indicated with a unique letter in red font. The dashed line in (B), (C), and (D) 
represents the limit of detection for promoter expression and is derived from the maximal 
luminescence values measured from S. Typhimurium 14028 containing a promoterless 
vector construct; #, measured value below limit of detection. (G) Western blot analysis of 
RpoS sigma factor protein in whole cell lysates of multicellular aggregates or planktonic 
cells derived from nontyphoidal and typhoidal Salmonella strains collected following 24 
hours of growth at 28˚C in liquid cultures of 1% tryptone. Recombinant RpoS protein 
purified from E. coli cells was used as a technical control for RpoS detection. GroEL was 
detected as a loading control to ensure that each lane was loaded with equal amounts of 
protein. The Western blots are representative of two biological replicates. 
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29,000 CPS in biofilm-positive strains and was strongest in S. Typhimurium 14028 (Fig. 
5.2D). In contrast, expression of csgBAC and adrA in S. Enteritidis D7795 and all S. 
Typhi strains was comparable to reporter noise recorded from control strains containing a 
promoterless reporter vector. 
 The csgD promoter region is targeted by several transcriptional regulators and 
represents an important site of integration for environmental signals, such as temperature, 
osmolarity, and nutritional limitation. We reasoned that loss of the biofilm phenotype in 
S. Enteritidis D7795 and S. Typhi strains could result from mutations affecting trans-
acting regulatory elements that modulate the expression of csgD. We detected csgD 
promoter activity in all of the Salmonella strains included in our panel (Fig. 5.2E). 
However, S. Enteritidis D7795, S. Typhi E02-2759, and S. Typhi E03-9804 demonstrated 
a 5- to 6-fold reduction in maximal promoter expression compared to S. Typhimurium 
14028. For these strains, loss of the biofilm phenotype may reflect the presence of 
mutations in the regulatory network that consequentially result in reduced csgD promoter 
expression. 
 Expression of csgD is dependent on RpoS, a sigma factor with maximal 
expression during stationary phase that promotes the transcription of genes important for 
cell survival under conditions of starvation or stress (35). While rpoS mutant alleles are 
common in S. Typhi, they are relatively rare in nontyphoidal Salmonella isolates and are 
often associated with strain passaging and growth in laboratory conditions (32, 60-62). 
We tracked RpoS activity in our panel of strains by using an RpoS-responsive synthetic 
promoter fused to the luxCDABE operon, sig38H4 (26). This promoter was previously 
demonstrated to have a maximal activity of less than 10,000 CPS in rpoS deficient strains 
of Salmonella (32). The majority of strains in our panel exceeded this threshold; 
however, maximal expression of the sig38H4 promoter in S. Enteritidis D7795 was 
significantly different from the expression levels observed for all other strains in the 
panel, with a mean value of 5,900 CPS (Fig. 5.2F). To confirm the presence of RpoS at 
the protein level, we probed whole-cell lysates of each strain obtained from the flask 
cultures we had used to assess for the biofilm phenotype (Fig. 5.1). The sigma factor was 
detectable in all nontyphoidal Salmonella strains, including both multicellular aggregate 
and planktonic cell subpopulations derived from biofilm-producing strains (Fig. 5.2G). 
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We noted significant variation in RpoS protein levels detected in each strain at the 24-
hour time point used for sampling, with nearly undetectable levels of RpoS observed for 
E03-9804 and 8(04)N. 
5.5.3 Species and strain-specific allelic variation in csg promoter expression and protein 
synthesis 
 We hypothesized that mutations affecting csgD expression or synthesis may 
account for the significant reduction in csgBAC promoter expression for S. Typhimurium 
D23580 or absence of csgBAC and adrA promoter expression for S. Enteritidis D7795. 
To identify these potential mutations, we performed a genetic alignment of the sequences 
for the csg region from the nontyphoidal and typhoidal strains included in our panel (Fig. 
5.3A). Sequence identity was high overall, scoring 98% for the full-length csg region 
(4,450 bp), and 94% for the intergenic region (755 bp). Several serovar-specific sequence 
changes were observed for both csg operons as well as the intergenic region. Our 
alignment did not identify any mutations within the csg operons for S. Typhimurium 
D23580 or S. Enteritidis D7795 (data not shown). However, we identified unique single 
nucleotide polymorphisms within the intergenic region that were specific to either strain 
of invasive nontyphoidal Salmonella (Fig. 5.3B). For S. Typhimurium D23580, a G-to-T 
transversion was found 80 bp upstream of the csgD transcriptional start site, where 
OmpR and H-NS have been demonstrated to bind and subsequently repress csgD 
transcription (63). A second mutation in the S. Typhimurium D23580 sequence, a C-to-T 
transition, was observed 189 bp upstream. This area of the intergenic region is linked to 
both enhancement and repression of csgD transcription, resulting from an overlap of an 
activating binding site for integration host factor (IHF) and inactivating binding sites for 
OmpR and the nucleoid associated factor H-NS (63, 64). For S. Enteritidis D7795, a G-
to-A transition mutation was observed at position 47 upstream of the csgD transcriptional 
start site, an area corresponding to a high-affinity binding site for OmpR and an 
important region for the transcriptional activation of csgD (63). 
 To determine the impact of these polymorphisms, we amplified the csg intergenic 
region to generate a set of csgDEFG and csgBAC promoter-luciferase fusion vectors from 
each strain. We then compared the functionality of each promoter by measuring their 
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expression levels in our biofilm-positive control strain, S. Typhimurium 14028 (Fig. 
5.3C). We observed a similar level of maximal expression for the csgD promoters from 
our control strains of nontyphoidal and typhoidal Salmonella. Similarly, peak expression 
measured for the csgD promoters for S. Typhimurium D23580 and S. Enteritidis D7795 
was comparable to most of the strains included in our panel. However, our statistical 
analysis revealed a significant difference in csgD promoter expression between either 
invasive nontyphoidal Salmonella strain and S. Typhimurium 14028. In agreements with 
our multiple sequence alignments, we found that the functionality of the S. Typhimurium 
D23580 and S. Enteritidis D7795 csgB promoters was not statistically different from that 
of either nontyphoidal or typhoidal promoters. Surprisingly, expression from the csgB 
promoter of biofilm-producing strain S. Typhimurium SL1344 was statistically below 
expression levels for promoters from half of the strains in our panel. 
 We hypothesized that variation in csgD promoter expression may account for 
differences in the biofilm phenotype between both S. Typhimurium D23580 and S. 
Enteritidis D7795 and nontyphoidal Salmonella strains associated with gastroenteritis or 
invasive disease. Using western blot, we evaluated CsgD synthesis and curli fimbriae 
biogenesis in whole cell lysates obtained from multicellular aggregates for biofilm-
positive strains and homogeneous planktonic cultures of biofilm-negative strains (Fig. 
5.3D). Consistent with our previous work (45), both CsgD protein and CsgA, the major 
subunit of curli fimbriae, was detected in lysates from multicellular aggregates for all 
biofilm-positive strains, including S. Typhimurium D23580. In contrast, CsgD and CsgA 
synthesis was not observed for S. Enteritidis D7795 or any of the S. Typhi strains. While 
csgD promoter strength was comparable between S. Typhi and our control strains of 
biofilm-positive nontyphoidal Salmonella, absence of CsgD synthesis may result from 
predicted truncation of 8 amino acids from the N-terminal end that is conserved across all 
typhoidal strains in our panel (14, 16). 
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Figure 5.3. Identification of sequence changes and comparison of promoter activity 
in the csgD-csgB intergenic region from different Salmonella strains. 
(A) Multiple sequence alignment of the intergenic and 5ʹ untranslated regions for the 
csgDEFG and csgBAC operons from each Salmonella strain included in this study. The 
neighbour-joining dendrograms included to the left of the sequence alignments are 
established based on bootstrapping parameters set to 1,000 replicates and a support 
threshold of 70%. Both transcriptional start sites (arrows) and transcription factor binding 
regions that have been experimentally verified in Salmonella are indicated above the 
consensus sequence. CpxR, black boxes; H-NS, dark grey boxes; IHF, light grey boxes; 
OmpR, hatched boxes. The start of the csgD and csgB open reading frames and the -10 or 
-35 regions for either operon are included below the consensus sequence. Red boxes that 
span the sequence alignment indicate regions containing strain-specific mutations for S. 
Typhimurium D23850 or S. Enteritidis D7795, which are expanded in (B).  (C) 
Maximum luminescence from promoter-reporter constructs driven by csgD and csgB 
promoters from each Salmonella strain. Expression of each reporter was measured in S. 
Typhimurium 14028. The maximal luminescence value reported represents the mean and 
standard deviation of values recorded from 3 independent biological replicates. Statistical 
significance: *, P < 0.05; **, P < 0.01. (D) Whole cell lysates of multicellular aggregates 
or planktonic cells from biofilm-positive or biofilm-negative strains, respectively, were 
analyzed by western blotting for the presence of CsgD and CsgA, the major subunit of 
curli fimbriae. Whole cell lysates were derived from nontyphoidal and typhoidal 
Salmonella strains collected following 24 hours of growth at 28˚C in liquid cultures of 
1% tryptone. Black arrows indicate monomerized (M) and dimerized (D) CsgA protein 
subunits. A CsgD-6xHis recombinant protein was used as a technical control for CsgD 
detection. The control lane was used for inter-blot normalization of band intensities and 
represents the pooled whole cell lysates derived from S. Typhimurium strains 14028 and 
SL1344, as well as S. Enteritidis 4931 and 301. The western blots are representative of 
two biological replicates. 
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5.5.4 A missense mutation in the Cache1 domain of STM1987 results in differential 
expression of cellulose between S. Typhimurium D23580 and 14028  
 BcsA, the catalytic subunit for cellulose biosynthesis, is allosterically activated 
via binding of the bacterial secondary messenger molecule bis-(3’,5’)-cyclic dimeric 
guanosine monophosphate (c-di-GMP) to the protein’s PilZ domain (65). While AdrA is 
the predominant contributor to this inducing c-di-GMP pool during CsgD-regulated 
biofilm formation, additional diguanylate cyclases such as STM1987 further enhance 
intracellular levels of this secondary messenger and promote cellulose production (45, 
66-68). Mills et al. recently identified the Cache1 domain of the STM1987 enzyme as the 
potential activation site for enzyme activity in response to inducing molecules such as L-
arginine (69). We compared the gene sequence for STM1987 from S. Typhimurium 
strains 14028 and D23580 and observed a C-to-G transversion located 566 bp 
downstream of the translational start site. For S. Typhimurium D23580, this transversion 
results in a replacement of threonine with arginine at residue 189, located within the 
Cache1 domain region for STM1987.  
 To determine the effect of this mutation, the alleles for STM1987 from S. 
Typhimurium 14028 and D23580 were cloned into plasmid vectors and transformed into 
an S. Typhimurium ∆STM1987 mutant strain (Fig. 5.4). Plasmid-based expression of 
diguanylate cyclases has been previously demonstrated to result in the overexpression of 
cellulose in otherwise non-inducing conditions (66, 70). Consistent with these 
observations, either complemented strain demonstrated uncharacteristic biofilm 
production at the air-liquid interface following overnight growth in LB broth at 37˚C 
(Fig. 5.4A). We noted a difference in the thickness of this biofilm layer between cultures 
of each complemented strain, suggesting that the STM1987 allele from S. Typhimurium 
D23580 may have decreased enzymatic activity. This effect was visible during 
macrocolony growth of either complemented strain on T agar containing calcofluor white 
(Fig. 5.4B). Following 12 hours of growth at 28˚C, the fluorescent intensity of 
macrocolonies of the STM1987 (D23580) complemented strain was observably less than 
that of the STM1987 (14028) complemented strain (Fig. 5.4C). However, these 
differences in fluorescence were no longer visible by 20 hours of growth (Fig. 5.4D).  
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5.6 Discussion 
 In this study, we evaluated the biofilm phenotype of invasive nontyphoidal strains 
S. Typhimurium D23580 and S. Enteritidis D7795. Our results showed that invasive 
nontyphoidal Salmonellae vary in their capacity for biofilm formation. While S. 
Typhimurium D23580 demonstrated a partial rdar morphotype and produced 
multicellular aggregates in liquid cultures, S. Enteritidis D7795 was rdar-negative and 
solely consisted of a homogenous planktonic population. Consistent with these 
phenotypic differences, we observed that curli fimbriae and cellulose extracellular matrix 
components could be detected from macrocolonies or multicellular aggregates of S. 
Typhimurium D23580, but not S. Enteritidis D7795. Our sequence alignment of csgD 
promoter regions from multiple nontyphoidal and typhoidal Salmonella strains revealed a 
small nucleotide polymorphism unique to S. Enteritidis D7795, located in a critical 
OmpR binding site required for activation of csgD transcriptional expression (63). This 
mutation resulted in a drop in csgD promoter activity to near background levels, which 
correlates with the absence of csgBAC and adrA promoter expression in this invasive S. 
Enteritidis strain.  
 Our findings contradict a recent study from Singletary et al. that had 
demonstrated a rdar-negative phenotype for S. Typhimurium D23580 (43). Their 
comparative analysis of the csg and bcs operons of S. Typhimurium strains 14028 and 
D23580 identified three potential mutations, including a nonsynonymous mutation within 
csgE and a premature stop codon in bcsG. Our multiple sequence alignment of the csg 
operons from strains included in this study found that this allelic difference in csgE, 
located 108 bp from the csgE translational start site, is in fact unique to S. Typhimurium 
14028 compared to all other nontyphoidal Salmonella strains in this study (data not 
shown). Singletary et al. demonstrated that complementation of S. Typhimurium D23580 
with a plasmid-based copy of the bcsG allele from S. Typhimurium 14028 resulted in 
rescue of the rdar morphotype. BcsG encodes a putative endoglucanase, an enzyme that 
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Figure 5.4. Phenotypic comparison between STM1987 alleles from S. Typhimurium 
14028 and D23580. 
(A) Biofilm production was visible as an adhered ring of cells and extracellular matrix 
production in overnight LB broth cultures of S. Typhimurium ∆STM1987 complemented 
by vector-based alleles of STM1987 from S. Typhimurium 14028 or D23580. (B) To 
observe the effect of STM1987 complementation on cellulose production, we spotted 2 
µL of each overnight culture on T agar supplemented with 200 µg mL-1 calcofluor white 
dye. S. Typhimurium 14028 ∆STM1987 containing an empty pBR322 vector was used as 
a negative control. Macrocolony binding of calcofluor white was visualized by UV light 
after (C) 12 and (D) 20 hours of growth at 28˚C. 
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is normally responsible for cleavage of polymeric cellulose (34, 71). While the bcsEFG 
operon has been shown as necessary for optimal cellulose production in S. Enteritidis, the 
exact role and level of importance of BcsG has yet to be determined (34, 72). We 
demonstrated that macrocolonies of S. Typhimurium D23580 retain the ability to produce 
cellulose despite this mutated bcsG allele. However, mutation of the bcsG gene and sub-
optimal cellulose biosynthesis may represent one of many factors that contribute to the 
impaired biofilm phenotype that we observed for S. Typhimurium D23580.  
 We identified a missense mutation in the S. Typhimurium D23580 sequence for 
STM1987, a diguanylate cyclase responsible for c-di-GMP biosynthesis. This important 
secondary messenger molecule is involved in the regulation of multiple cellular processes 
for enteric bacteria, including motility, biofilm formation, and virulence (reviewed in 
(73)). In Salmonella, at least 5 diguanylate cyclases and 4 phosphodiesterases have been 
associated with modulation of the c-di-GMP pool that regulates the rdar morphotype (50, 
66-68, 73-76). However, STM1987 is the only other diguanylate cyclase apart from 
AdrA that induces cellulose biosynthesis under physiological conditions, without the 
requirement for overexpression (45, 67). Our improved understanding of enzyme-specific 
regulation, including the conditions for transcriptional expression, membrane versus 
cytoplasmic enzyme localization, and signals that induce enzymatic activity, may explain 
how c-di-GMP enzymes can produce the same messenger molecule but affect different 
levels in the biofilm regulatory pathway (73). While transcription of both STM1987 and 
AdrA is maximal during stationary phase, STM1987 is unique in that its transcription is 
not dependent on CsgD synthesis (N. Herman and A. White, unpublished data, (77)). 
Pontes et al. recently provided evidence for cellulose production by S. Typhimurium 
while within the Salmonella-containing vacuole of infected macrophages (78). STM1987 
may induce biosynthesis of cellulose under these conditions in response to sensing 
increased vacuolar concentrations of L-arginine via its Cache1 domain (69). It is 
tempting to speculate that decreased activity of STM1987 in S. Typhimurium D23580 
may result from differences in macrophage activation and intracellular killing in 
immunocompromised individuals. Reduced cellulose biosynthesis during infection may 
improve the virulence and replication of S. Typhimurium D23580 in its 
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immunocompromised host, but would impair its ability to produce the rdar morphotype 
and survive in the environment between host infections (12, 38, 45). 
 Both csgD expression and the rdar morphotype are highly conserved across the 
Salmonella species (32, 34, 63, 79). Strains that are negative for the rdar morphotype, 
including Salmonella Typhi, Paratyphi A, Choleraesuis, Gallinarum, and Typhimurium 
var. Copenhagen, are often associated with a restricted host range and are responsible for 
invasive forms of salmonellosis in their respective hosts (2, 31, 32). The transition from 
the intestinal to systemic niche is thought to represent an evolutionary bottleneck for 
Salmonella, with significant losses in the functional gene repertoire consistently observed 
for invasive serovars and strains of Salmonella (12, 80, 81). Some serovars and strains, 
including S. Typhi, S. Paratyphi A, as well as invasive nontyphoidal Salmonella, have 
demonstrated an ability to develop an asymptomatic chronic carrier state within the 
human host, removing the selection pressure on genes that may specifically aid in 
transmission via the fecal-oral route (37, 38). As the CsgD-regulated biofilm phenotype is 
hypothesized to aid cell survival during the environmental phase of transmission, it is 
possible that genes for this phenotype are functionally inactivated as part of host 
adaptation (25, 26, 31, 34, 45, 82, 83). However, the function of some biofilm-related 
processes, such as exopolysaccharide production, may be selected due to their importance 
for CsgD-independent biofilm formation in the gall bladder (8, 84, 85).  
 We recently reported the increased expression of over 780 genes during the 
development of multicellular aggregates in cultures of S. Typhimurium 14028 (45). This 
significant shift in the transcriptome of Salmonella cells contrasts sharply with both the 
small regulon of genes directly controlled by CsgD as well as the complex but limited 
number of regulatory factors that influence expression and synthesis of CsgD itself ((86), 
reviewed in (87)). It is possible that patterns of genomic degradation that accompany host 
adaptation may affect the biofilm phenotype in a graded manner. Neutral or mildly 
deleterious mutations affecting the core CsgD regulatory pathway or functional 
inactivation of genes included in the transcriptome may result in impairment of the rdar 
morphotype. However, gene inactivation or deletions in the core biofilm regulatory 
pathway would result in loss of the rdar morphotype altogether. It is interesting to note 
that variation in the biofilm phenotype of invasive nontyphoidal Salmonella strains 
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included in this study reflects differences in the known host range of either strain. S. 
Typhimurium D23580 demonstrated a partial rdar morphotype and has been shown to 
cause infection in several host species, including humans, mice, chicks, cows, and rhesus 
macaques (43). In contrast, S. Enteritidis D7795 was negative for the rdar morphotype, 
and has thus far been demonstrated to have reduced invasiveness and overall fitness 
during experimental infection of chicks (19). We propose that genetic changes impacting 
the CsgD-regulated biofilm phenotype result in the loss of an environmental persistence 
strategy that is central to ancestral strains of E. coli and Salmonella that transmit via the 
fecal-oral route, and may therefore represent an important genetic signature of host 
adaptation.  
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6.0 GENERAL CONCLUSIONS, DISCUSSION, AND FUTURE DIRECTIONS 
6.1 General Conclusions 
• We have modified an existing Tn7 transposition system and demonstrated its 
improved efficiency for integrating genetic elements into the chromosome of 
Salmonella and other Enterobacteriaceae 
• Plasmid-based complementation of a csgD mutant resulted in overexpression of 
both csgD and the biofilm phenotype 
• Chromosomal-based complementation of a csgD mutant strain closely matched 
wildtype Salmonella in terms of timing of biofilm gene expression and quality of 
the biofilm phenotype 
• Transcriptome analysis via RNA-seq identified 1856 genes that were 
differentially expressed between multicellular aggregates and planktonic cells 
exposed to the same environmental conditions 
• The genetic profile of multicellular aggregates is consistent with previous 
characterizations of gene expression associated with the Salmonella rdar 
morphotype 
• Planktonic cells display a genetic profile consistent with increased expression of 
virulence factors, including the SPI-1 and SPI-2 type three secretion systems, cell 
motility, and chemotaxis systems 
• Planktonic cells synthesize a secretion-competent SPI-1 type three secretion 
system, which correlated with enhanced invasion of a polarized Caco-2 human 
intestinal cell line and a fitness advantage in the systemic model of murine 
infection compared to multicellular aggregates 
• Multicellular aggregates demonstrated enhanced cell survival compared to 
planktonic cells following desiccation 
• The fitness advantage of planktonic cells in the systemic model of murine 
infection was abolished when both cell subpopulations were pre-exposed to 
conditions of desiccation 
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• CsgD bistability may represent a conserved evolutionary strategy for generating 
phenotypic heterogeneity within the Salmonella population 
• Planktonic cells and multicellular aggregates are specialized cell types that may 
enhance the transmission of Salmonella 
• The invasive nontyphoidal Salmonella strains S. Typhimurium D23580 and S. 
Enteritidis D7795 are impaired for the biofilm phenotype 
• Impairment of the biofilm phenotype of S. Typhimurium D23580 and S. 
Enteritidis D7795 are due to strain-specific genetic polymorphisms that affect the 
expression and/or function of genes associated with biofilm formation 
• A csgD promoter mutation in S. Enteritidis D7795 correlated with loss of CsgD 
synthesis, absence of curli fimbriae and cellulose biosynthesis, and a biofilm-
negative phenotype 
• CsgD is synthesized by S. Typhimurium D23580, which correlated with detection 
of curli fimbriae and cellulose biosynthesis and an intermediate biofilm phenotype 
6.2 General Discussion and Future Directions 
 The starting goal of my Ph.D. research was to characterize the transcriptome of 
Salmonella cells during the process of biofilm formation. Previously, Salmonella biofilm 
biology had been studied as a population-level phenomenon termed the rdar morphotype, 
where wildtype Salmonella colonies formed a highly organized extracellular matrix 
structure (1). CsgD, the master transcriptional regulator of the rdar morphotype, was 
known to activate genes that were responsible for the extracellular matrix structure itself 
(2). However, there was evidence that many other genetic changes occurred during 
biofilm formation as part of a global shift in the gene expression profile of Salmonella 
cells (3, 4). To determine the role of csgD in influencing the transcriptome during biofilm 
development, our approach was to compare biofilm-positive colonies of our wildtype 
Salmonella strain to biofilm-negative colonies of a csgD mutant strain. As a control for 
this and future experiments, we developed a csgD revertant strain using Tn7 
transposition-based biotechnology and chromosomal complementation (Objectives 1 and 
2 for this thesis, presented in Chapter 3). 
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 Chromosomal complementation and Tn7-based transposition offered several 
attractive benefits for gene expression analysis. With plasmid-based complementation 
there was a concern regarding gene dosage effects; the biological mechanism of Tn7 
transposition would instead allow for single-copy insertion of the gene of interest into an 
innocuous site in the chromosome. We chose the dual-plasmid Tn7 transposition system 
created by Choi et al. as it was heavily cited within the literature, and its suicide-vector 
approach allowed for generation of a chromosomal integrant in a single step (5). We 
found that a major limitation of this approach was the transient expression of the 
transposition machinery. While this issue was not implicitly stated in the literature, the 
authors had published sequential papers where new helper plasmid derivatives (pTNS2 
and pTNS3) had been generated to improve expression of the transposition machinery via 
stronger promoter constructs (5, 6). Nancy Craig and colleagues offered a different 
solution by placing the transposition machinery and the mini-Tn7 transposon element 
onto a single plasmid with temperature-sensitive replication (7). Unfortunately, in our 
hands, cloning into the large plasmid was difficult, and when our construct was 
eventually cloned successfully, the procedure did not work (i.e., 20 independent 
experiments performed by four difference people). Our solution was to combine features 
of both systems by transferring the tnsABCD genes from pTNS2 onto a temperature-
sensitive plasmid, while maintaining the original carrier vector for easier cloning (8). Our 
approach resulted in improved transposition efficiencies compared to the original dual-
plasmid Tn7 transposition system when tested with pathogenic strains of E. coli and 
Salmonella. Further, we provided strong evidence that transposition success was 
correlated to increased expression of the tnsABCD genes from our new helper plasmid. In 
the 6 months following publication of our method, our new helper plasmid system has 
been requested by 15 laboratories around the world and has been successfully used by 
two of our collaborators for their chromosomal integration projects. 
 Our Tn7 transposition system provided a robust pipeline for chromosomal 
complementation. We evaluated plasmid- and chromosomal-complemented csgD 
revertant strains for their ability to restore the genetic and phenotypic biofilm profiles of 
the wildtype S. Typhimurium strain (8). Plasmid-based complementation resulted in 
overexpression of the csgD gene; this was demonstrated by the strain’s overproduction of 
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curli fimbriae and cellulose and elevated csgB and adrA promoter expression compared 
to the wildtype strain. In contrast, the chromosomal-complemented strain was 
comparable to the wildtype strain both in the timing of gene expression and in the 
qualitative features of the biofilm phenotype. As it turned out, we did not use the csgD 
chromosomal revertant strain in the final transcriptomic study due to changes in the 
experimental design following the discovery of CsgD bistability. However, our research 
did make use of a second modification to the Tn7 system – the incorporation of the 
pCS26 reporter vector into the miniTn7 carrier plasmid. This allowed us to tag our 
wildtype S. Typhimurium strain with two different antibiotic markers for use in 
subsequent experiments, such as comparing the fitness of multicellular aggregates and 
planktonic cells in in vitro survival assays and in competitive infections of mice 
(Objective 8 of this thesis, presented in Chapter 4) (9). Therefore, our modified Tn7 
transposition system allowed us to carry out important functional studies that validated 
and strengthened the results of the transcriptomic analysis. 
 To perform a successful RNA-seq experiment with Salmonella biofilms (Chapter 
4), we were forced to develop several specialized methodologies for the genetic and 
physiological analysis of Salmonella biofilm formation. The reality is that most 
microbiological procedures are designed for the study of homogeneous populations of 
planktonic bacterial cells. We were faced with two main challenges: first, to modify 
existing tools to allow for reproducible extraction of biofilm cells embedded within the 
recalcitrant extracellular matrix, and second, to devise a way to compare the disparate 
cell physiologies of multicellular aggregates and planktonic cells. Our use of low speed 
centrifugation to isolate aggregated cells from planktonic cells was central to this study 
and provided an efficient method for separating the cell types with minimum impact to 
their transcriptome or physiology (Objective 4, presented in Chapter 4). For 
transcriptome analysis, we chose a column-based RNA extraction kit that allowed us to 
maximize our yield of high-quality RNA samples while facilitating the recovery of total 
RNA, including the small RNAs involved in csgD regulation. We successfully adapted a 
commercially available kit for the isolation of RNA from Salmonella biofilm samples 
(Objective 5, presented in Chapter 4). Our adjustments to minimize the effect of the 
extracellular matrix for cell lysis and on-column RNA purification resulted in a procedure 
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that elevated the power of our transcriptomic analysis due to its technical reproducibility. 
To compare the cell subpopulations by in vitro and in vivo functional assays, we 
generated additional procedures to accurately predict Salmonella cell numbers within 
multicellular aggregates. Our exhaustive development of a ratio of cell number to biofilm 
mass (Objective 6, presented in Chapter 4; Figure 4.3) allowed for us to accurately 
deliver equal quantities of cells from both subpopulations and enabled our fitness studies 
that compared these cell types in conditions of survival and infection. One issue we were 
faced with was to try to maintain the physical nature of the multicellular aggregates for 
these functional experiments, since previous studies had revealed that the extracellular 
matrix could impact gene expression (3). Initially, the adhesive nature of the extracellular 
matrix resulted in significant loss of cell aggregates that stuck to the surface of common 
laboratory tools such as pipette tips and microcentrifuge tubes. We observed that 
multicellular aggregates remain as individual, suspended  “units” during growth in the 
culture media. Therefore, we used conditioned media as a suspension reagent in our 
experiments. This simple strategy abrogated the adhesive nature of the biofilm matrix and 
facilitated our studies that demanded the accurate delivery of a desired amount of biofilm 
cells. Altogether, our efforts resulted in the development of procedures and tools that 
made it possible to study the Salmonella cell subpopulations formed due to bistable CsgD 
expression and can be used by other researchers to study bacterial biofilms 
 In our main RNA-seq experiment, we characterized the gene expression profile of 
Salmonella multicellular aggregates and planktonic cells. Under the same environmental 
conditions, these clonal cell types had differential expression of over 1856 genes. The 
largest difference in gene expression between these subpopulations coincided with peak 
expression of csgD and the formation of multicellular aggregates. Previous work had 
found that several genes corresponding to carbon central metabolism and the cell stress 
response were expressed during biofilm formation (3). Our transcriptome analysis with 
RNA-seq expanded this finding by identifying the increased expression of genes 
important for the metabolism of amino acids, lipids, and nucleotides. This result supports 
our previous hypothesis that a metabolic shift accompanies the process of biofilm 
formation (3). The planktonic cell subpopulation and the CsgD-OFF state had never 
previously been characterized in the literature. We found that planktonic cells had a 
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comparable number of genes with increased expression as the multicellular aggregates. 
However, the transcriptomic profile of planktonic cells was vastly different from 
multicellular aggregates, with significant expression of multiple virulence traits, 
including the SPI-1 type three secretion system. In the literature, the dogma was that 
expression of the SPI-1 type three secretion system was exclusively induced by the host 
environment, which is an important first step in Salmonella pathogenesis. As such, SPI-1 
expression in our experimental conditions was highly unexpected and required rigorous 
functional validation (Objectives 7 and 8, presented in Chapter 4). We confirmed that the 
proteins for the secretion apparatus and its effectors are synthesized under these atypical 
environmental conditions. Further, we showed that their synthesis provided a virulence 
advantage for planktonic cells compared to multicellular aggregates both in in vitro Caco-
2 invasion assays and during competitive infections in susceptible mice. An important 
question remains of how expression of the SPI-1 type three secretion system is induced in 
the planktonic cell subpopulation. We found that several of the transcriptional activators 
associated with SPI-1 were expressed in planktonic cells, indicating that this inducing 
signal likely occurs early in the regulatory pathway. The relative absence of SPI-1 
expression in multicellular aggregates may also provide an important clue for the 
molecular link between the persistence and virulence phenotypes. While it is tempting to 
speculate that there is a direct link between CsgD and SPI-1 expression, such a 
relationship has never before been described. It is plausible that the presence of the 
extracellular matrix may provide an important feedback signal that ultimately inhibits the 
expression of virulence factors such as the SPI-1 type three secretion system. Regulation 
between SPI-1 and biofilm formation may also be indirect in nature. Desai and colleagues 
recently demonstrated that SsrB, a transcriptional regulator encoded within SPI-2, can 
switch between promoting expression of the SPI-2 type three secretion system within the 
acidic macrophage vacuole and relieving H-NS silencing of csgD expression (10). 
Establishing the link between persistence and virulence is an important direction for the 
future of Salmonella biofilm research. 
 Our understanding of the Salmonella biofilm phenotype has historically been 
shaped by its characterization in the laboratory. The in vitro conditions that induced 
biofilm formation, together with the characteristics of the biofilm phenotype, suggested 
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that this physiology was important for the survival of Salmonella in non-host 
environments. An environmental setting likely presents many challenges to bacterial 
growth and replication, including nutrient limitation, extreme temperatures, pH 
fluctuations, UV and oxidative stress, and predation (11, 12). Therefore, the prevailing 
hypothesis was that Salmonella biofilm formation was an important mechanism for 
enhancing the persistence of cells in the non-host environment and improving the odds of 
their transmission to the next host (13). However, bistable CsgD expression and analysis 
of the cell subpopulations has shifted our perception of Salmonella biofilm formation and 
the process of pathogen transmission. What once was considered a population-level 
phenotype is now understood as a regulatory phenomenon mediated at the single cell 
level (14). Our research has uncovered an important, intimate link between the 
contrasting phenotypes of persistence and virulence. What is the purpose of this 
phenotypic heterogeneity in the life cycle of Salmonella? What is the advantage of 
expressing virulence factors in a non-host setting? Compared to the host niche, where the 
conditions of host-pathogen interactions are relatively defined, life in non-host 
environments and the process of transmission are unpredictable. Based on our 
characterization of the planktonic cell subpopulation, we have put forth the hypothesis 
that bistable CsgD expression is central to a bet-hedging strategy that improves the 
overall chances for Salmonella transmission. In a scenario where Salmonella immediately 
encounters the next host, planktonic cells would be readily able to instigate a new 
infection. In contrast, Salmonella biofilm cells would be prepared for extended exposure 
to the non-host environment prior to interactions with their next host. This unpredictable 
step in the Salmonella life cycle places equal selection pressure on virulence and 
persistence phenotypes. Through bistable CsgD expression, Salmonella cells can 
maintain the same genetic repertoire but simultaneously produce two disparate 
phenotypes. 
 Passage into non-host environments likely requires anticipatory genetic 
regulation, where Salmonella cells pre-emptively express the phenotype that is necessary 
for the next step in their life cycle. Thus, conditions within the gastrointestinal (GI) tract 
may also provide important cues for bistable CsgD expression. In the GI niche, 
Salmonella cells are exposed to host temperatures, low pH, high osmolarity, bile acids, 
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antimicrobial peptides, iron limitation, and in some cases, nutrient limitation (12, 15). 
Some of these conditions (i.e. temperature and osmolarity) may favour the expression of 
virulence factors such as the SPI-1 type three secretion system (15), while repressing 
Salmonella biofilm formation (1, 16). Conversely, exposure to stresses such as bile, 
antimicrobial peptides, iron limitation, or poor nutrient availability would promote csgD 
expression and the biofilm phenotype. Regulation of csgD expression and synthesis is 
incredibly complex, and few studies have attempted to understand the hierarchy of this 
regulation (1, 16-18). For example, iron limitation has been shown to over-ride the 
normal temperature shut-off of biofilm formation at 37˚C (1). It is possible that 
microenvironments within the intestinal niche provide strong activating signals required 
to generate the CsgD-ON state. In the lumen of the small intestine, high bile 
concentrations have been shown to increase the intracellular concentration of cyclic-di-
GMP in the enteropathogen Vibrio cholerae (reviewed in (12)). For Salmonella, high 
concentrations of c-di-GMP activate csgD expression and promote the biofilm phenotype 
(19). Similarly, Diard et al. recently demonstrated that expression of the SPI-1 type three 
secretion system is location-dependent within the intestine (20). Salmonella cells 
positioned at the surface of the intestinal epithelial layer were 100% positive for SPI-1 
type three secretion expression, while the majority of cells in the lumen were negative for 
this virulence trait. We predict that in anticipation of exit from the host, biofilm 
expression may also be induced by signals produced towards the end of host-pathogen 
interactions, including intestinal inflammation and the associated rapid replication of 
Salmonella within the lumen (21-24). The reactive oxygen species produced by 
neutrophils undoubtedly provides an important cue for activation of the bacterial cell 
stress response. Metabolic cues, such as the pathways involved with anaerobic respiration 
during this stage (i.e., ethanolamine and 1,2-propanediol) or the nutrient limitation caused 
by rapid Salmonella replication following inflammation, may also add a temporal 
element to the anticipatory regulation of Salmonella biofilm formation. Consistent with 
this, our transcriptomic analysis revealed that genes for the ethanolamine and 1,2-
propanediol metabolic pathways have increased expression within multicellular 
aggregates (9). 
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 Our ability to elucidate the in situ regulation of Salmonella biofilm formation is 
limited by the reality that Salmonella biofilms have yet to be observed in nature. 
However, the enteric bacteria Vibrio cholerae has been shown to exist both as planktonic 
cells and in multicellular aggregates in human stool samples (25, 26). Previously, White 
et al. investigated csgD expression and the biofilm phenotype during murine infection by 
using Salmonella with luciferase reporters fused to the biofilm-related gene promoters 
(13). They observed that csgD expression was activated within the mouse intestine during 
the course of infection, but that expression of curli biosynthesis genes (csgBAC) was only 
observed within fecal pellets that had passed out of the infected mice (13). Based on this 
result, they concluded that synthesis of the extracellular matrix occurs after passage from 
the host. However, work by Dylan Shivak as part of his M.Sc. thesis demonstrated that 
there is a limitation in the ability to detect of bacterial luciferase during the course of 
infection (8, 27). In his work, Shivak found that heavy bacterial loads were required for 
luciferase detection, despite expression from a strong constitutive promoter (8). If 
activation of extracellular matrix production were limited to only a subpopulation of 
Salmonella cells, signaling from the csgBAC promoter would not be detectable using 
bioluminescence as a marker. Work in our laboratory is currently underway to determine 
if curli fimbriae and multicellular aggregates can be observed during murine infections by 
using single cells detection techniques (i.e., tissue sectioning and confocal microscopy). 
 Our work with invasive nontyphoidal Salmonella strains from sub-Saharan Africa 
follows from the results of our RNA-seq experiment. As explained in the Literature 
Review chapter, invasive nontyphoidal Salmonella are a phylogenetically distinct group 
of nontyphoidal Salmonella that are responsible for invasive bloodstream infections (28, 
29). Like typhoidal serovars, strains of invasive nontyphoidal Salmonella induce a fever-
like illness and persist within the systemic compartment of infected individuals (30). At 
the current time, humans are the only identified reservoir for invasive strains of 
nontyphoidal Salmonella (31, 32). There is an established correlation that biofilm 
formation is highly conserved in nontyphoidal Salmonella serovars that can infect a broad 
host range and cause gastroenteritis in humans (33-36). In contrast, typhoidal Salmonella 
serovars associated with systemic infections and a restricted host range have lost the 
capacity for biofilm formation (33). At the time of our study, the biofilm phenotype of 
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invasive nontyphoidal Salmonella strains had never been determined. However, the 
significant mortality rate associated with invasive nontyphoidal Salmonella infections (an 
estimated 681 316 deaths annually) emphasized the need to better understand the 
transmission of invasive nontyphoidal Salmonella transmission. We hypothesized that 
what we learned about Salmonella biofilm formation could help us to understand more 
about the lifecycle of invasive nontyphoidal Salmonella. Based on their intimate 
association with the human host, we predicted that invasive nontyphoidal Salmonella 
strains would be negative for the biofilm phenotype.  
 We focused our evaluation of invasive nontyphoidal Salmonella on S. 
Typhimurium D23580 and S. Enteritidis D7795, two strains with recently completed 
genome sequences. These strains were compared to a panel of biofilm-positive, 
nontyphoidal strains and biofilm-negative, typhoidal Salmonella strains. Genome 
sequences from all panel strains were obtained from databases or were completed by us; 
we wondered if we would be able to demonstrate a consistent pattern of gene degradation 
in Salmonella biofilm formation that is shared between invasive nontyphoidal and 
typhoidal Salmonella strains. We know that host-adapted and host-restricted Salmonella 
strains, including Typhi and invasive nontyphoidal Salmonella, demonstrate a consistent 
pattern of genomic degradation (29, 37), where the genes associated with intestinal 
replication following inflammation are functionally inactive (24). These genes are 
functional in nontyphoidal Salmonella serovars associated with gastroenteritis and are 
thought to play an essential role in their transmission, allowing for an intestinal bloom 
and subsequent shedding of high bacterial loads from the host (38). Phenotypically, both 
invasive nontyphoidal strains were impaired in their biofilm-forming capacity; S. 
Enteritidis D7795 was negative in every assay, whereas S. Typhimurium D23580 had an 
intermediate phenotype (i.e., partial biofilm pattern on its colony surface, the slime-like 
texture of its multicellular aggregates, and the detection of trace amounts of curli fimbriae 
and cellulose polymers). Our observations with S. Typhimurium D23580 did not match 
the first published report stating that this strain was biofilm-negative (37). We assume 
that the differences in our results could reflect disparities in the strain histories and 
perhaps whether they had been passaged in vitro (i.e., our version was not). S. Enteritidis 
D7795 and all typhoidal Salmonella strains included in our strain panel were negative for 
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curli and cellulose biosynthesis, and the CsgD protein could not be detected. We 
identified an inactivating csgD promoter mutation in S. Enteritidis D7795, while strains 
of S. Typhi were mutated within the coding sequence for csgD. S. Typhimurium D23580 
also had two cis-acting mutations upstream of the csgD promoter, which correlated with a 
significant reduction in csgD transcriptional expression. However, CsgD protein levels 
could be detected in lysates obtained from this strain. We assume that the biofilm-
negative phenotype of S. Enteritidis D7795 can be fully explained by the csgD promoter 
mutation, whereas for S. Typhimurium D23580 the answer is more complex. Our 
preliminary genomic comparisons (which are incomplete and thus not reported in my 
thesis) identified a single nucleotide polymorphism in STM1987 (STM14_2408), which 
encodes an important cyclic-di-GMP producing enzyme that positively regulates biofilm 
formation. This polymorphism exists within the sensory domain of the STM1987 protein 
that is associated with activating the enzyme in response to sensing an unknown signal 
from the external environment. Genome engineering experiments are currently underway 
in the White laboratory to determine if these identified mutations in S. Enteritidis D7795 
and S. Typhimurium D23580 can be linked to the impairment in biofilm formation. Our 
study represents a thorough analysis of biofilm formation in two invasive nontyphoidal 
Salmonella strains and should form the benchmark for the future analysis of any 
additional invasive nontyphoidal strains. 
 My body of work has identified a new aspect of Salmonella biology that has 
important implications for understanding the transmission of this pathogen. Nontyphoidal 
Salmonella strains that briefly colonize the host and cause gastroenteritis must contend 
with survival in both the host and non-host environment. Bistable expression of csgD, 
biofilm formation, and specialized subpopulations of multicellular aggregates and 
planktonic cells represent an evolutionary adaptation for mitigating the unpredictable 
nature of transmission via the fecal-oral route. In contrast, invasive strains of 
nontyphoidal and typhoidal Salmonella have evolved to persist chronically within the 
systemic niche of the host. This feature of host adaptation relieves the selection pressure 
placed on Salmonella to persist within an environmental reservoir and correlates with loss 
of the biofilm phenotype. Identifying Salmonella reservoirs is crucial for developing 
effective public health efforts to reduce disease burden. Recent advancements in DNA 
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sequencing technology have vastly expanded the availability of pathogen genomic 
sequences, and have allowed unprecedented characterization of both classical and 
emerging Salmonella strains. Invasive nontyphoidal Salmonella strains are an example of 
how genome sequencing can be complemented by our understanding of Salmonella 
pathogenesis to develop a genetic signature for host adaptation and predict the nature of 
host-pathogen interactions. Similarly, we predict that our gene expression profile of 
Salmonella biofilm formation could be used to predict the transmission properties of 
Salmonella strains. Future research efforts should use our transcriptomic analysis as a 
guide to isolate the core genetic processes that govern biofilm formation. This core 
biofilm genetic signature would be an invaluable aid for predicting the nature of 
transmission of Salmonella strains associated with future outbreaks. 
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